[
  {
    "id": "r366f5T3",
    "URL": "https://arxiv.org/abs/2102.01521",
    "number": "2102.01521",
    "title": "Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through analysis of Viral Genomics and Structure",
    "issued": {
      "date-parts": [
        [
          2021,
          2,
          15
        ]
      ]
    },
    "author": [
      {
        "given": "Halie M.",
        "family": "Rando"
      },
      {
        "given": "Adam L.",
        "family": "MacLean"
      },
      {
        "given": "Alexandra J.",
        "family": "Lee"
      },
      {
        "given": "Sandipan",
        "family": "Ray"
      },
      {
        "given": "Vikas",
        "family": "Bansal"
      },
      {
        "given": "Ashwin N.",
        "family": "Skelly"
      },
      {
        "given": "Elizabeth",
        "family": "Sell"
      },
      {
        "given": "John J.",
        "family": "Dziak"
      },
      {
        "given": "Lamonica",
        "family": "Shinholster"
      },
      {
        "given": "Lucy D'Agostino",
        "family": "McGowan"
      },
      {
        "given": "Marouen Ben",
        "family": "Guebila"
      },
      {
        "given": "Nils",
        "family": "Wellhausen"
      },
      {
        "given": "Sergey",
        "family": "Knyazev"
      },
      {
        "given": "Simina M.",
        "family": "Boca"
      },
      {
        "given": "Stephen",
        "family": "Capone"
      },
      {
        "given": "Yanjun",
        "family": "Qi"
      },
      {
        "given": "YoSon",
        "family": "Park"
      },
      {
        "given": "Yuchen",
        "family": "Sun"
      },
      {
        "given": "David",
        "family": "Mai"
      },
      {
        "given": "Christian",
        "family": "Brueffer"
      },
      {
        "given": "James Brian",
        "family": "Byrd"
      },
      {
        "given": "Jinhui",
        "family": "Wang"
      },
      {
        "given": "Ronan",
        "family": "Lordan"
      },
      {
        "given": "Ryan",
        "family": "Velazquez"
      },
      {
        "given": "Gregory L",
        "family": "Szeto"
      },
      {
        "given": "John P.",
        "family": "Barton"
      },
      {
        "given": "Rishi Raj",
        "family": "Goel"
      },
      {
        "given": "Serghei",
        "family": "Mangul"
      },
      {
        "given": "Tiago",
        "family": "Lubiana"
      },
      {
        "given": "COVID-19 Review",
        "family": "Consortium"
      },
      {
        "given": "Anthony",
        "family": "Gitter"
      },
      {
        "given": "Casey S.",
        "family": "Greene"
      }
    ],
    "container-title": "arXiv",
    "publisher": "arXiv",
    "type": "report",
    "abstract": "  The novel coronavirus SARS-CoV-2, which emerged in late 2019, has since spread around the world infecting tens of millions of people with coronavirus disease 2019 (COVID-19). While this viral species was unknown prior to January 2020, its similarity to other coronaviruses that infect humans has allowed for rapid insight into the mechanisms that it uses to infect human hosts, as well as the ways in which the human immune system can respond. Here, we contextualize SARS-CoV-2 among other coronaviruses and identify what is known and what can be inferred about its behavior once inside a human host. Because the genomic content of coronaviruses, which specifies the virus's structure, is highly conserved, early genomic analysis provided a significant head start in predicting viral pathogenesis. The pathogenesis of the virus offers insights into symptomatology, transmission, and individual susceptibility. Additionally, prior research into interactions between the human immune system and coronaviruses has identified how these viruses can evade the immune system's protective mechanisms. We also explore systems-level research into the regulatory and proteomic effects of SARS-CoV-2 infection and the immune response. Understanding the structure and behavior of the virus serves to contextualize the many facets of the COVID-19 pandemic and can influence efforts to control the virus and treat the disease. ",
    "note": "license: http://creativecommons.org/licenses/by/4.0/\nThis CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: arxiv:2102.01521"
  },
  {
    "id": "rUTsIlZs",
    "type": "webpage",
    "title": "A Trial of Remdesivir in Adults With Mild and Moderate COVID-19 - Full Text View - ClinicalTrials.gov",
    "abstract": "A Trial of Remdesivir in Adults With Mild and Moderate COVID-19 - Full Text View.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04252664",
    "language": "en",
    "accessed": {
      "date-parts": [
        [
          "2021",
          2,
          8
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: clinicaltrials:NCT04252664\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: rUTsIlZs"
  },
  {
    "id": "JSoOOX98",
    "type": "report",
    "title": "A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Remdesivir in Hospitalized Adult Patients With Severe COVID-19.",
    "publisher": "clinicaltrials.gov",
    "genre": "Clinical trial registration",
    "source": "clinicaltrials.gov",
    "abstract": "In December 2019, Wuhan, in Hubei province, China, became the center of an outbreak of pneumonia of unknown cause. In a short time, Chinese scientists had shared the genome information of a novel coronavirus (SARS-CoV-2) from these pneumonia patients and developed a real-time reverse transcription PCR (real-time RT-PCR) diagnostic assay.\n\nGiven no specific antiviral therapy for COVID-19 and the ready availability of remdesvir as a potential antiviral agent, based on pre-clinical studies in SARS-CoV and MERS-CoV infections, this randomized, controlled, double blind trial will evaluate the efficacy and safety of remdesivir in patients hospitalized with severe COVID-19.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04257656",
    "note": "submitted: January 31, 2020\nThis CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: clinicaltrials:NCT04257656\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: JSoOOX98",
    "number": "NCT04257656",
    "shortTitle": "A Trial of Remdesivir in Adults With Severe COVID-19",
    "author": [
      {
        "family": "Cao",
        "given": "Bin"
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2020",
          4,
          13
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          2,
          6
        ]
      ]
    }
  },
  {
    "id": "1ATTPbCCO",
    "type": "report",
    "title": "A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults",
    "publisher": "clinicaltrials.gov",
    "genre": "Clinical trial registration",
    "source": "clinicaltrials.gov",
    "abstract": "This study is an adaptive, randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized adults diagnosed with COVID-19. The study is a multicenter trial that will be conducted in up to approximately 100 sites globally. The study will compare different investigational therapeutic agents to a control arm. There will be interim monitoring to introduce new arms and allow early stopping for futility, efficacy, or safety. If one therapy proves to be efficacious, then this treatment may become the control arm for comparison(s) with new experimental treatment(s). Any such change would be accompanied by an updated sample size. Because background standards of supportive care may evolve/improve over time as more is learned about successful management of COVID-19, comparisons of safety and efficacy will be based on data from concurrently randomized subjects. An independent Data and Safety Monitoring Board (DSMB) will actively monitor interim data to make recommendations about early study closure or changes to study arms. To evaluate the clinical efficacy, as assessed by time to recovery, of different investigational therapeutics as compared to the control arm.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04280705",
    "note": "submitted: February 20, 2020\nThis CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: clinicaltrials:NCT04280705\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 1ATTPbCCO",
    "number": "NCT04280705",
    "shortTitle": "Adaptive COVID-19 Treatment Trial (ACTT)",
    "author": [
      {
        "family": "National Institute of Allergy and Infectious Diseases (NIAID)",
        "given": ""
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2020",
          12,
          5
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          2,
          6
        ]
      ]
    }
  },
  {
    "id": "oso9r21L",
    "type": "report",
    "title": "A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate COVID-19 Compared to Standard of Care Treatment",
    "publisher": "clinicaltrials.gov",
    "genre": "Clinical trial registration",
    "source": "clinicaltrials.gov",
    "abstract": "The primary objective of this study was to evaluate the efficacy of 2 remdesivir (RDV) regimens compared to standard of care (SOC), with respect to clinical status assessed by a 7-point ordinal scale on Day 11.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04292730",
    "note": "submitted: February 28, 2020\nThis CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: clinicaltrials:NCT04292730\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: oso9r21L",
    "number": "NCT04292730",
    "shortTitle": "Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment",
    "author": [
      {
        "family": "Gilead Sciences",
        "given": ""
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2021",
          1,
          21
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          2,
          6
        ]
      ]
    }
  },
  {
    "id": "yTCAmOyt",
    "type": "report",
    "title": "A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe COVID-19",
    "publisher": "clinicaltrials.gov",
    "genre": "Clinical trial registration",
    "source": "clinicaltrials.gov",
    "abstract": "The primary objective of this study is to evaluate the efficacy of 2 remdesivir (RDV) regimens with respect to clinical status assessed by a 7-point ordinal scale on Day 14.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04292899",
    "note": "submitted: February 28, 2020\nThis CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: clinicaltrials:NCT04292899\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: yTCAmOyt",
    "number": "NCT04292899",
    "shortTitle": "Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)",
    "author": [
      {
        "family": "Gilead Sciences",
        "given": ""
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2020",
          12,
          15
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          2,
          6
        ]
      ]
    }
  },
  {
    "id": "3ccJAyrG",
    "type": "webpage",
    "title": "Losartan for Patients With COVID-19 Not Requiring Hospitalization - Full Text View - ClinicalTrials.gov",
    "abstract": "Losartan for Patients With COVID-19 Not Requiring Hospitalization - Full Text View.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04311177",
    "language": "en",
    "accessed": {
      "date-parts": [
        [
          "2021",
          2,
          8
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: clinicaltrials:NCT04311177\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 3ccJAyrG"
  },
  {
    "id": "NCb9Wq2z",
    "type": "webpage",
    "title": "Losartan for Patients With COVID-19 Requiring Hospitalization - Full Text View - ClinicalTrials.gov",
    "abstract": "Losartan for Patients With COVID-19 Requiring Hospitalization - Full Text View.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04312009",
    "language": "en",
    "accessed": {
      "date-parts": [
        [
          "2021",
          2,
          8
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: clinicaltrials:NCT04312009\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: NCb9Wq2z"
  },
  {
    "id": "JCMhG5r9",
    "type": "report",
    "title": "Baricitinib Combined With Antiviral Therapy in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study",
    "publisher": "clinicaltrials.gov",
    "genre": "Clinical trial registration",
    "source": "clinicaltrials.gov",
    "abstract": "There is no specific antiviral treatment recommended for COVID-19, and no vaccine is currently available. Baricitinib, an anti-Janus kinase inhibitor (anti-JAK) acting against JAK1 and JAK2. The drug was found capable to reduce or interrupt the passage of the virus into target cells, and to inhibit the JAK1- and JAK2-mediated cytokine release. The drug was licensed for the treatment of rheumatoid arthritis at the daily dose of 4 mg/orally, with excellent results in terms of clinical response and a good safety profile. Since baricitinib does not interact with antivirals due to its prevalent renal elimination, it may be used in combination.The evidence on the advantageous action of baricitinib on viral entry and cytokine outbreak constituted the rationale to perform a trial on patients with mild to moderate COVID-19 infection receiving baricitinib combined with antiviral therapy.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04320277",
    "note": "submitted: March 20, 2020\nThis CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: clinicaltrials:NCT04320277\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: JCMhG5r9",
    "number": "NCT04320277",
    "shortTitle": "Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.",
    "author": [
      {
        "family": "Cantini",
        "given": "Fabrizio"
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2020",
          4,
          19
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          2,
          6
        ]
      ]
    }
  },
  {
    "id": "SytvPCdR",
    "type": "report",
    "title": "A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia",
    "publisher": "clinicaltrials.gov",
    "genre": "Clinical trial registration",
    "source": "clinicaltrials.gov",
    "abstract": "This study will evaluate the efficacy, safety, pharmacodynamics, and pharmacokinetics of tocilizumab (TCZ) compared with a matching placebo in combination with standard of care (SOC) in hospitalized patients with severe COVID-19 pneumonia.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04320615",
    "note": "submitted: March 23, 2020\nThis CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: clinicaltrials:NCT04320615",
    "number": "NCT04320615",
    "shortTitle": "A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia",
    "author": [
      {
        "family": "Hoffmann-La Roche",
        "given": ""
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2021",
          6,
          28
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          8,
          11
        ]
      ]
    }
  },
  {
    "id": "amy3rDsj",
    "type": "webpage",
    "title": "Sarilumab COVID-19 - Full Text View - ClinicalTrials.gov",
    "abstract": "Sarilumab COVID-19 - Full Text View.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04327388",
    "language": "en",
    "accessed": {
      "date-parts": [
        [
          "2021",
          2,
          8
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: clinicaltrials:NCT04327388\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: amy3rDsj"
  },
  {
    "id": "5fkIarR7",
    "type": "report",
    "title": "The CORONAvirus Disease 2019 Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker InvestigatiON (CORONACION) Randomized Clinical Trial",
    "publisher": "clinicaltrials.gov",
    "genre": "Clinical trial registration",
    "source": "clinicaltrials.gov",
    "abstract": "Coronavirus disease 2019 (COVID-19) is a pandemic infection caused by a virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Because SARS-CoV-2 is known to require the angiotensin-converting enzyme 2 (ACE-2) receptor for uptake into the human body, there have been questions about whether medications that upregulate ACE-2 receptors might increase the risk of infection and subsequent complications. One such group of medications are anti-hypertensives that block the renin-angiotensin system, including both angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB). Both ACEi and ARB are widely used for the treatment of hypertension. Early reports from China and Italy suggest that many of those who die from COVID-19 have a coexisting history of hypertension. Consequently, there have been questions raised as to whether these 2 types of blood pressure medication might increase the risk of death among patients with COVID-19. However, it is well known that the prevalence of hypertension increases linearly with age. Therefore, it is possible that the high prevalence of hypertension and ACEi/ARB use among persons who die from COVID-19 is simply confounded by age (older people are at risk of both a history of hypertension and dying from COVID-19). Whether these commonly prescribed blood pressure medications increase the risk of COVID-19 or not remains unanswered. Statements from professional cardiology societies on both sides of the Atlantic have called for urgent research into this question. Our study aims to randomize patients with primary (essential) hypertension who are already taking ACEi/ARB to either switch to an alternative BP medication or continue with the ACEi/ARB that they have already been prescribed. Adults with compelling indications for ACEi/ARB will not be enrolled.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04330300",
    "note": "submitted: March 30, 2020\nThis CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: clinicaltrials:NCT04330300\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 5fkIarR7",
    "number": "NCT04330300",
    "shortTitle": "Coronavirus (COVID-19) ACEi/ARB Investigation",
    "author": [
      {
        "family": "McEvoy",
        "given": "Prof John William"
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2020",
          6,
          26
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          2,
          6
        ]
      ]
    }
  },
  {
    "id": "H0oEjZR8",
    "type": "webpage",
    "title": "Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019 - Full Text View - ClinicalTrials.gov",
    "abstract": "Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019 - Full Text View.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04338009",
    "language": "en",
    "accessed": {
      "date-parts": [
        [
          "2021",
          2,
          8
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: clinicaltrials:NCT04338009\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: H0oEjZR8"
  },
  {
    "id": "kuUcA1G9",
    "type": "webpage",
    "title": "Stopping ACE-inhibitors in COVID-19 - Full Text View - ClinicalTrials.gov",
    "abstract": "Stopping ACE-inhibitors in COVID-19 - Full Text View.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04353596",
    "language": "en",
    "accessed": {
      "date-parts": [
        [
          "2021",
          2,
          8
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: clinicaltrials:NCT04353596\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: kuUcA1G9"
  },
  {
    "id": "JP1lU6DV",
    "type": "report",
    "title": "Suspension of Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Hospitalized Patients With Coronavirus Infection (COVID-19). A Randomized Trial",
    "publisher": "clinicaltrials.gov",
    "genre": "Clinical trial registration",
    "source": "clinicaltrials.gov",
    "abstract": "Suspension of Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Hospitalized Patients With Coronavirus Infection.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04364893",
    "note": "submitted: April 7, 2020\nThis CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: clinicaltrials:NCT04364893",
    "number": "NCT04364893",
    "shortTitle": "Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19",
    "author": [
      {
        "family": "D'Or Institute for Research and Education",
        "given": ""
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2020",
          7,
          1
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          8,
          11
        ]
      ]
    }
  },
  {
    "id": "c7V9rAFR",
    "type": "webpage",
    "title": "Ramipril for the Treatment of COVID-19 - Full Text View - ClinicalTrials.gov",
    "abstract": "Ramipril for the Treatment of COVID-19 - Full Text View.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04366050",
    "language": "en",
    "accessed": {
      "date-parts": [
        [
          "2021",
          2,
          8
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: clinicaltrials:NCT04366050\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: c7V9rAFR"
  },
  {
    "id": "eUSZ6Jb5",
    "type": "report",
    "title": "A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia",
    "publisher": "clinicaltrials.gov",
    "genre": "Clinical trial registration",
    "source": "clinicaltrials.gov",
    "abstract": "This study (EMPACTA) will a) evaluate the efficacy and safety of tocilizumab (TCZ) compared with a placebo in combination with standard of care (SOC) in hospitalized participants with COVID-19 pneumonia, and b) include an optional long-term extension for eligible participants to explore the long-term sequelae of resolved COVID-19 pneumonia.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04372186",
    "note": "submitted: April 29, 2020\nThis CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: clinicaltrials:NCT04372186",
    "number": "NCT04372186",
    "shortTitle": "A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia",
    "author": [
      {
        "family": "Genentech, Inc.",
        "given": ""
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2021",
          7,
          13
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          8,
          11
        ]
      ]
    }
  },
  {
    "id": "5GxCGzrT",
    "type": "report",
    "title": "A Randomised Double-blind Placebo-controlled Trial to Determine the Safety and Efficacy of Inhaled SNG001 (IFN-β1a for Nebulisation) for the Treatment of Patients With Confirmed SARS-CoV-2 Infection",
    "publisher": "clinicaltrials.gov",
    "genre": "Clinical trial registration",
    "source": "clinicaltrials.gov",
    "abstract": "SNG001 is an inhaled drug that contains a antiviral protein called interferon beta (IFN-β). IFN-β in produced in the lungs during viral lung infections. It has been shown that older people and people with some chronic diseases have an IFN-β deficiency. Many viruses inhibit IFN-β as part of their strategy to evade the immune system.\n\nAddition of IFN-β in vitro protects lung cells from viral infection. IFN-β protects cells against the MERS and SARS coronaviruses (close relatives of SARS-CoV-2, the virus that causes COVID-19).\n\nSNG001 is an inhaled formulation of interferon beta-1a it is currently in Phase II clinical trials for COPD patients.\n\nSynairgen has conducted randomised placebo controlled clinical trials of SNG001 involving >200 asthma and COPD patients. These trials have shown that SNG001 has:\n\nbeen well tolerated during virus infections\nenhanced antiviral activity in the lungs (measured in sputum and blood samples)\nprovided significant lung function benefit over placebo in asthma in two Phase II trials.\n\nSynairgen believes SNG001 could help prevent worsening or accelerate recovery of severe lower respiratory tract illness in COVID-19 patients.\n\nPatients who are in hospital or non-hospitalised but are a high risk groups (e.g. elderly or diabetics) will be invited to take part in the trial. The patient would receive either SNG001 or placebo once daily for 14 days. The severity of the patients condition would be recorded on a scale developed by the World Health Organisation and the patient would be asked questions about their breathlessness, cough and sputum every day, as well as assess their general medical condition and safety.\n\nThe study will start as a Pilot phase where 100 patients will be randomised in the hospital setting and a 120 patients randomised in the home setting.\n\nOnce each of the Pilot phases are complete, a Pivotal phase will be conducted. It is estimated that the size of each of the Pivotal phases (hospital and home) will be around 100 to 300 patients per arm. The actual number will be determined after the data review at the end of each of the Pilot phases.\n\nIf SNG001 proves to be beneficial it would be a major breakthrough for the treatment of COVID-19.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04385095",
    "note": "submitted: April 24, 2020\nThis CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: clinicaltrials:NCT04385095",
    "number": "NCT04385095",
    "shortTitle": "Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection",
    "author": [
      {
        "family": "Synairgen Research Ltd.",
        "given": ""
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2021",
          3,
          19
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          8,
          11
        ]
      ]
    }
  },
  {
    "id": "TBjYbLjT",
    "type": "report",
    "title": "A Phase III, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Patients With Severe COVID-19 Pneumonia",
    "publisher": "clinicaltrials.gov",
    "genre": "Clinical trial registration",
    "source": "clinicaltrials.gov",
    "abstract": "This study will evaluate the efficacy and safety of combination therapy with remdesivir plus tocilizumab compared with remdesivir plus placebo in hospitalized patients with COVID-19 pneumonia.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04409262",
    "note": "submitted: May 28, 2020\nThis CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: clinicaltrials:NCT04409262",
    "number": "NCT04409262",
    "shortTitle": "A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia",
    "author": [
      {
        "family": "Hoffmann-La Roche",
        "given": ""
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2021",
          3,
          9
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          8,
          11
        ]
      ]
    }
  },
  {
    "id": "4IdGvvyC",
    "type": "report",
    "title": "A Randomized, Placebo-Controlled, Double-Blind, Sponsor Unblinded, Single Ascending Dose, Phase 1 First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous LY3819253 in Participants Hospitalized for COVID-19",
    "publisher": "clinicaltrials.gov",
    "genre": "Clinical trial registration",
    "source": "clinicaltrials.gov",
    "abstract": "The purpose of this study is to test the safety and tolerability of LY3819253 when it is given by injection into a vein to participants hospitalized with COVID-19. Blood tests will be done to check how much LY3819253 is in the bloodstream and how long the body takes to eliminate it. Participation could last about 8 weeks and may include up to 15 visits in the hospital or the home.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04411628",
    "note": "submitted: May 29, 2020\nThis CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: clinicaltrials:NCT04411628",
    "number": "NCT04411628",
    "shortTitle": "A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19",
    "author": [
      {
        "family": "Eli Lilly and Company",
        "given": ""
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2020",
          10,
          29
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          8,
          11
        ]
      ]
    }
  },
  {
    "id": "1stdSBxx",
    "type": "report",
    "title": "A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Patients With COVID-19",
    "publisher": "clinicaltrials.gov",
    "genre": "Clinical trial registration",
    "source": "clinicaltrials.gov",
    "abstract": "Phase 1\n\nTo evaluate the safety and tolerability of REGN10933+REGN10987 compared to placebo\nTo evaluate the virologic efficacy of REGN10933+REGN10987 compared to placebo in reducing viral load of SARS-CoV-2\n\nPhase 2\n\n• To evaluate the virologic efficacy of REGN10933+REGN10987 compared to placebo in reducing viral load of SARS-CoV-2\n\nPhase 3\n\nCohort 1 (≥18 Years Old, Not Pregnant at Randomization)\n\n• To evaluate the clinical efficacy of REGN10933+REGN10987 compared to placebo as measured by COVID-19-related hospitalizations or all-cause death\n\nCohort 2 (<18 Years Old, Not Pregnant at Randomization)\n\nTo evaluate the safety and tolerability of REGN10933+REGN10987 compared to placebo\nTo further characterize the concentrations of REGN10933 and REGN10987 in serum over time\nCohort 3 (Pregnant at Randomization) • To evaluate the safety and tolerability of REGN10933+REGN10987",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04425629",
    "note": "submitted: June 8, 2020\nThis CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: clinicaltrials:NCT04425629",
    "number": "NCT04425629",
    "shortTitle": "Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19",
    "author": [
      {
        "family": "Regeneron Pharmaceuticals",
        "given": ""
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2021",
          5,
          19
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          8,
          11
        ]
      ]
    }
  },
  {
    "id": "Tn0PkRlx",
    "type": "report",
    "title": "A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Hospitalized Patients With COVID-19",
    "publisher": "clinicaltrials.gov",
    "genre": "Clinical trial registration",
    "source": "clinicaltrials.gov",
    "abstract": "The primary objectives are:\n\nPhase 1/2 (Cohort 1)\n\nTo exclude futility of REGN10933+REGN10987 compared to placebo, as measured by death or mechanical ventilation\nTo evaluate the safety and tolerability of REGN10933+REGN10987 compared to placebo Phase 2 (Cohort 1A)\nTo evaluate the clinical efficacy of REGN10933+REGN10987 compared to placebo, as measured by death or mechanical ventilation\nTo evaluate the safety and tolerability of REGN10933+REGN10987 compared to placebo Phase 3 (Cohort 1 and Cohort 1A)\nTo evaluate the clinical efficacy of REGN10933+REGN10987 compared to placebo, as measured by death or mechanical ventilation",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04426695",
    "note": "submitted: June 8, 2020\nThis CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: clinicaltrials:NCT04426695",
    "number": "NCT04426695",
    "shortTitle": "Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19",
    "author": [
      {
        "family": "Regeneron Pharmaceuticals",
        "given": ""
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2021",
          5,
          11
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          8,
          11
        ]
      ]
    }
  },
  {
    "id": "f6m2SeLi",
    "type": "report",
    "title": "A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness",
    "publisher": "clinicaltrials.gov",
    "genre": "Clinical trial registration",
    "source": "clinicaltrials.gov",
    "abstract": "The purpose of this study is to measure how well LY3819253 and LY3832479 work against the virus that causes COVID-19. LY3819253 and LY3832479 will be given to participants with early symptoms of COVID-19. Samples will be taken from the back of the nose to determine how much virus is in the body at various times during the study. Participation could last about 12 weeks and includes one required visit to the study site, with the remainder of assessments performed in the home or by phone.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04427501",
    "note": "submitted: June 9, 2020\nThis CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: clinicaltrials:NCT04427501",
    "number": "NCT04427501",
    "shortTitle": "A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness",
    "author": [
      {
        "family": "Eli Lilly and Company",
        "given": ""
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2021",
          8,
          6
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          8,
          11
        ]
      ]
    }
  },
  {
    "id": "coZGelVr",
    "type": "report",
    "title": "A Phase 1, Randomized, Placebo-Controlled Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Immunogenicity of LY3832479 Given as a Single Intravenous Dose in Healthy Participants",
    "publisher": "clinicaltrials.gov",
    "genre": "Clinical trial registration",
    "source": "clinicaltrials.gov",
    "abstract": "The main purpose of this study is to learn more about the safety of LY3832479 and any side effects that might be associated with it. Blood tests will be done to measure how much LY3832479 is in the bloodstream and how long it takes the body to eliminate it. Participation could last up to 16 weeks and may include up to 10 visits to the study center.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04441931",
    "note": "submitted: June 19, 2020\nThis CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: clinicaltrials:NCT04441931",
    "number": "NCT04441931",
    "shortTitle": "A Study of LY3832479 (LY-CoV016) in Healthy Participants",
    "author": [
      {
        "family": "Eli Lilly and Company",
        "given": ""
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2020",
          10,
          7
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          8,
          11
        ]
      ]
    }
  },
  {
    "id": "K13XqU1J",
    "type": "report",
    "title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety and Efficacy of SPI-1005 in Severe COVID-19 Patients",
    "publisher": "clinicaltrials.gov",
    "genre": "Clinical trial registration",
    "source": "clinicaltrials.gov",
    "abstract": "The study is a randomized, double-blind, placebo-controlled, dose escalation, multi-center clinical trial (RCT) of SPI-1005 in adult subjects with positive PCR test for novel SARS-CoV-2 (nCoV2) and severe symptoms of COVID-19 disease.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04483973",
    "note": "submitted: July 13, 2020\nThis CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: clinicaltrials:NCT04483973",
    "number": "NCT04483973",
    "shortTitle": "SPI-1005 Treatment in Severe COVID-19 Patients",
    "author": [
      {
        "family": "Sound Pharmaceuticals, Incorporated",
        "given": ""
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2021",
          6,
          14
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          8,
          11
        ]
      ]
    }
  },
  {
    "id": "cUTgHTRj",
    "type": "report",
    "title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety and Efficacy of SPI-1005 in Moderate COVID-19 Patients",
    "publisher": "clinicaltrials.gov",
    "genre": "Clinical trial registration",
    "source": "clinicaltrials.gov",
    "abstract": "The study is a randomized, double-blind, placebo-controlled, dose escalation, multi-center clinical trial (RCT) of SPI-1005 in adult subjects with positive PCR test for novel SARS-CoV-2 (nCoV2) and moderate symptoms of COVID-19 disease.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04484025",
    "note": "submitted: July 13, 2020\nThis CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: clinicaltrials:NCT04484025",
    "number": "NCT04484025",
    "shortTitle": "SPI-1005 Treatment in Moderate COVID-19 Patients",
    "author": [
      {
        "family": "Sound Pharmaceuticals, Incorporated",
        "given": ""
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2021",
          6,
          14
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          8,
          11
        ]
      ]
    }
  },
  {
    "id": "17so9kzfj",
    "type": "report",
    "title": "A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults (ACTT-3)",
    "publisher": "clinicaltrials.gov",
    "genre": "Clinical trial registration",
    "source": "clinicaltrials.gov",
    "abstract": "ACTT-3 will evaluate the combination of interferon beta-1a and remdesivir compared to remdesivir alone. Subjects will be assessed daily while hospitalized. If the subjects are discharged from the hospital, they will have a study visit at Days 15, 22, and 29. For discharged subjects, it is preferred that the Day 15 and 29 visits are in person to obtain safety laboratory tests and oropharyngeal (OP) swab and blood (serum only) samples for secondary research as well as clinical outcome data. However, infection control or other restrictions may limit the ability of the subject to return to the clinic. In this case, these visits may be conducted by phone, and only clinical data will be obtained. The Day 22 visit does not have laboratory tests or collection of samples and is conducted by phone. The primary outcome is time to recovery by Day 29.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04492475",
    "note": "submitted: July 28, 2020\nThis CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: clinicaltrials:NCT04492475",
    "number": "NCT04492475",
    "shortTitle": "Adaptive COVID-19 Treatment Trial 3 (ACTT-3)",
    "author": [
      {
        "family": "National Institute of Allergy and Infectious Diseases (NIAID)",
        "given": ""
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2021",
          2,
          4
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          8,
          11
        ]
      ]
    }
  },
  {
    "type": "article-journal",
    "id": "bSNVCQbh",
    "author": [
      {
        "family": "Cohen",
        "given": "Abraham"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1960,
          10,
          15
        ]
      ]
    },
    "container-title": "JAMA",
    "DOI": "10.1001/jama.1960.03030070009002",
    "volume": "174",
    "issue": "7",
    "page": "831",
    "publisher": "American Medical Association (AMA)",
    "title": "Treatment of Rheumatoid Arthritis with Dexamethasone",
    "URL": "https://doi.org/csfmhc",
    "PMID": "13694317",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1001/jama.1960.03030070009002\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: bSNVCQbh"
  },
  {
    "type": "article-journal",
    "id": "B2urVDo5",
    "author": [
      {
        "family": "Ranieri",
        "given": "V. Marco"
      },
      {
        "family": "Pettilä",
        "given": "Ville"
      },
      {
        "family": "Karvonen",
        "given": "Matti K."
      },
      {
        "family": "Jalkanen",
        "given": "Juho"
      },
      {
        "family": "Nightingale",
        "given": "Peter"
      },
      {
        "family": "Brealey",
        "given": "David"
      },
      {
        "family": "Mancebo",
        "given": "Jordi"
      },
      {
        "family": "Ferrer",
        "given": "Ricard"
      },
      {
        "family": "Mercat",
        "given": "Alain"
      },
      {
        "family": "Patroniti",
        "given": "Nicolò"
      },
      {
        "family": "Quintel",
        "given": "Michael"
      },
      {
        "family": "Vincent",
        "given": "Jean-Louis"
      },
      {
        "family": "Okkonen",
        "given": "Marjatta"
      },
      {
        "family": "Meziani",
        "given": "Ferhat"
      },
      {
        "family": "Bellani",
        "given": "Giacomo"
      },
      {
        "family": "MacCallum",
        "given": "Niall"
      },
      {
        "family": "Creteur",
        "given": "Jacques"
      },
      {
        "family": "Kluge",
        "given": "Stefan"
      },
      {
        "family": "Artigas-Raventos",
        "given": "Antonio"
      },
      {
        "family": "Maksimow",
        "given": "Mikael"
      },
      {
        "family": "Piippo",
        "given": "Ilse"
      },
      {
        "family": "Elima",
        "given": "Kati"
      },
      {
        "family": "Jalkanen",
        "given": "Sirpa"
      },
      {
        "family": "Jalkanen",
        "given": "Markku"
      },
      {
        "family": "Bellingan",
        "given": "Geoff"
      },
      {
        "literal": "for the INTEREST Study Group"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          25
        ]
      ]
    },
    "container-title": "JAMA",
    "DOI": "10.1001/jama.2019.22525",
    "volume": "323",
    "issue": "8",
    "page": "725",
    "publisher": "American Medical Association (AMA)",
    "title": "Effect of Intravenous Interferon β-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome",
    "URL": "https://doi.org/ghzkww",
    "PMID": "32065831",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1001/jama.2019.22525"
  },
  {
    "type": "article-journal",
    "id": "82XnTbtX",
    "author": [
      {
        "family": "Klompas",
        "given": "Michael"
      },
      {
        "family": "Baker",
        "given": "Meghan A."
      },
      {
        "family": "Rhee",
        "given": "Chanu"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          8,
          4
        ]
      ]
    },
    "container-title": "JAMA",
    "DOI": "10.1001/jama.2020.12458",
    "volume": "324",
    "issue": "5",
    "page": "441",
    "publisher": "American Medical Association (AMA)",
    "title": "Airborne Transmission of SARS-CoV-2",
    "URL": "https://doi.org/gg4ttq",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1001/jama.2020.12458\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 82XnTbtX"
  },
  {
    "type": "article-journal",
    "id": "6NLZTSS0",
    "author": [
      {
        "family": "Spinner",
        "given": "Christoph D."
      },
      {
        "family": "Gottlieb",
        "given": "Robert L."
      },
      {
        "family": "Criner",
        "given": "Gerard J."
      },
      {
        "family": "Arribas López",
        "given": "José Ramón"
      },
      {
        "family": "Cattelan",
        "given": "Anna Maria"
      },
      {
        "family": "Soriano Viladomiu",
        "given": "Alex"
      },
      {
        "family": "Ogbuagu",
        "given": "Onyema"
      },
      {
        "family": "Malhotra",
        "given": "Prashant"
      },
      {
        "family": "Mullane",
        "given": "Kathleen M."
      },
      {
        "family": "Castagna",
        "given": "Antonella"
      },
      {
        "family": "Chai",
        "given": "Louis Yi Ann"
      },
      {
        "family": "Roestenberg",
        "given": "Meta"
      },
      {
        "family": "Tsang",
        "given": "Owen Tak Yin"
      },
      {
        "family": "Bernasconi",
        "given": "Enos"
      },
      {
        "family": "Le Turnier",
        "given": "Paul"
      },
      {
        "family": "Chang",
        "given": "Shan-Chwen"
      },
      {
        "family": "SenGupta",
        "given": "Devi"
      },
      {
        "family": "Hyland",
        "given": "Robert H."
      },
      {
        "family": "Osinusi",
        "given": "Anu O."
      },
      {
        "family": "Cao",
        "given": "Huyen"
      },
      {
        "family": "Blair",
        "given": "Christiana"
      },
      {
        "family": "Wang",
        "given": "Hongyuan"
      },
      {
        "family": "Gaggar",
        "given": "Anuj"
      },
      {
        "family": "Brainard",
        "given": "Diana M."
      },
      {
        "family": "McPhail",
        "given": "Mark J."
      },
      {
        "family": "Bhagani",
        "given": "Sanjay"
      },
      {
        "family": "Ahn",
        "given": "Mi Young"
      },
      {
        "family": "Sanyal",
        "given": "Arun J."
      },
      {
        "family": "Huhn",
        "given": "Gregory"
      },
      {
        "family": "Marty",
        "given": "Francisco M."
      },
      {
        "literal": "for the GS-US-540-5774 Investigators"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          9,
          15
        ]
      ]
    },
    "container-title": "JAMA",
    "DOI": "10.1001/jama.2020.16349",
    "volume": "324",
    "issue": "11",
    "page": "1048",
    "publisher": "American Medical Association (AMA)",
    "title": "Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19",
    "URL": "https://doi.org/ghhz6g",
    "PMCID": "PMC7442954",
    "PMID": "32821939",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1001/jama.2020.16349\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 6NLZTSS0"
  },
  {
    "type": "article-journal",
    "id": "QgKZfGgK",
    "author": [
      {
        "family": "Prescott",
        "given": "Hallie C."
      },
      {
        "family": "Rice",
        "given": "Todd W."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          10,
          6
        ]
      ]
    },
    "container-title": "JAMA",
    "DOI": "10.1001/jama.2020.16747",
    "volume": "324",
    "issue": "13",
    "page": "1292",
    "publisher": "American Medical Association (AMA)",
    "title": "Corticosteroids in COVID-19 ARDS",
    "URL": "https://doi.org/gg9wsv",
    "PMID": "32876693",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1001/jama.2020.16747"
  },
  {
    "type": "article-journal",
    "id": "jy4vKMhj",
    "author": [
      {
        "family": "Lenze",
        "given": "Eric J."
      },
      {
        "family": "Mattar",
        "given": "Caline"
      },
      {
        "family": "Zorumski",
        "given": "Charles F."
      },
      {
        "family": "Stevens",
        "given": "Angela"
      },
      {
        "family": "Schweiger",
        "given": "Julie"
      },
      {
        "family": "Nicol",
        "given": "Ginger E."
      },
      {
        "family": "Miller",
        "given": "J. Philip"
      },
      {
        "family": "Yang",
        "given": "Lei"
      },
      {
        "family": "Yingling",
        "given": "Michael"
      },
      {
        "family": "Avidan",
        "given": "Michael S."
      },
      {
        "family": "Reiersen",
        "given": "Angela M."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          12,
          8
        ]
      ]
    },
    "container-title": "JAMA",
    "DOI": "10.1001/jama.2020.22760",
    "volume": "324",
    "issue": "22",
    "page": "2292",
    "publisher": "American Medical Association (AMA)",
    "title": "Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19",
    "URL": "https://doi.org/ghjtd5",
    "PMCID": "PMC7662481",
    "PMID": "33180097",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1001/jama.2020.22760"
  },
  {
    "type": "article-journal",
    "id": "1DqZPaCtf",
    "author": [
      {
        "family": "Lopes",
        "given": "Renato D."
      },
      {
        "family": "Macedo",
        "given": "Ariane V. S."
      },
      {
        "family": "de Barros E Silva",
        "given": "Pedro G. M."
      },
      {
        "family": "Moll-Bernardes",
        "given": "Renata J."
      },
      {
        "family": "dos Santos",
        "given": "Tiago M."
      },
      {
        "family": "Mazza",
        "given": "Lilian"
      },
      {
        "family": "Feldman",
        "given": "André"
      },
      {
        "family": "D’Andréa Saba Arruda",
        "given": "Guilherme"
      },
      {
        "family": "de Albuquerque",
        "given": "Denílson C."
      },
      {
        "family": "Camiletti",
        "given": "Angelina S."
      },
      {
        "family": "de Sousa",
        "given": "Andréa S."
      },
      {
        "family": "de Paula",
        "given": "Thiago C."
      },
      {
        "family": "Giusti",
        "given": "Karla G. D."
      },
      {
        "family": "Domiciano",
        "given": "Rafael A. M."
      },
      {
        "family": "Noya-Rabelo",
        "given": "Márcia M."
      },
      {
        "family": "Hamilton",
        "given": "Alan M."
      },
      {
        "family": "Loures",
        "given": "Vitor A."
      },
      {
        "family": "Dionísio",
        "given": "Rodrigo M."
      },
      {
        "family": "Furquim",
        "given": "Thyago A. B."
      },
      {
        "family": "De Luca",
        "given": "Fábio A."
      },
      {
        "family": "dos Santos Sousa",
        "given": "Ítalo B."
      },
      {
        "family": "Bandeira",
        "given": "Bruno S."
      },
      {
        "family": "Zukowski",
        "given": "Cleverson N."
      },
      {
        "family": "de Oliveira",
        "given": "Ricardo G. G."
      },
      {
        "family": "Ribeiro",
        "given": "Noara B."
      },
      {
        "family": "de Moraes",
        "given": "Jeffer L."
      },
      {
        "family": "Petriz",
        "given": "João L. F."
      },
      {
        "family": "Pimentel",
        "given": "Adriana M."
      },
      {
        "family": "Miranda",
        "given": "Jacqueline S."
      },
      {
        "family": "de Jesus Abufaiad",
        "given": "Bárbara E."
      },
      {
        "family": "Gibson",
        "given": "C. Michael"
      },
      {
        "family": "Granger",
        "given": "Christopher B."
      },
      {
        "family": "Alexander",
        "given": "John H."
      },
      {
        "family": "de Souza",
        "given": "Olga F."
      },
      {
        "literal": "BRACE CORONA Investigators"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          1,
          19
        ]
      ]
    },
    "container-title": "JAMA",
    "DOI": "10.1001/jama.2020.25864",
    "volume": "325",
    "issue": "3",
    "page": "254",
    "publisher": "American Medical Association (AMA)",
    "title": "Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19",
    "URL": "https://doi.org/gh2tw5",
    "PMCID": "PMC7816106",
    "PMID": "33464336",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1001/jama.2020.25864"
  },
  {
    "type": "article-journal",
    "id": "vr7AH83b",
    "author": [
      {
        "family": "Wang",
        "given": "Wenling"
      },
      {
        "family": "Xu",
        "given": "Yanli"
      },
      {
        "family": "Gao",
        "given": "Ruqin"
      },
      {
        "family": "Lu",
        "given": "Roujian"
      },
      {
        "family": "Han",
        "given": "Kai"
      },
      {
        "family": "Wu",
        "given": "Guizhen"
      },
      {
        "family": "Tan",
        "given": "Wenjie"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          11
        ]
      ]
    },
    "container-title": "JAMA",
    "DOI": "10.1001/jama.2020.3786",
    "publisher": "American Medical Association (AMA)",
    "title": "Detection of SARS-CoV-2 in Different Types of Clinical Specimens",
    "URL": "https://doi.org/ggpp6h",
    "PMCID": "PMC7066521",
    "PMID": "32159775",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1001/jama.2020.3786\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: vr7AH83b"
  },
  {
    "type": "article-journal",
    "id": "JPUZjTnq",
    "author": [
      {
        "family": "Roback",
        "given": "John D."
      },
      {
        "family": "Guarner",
        "given": "Jeannette"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4,
          28
        ]
      ]
    },
    "container-title": "JAMA",
    "DOI": "10.1001/jama.2020.4940",
    "volume": "323",
    "issue": "16",
    "page": "1561",
    "publisher": "American Medical Association (AMA)",
    "title": "Convalescent Plasma to Treat COVID-19",
    "URL": "https://doi.org/ggqf6k",
    "PMID": "32219429",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1001/jama.2020.4940"
  },
  {
    "type": "article-journal",
    "id": "Gwct8aFG",
    "author": [
      {
        "family": "Gottlieb",
        "given": "Robert L."
      },
      {
        "family": "Nirula",
        "given": "Ajay"
      },
      {
        "family": "Chen",
        "given": "Peter"
      },
      {
        "family": "Boscia",
        "given": "Joseph"
      },
      {
        "family": "Heller",
        "given": "Barry"
      },
      {
        "family": "Morris",
        "given": "Jason"
      },
      {
        "family": "Huhn",
        "given": "Gregory"
      },
      {
        "family": "Cardona",
        "given": "Jose"
      },
      {
        "family": "Mocherla",
        "given": "Bharat"
      },
      {
        "family": "Stosor",
        "given": "Valentina"
      },
      {
        "family": "Shawa",
        "given": "Imad"
      },
      {
        "family": "Kumar",
        "given": "Princy"
      },
      {
        "family": "Adams",
        "given": "Andrew C."
      },
      {
        "family": "Van Naarden",
        "given": "Jacob"
      },
      {
        "family": "Custer",
        "given": "Kenneth L."
      },
      {
        "family": "Durante",
        "given": "Michael"
      },
      {
        "family": "Oakley",
        "given": "Gerard"
      },
      {
        "family": "Schade",
        "given": "Andrew E."
      },
      {
        "family": "Holzer",
        "given": "Timothy R."
      },
      {
        "family": "Ebert",
        "given": "Philip J."
      },
      {
        "family": "Higgs",
        "given": "Richard E."
      },
      {
        "family": "Kallewaard",
        "given": "Nicole L."
      },
      {
        "family": "Sabo",
        "given": "Janelle"
      },
      {
        "family": "Patel",
        "given": "Dipak R."
      },
      {
        "family": "Klekotka",
        "given": "Paul"
      },
      {
        "family": "Shen",
        "given": "Lei"
      },
      {
        "family": "Skovronsky",
        "given": "Daniel M."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          2,
          16
        ]
      ]
    },
    "container-title": "JAMA",
    "DOI": "10.1001/jama.2021.0202",
    "volume": "325",
    "issue": "7",
    "page": "632",
    "publisher": "American Medical Association (AMA)",
    "title": "Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19",
    "URL": "https://doi.org/ghvnrr",
    "PMCID": "PMC7821080",
    "PMID": "33475701",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1001/jama.2021.0202"
  },
  {
    "type": "article-journal",
    "id": "EuYDqR7q",
    "author": [
      {
        "family": "Janiaud",
        "given": "Perrine"
      },
      {
        "family": "Axfors",
        "given": "Cathrine"
      },
      {
        "family": "Schmitt",
        "given": "Andreas M."
      },
      {
        "family": "Gloy",
        "given": "Viktoria"
      },
      {
        "family": "Ebrahimi",
        "given": "Fahim"
      },
      {
        "family": "Hepprich",
        "given": "Matthias"
      },
      {
        "family": "Smith",
        "given": "Emily R."
      },
      {
        "family": "Haber",
        "given": "Noah A."
      },
      {
        "family": "Khanna",
        "given": "Nina"
      },
      {
        "family": "Moher",
        "given": "David"
      },
      {
        "family": "Goodman",
        "given": "Steven N."
      },
      {
        "family": "Ioannidis",
        "given": "John P. A."
      },
      {
        "family": "Hemkens",
        "given": "Lars G."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          3,
          23
        ]
      ]
    },
    "container-title": "JAMA",
    "DOI": "10.1001/jama.2021.2747",
    "volume": "325",
    "issue": "12",
    "page": "1185",
    "publisher": "American Medical Association (AMA)",
    "title": "Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19",
    "URL": "https://doi.org/gjjk4j",
    "PMCID": "PMC7911095",
    "PMID": "33635310",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1001/jama.2021.2747"
  },
  {
    "type": "article-journal",
    "id": "1EZ5IFkua",
    "author": [
      {
        "family": "Thompson",
        "given": "Alison E."
      },
      {
        "family": "Ranard",
        "given": "Benjamin L."
      },
      {
        "family": "Wei",
        "given": "Ying"
      },
      {
        "family": "Jelic",
        "given": "Sanja"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          11,
          1
        ]
      ]
    },
    "container-title": "JAMA Internal Medicine",
    "DOI": "10.1001/jamainternmed.2020.3030",
    "volume": "180",
    "issue": "11",
    "page": "1537",
    "publisher": "American Medical Association (AMA)",
    "title": "Prone Positioning in Awake, Nonintubated Patients With COVID-19 Hypoxemic Respiratory Failure",
    "URL": "https://doi.org/gg2pq4",
    "PMCID": "PMC7301298",
    "PMID": "32584946",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1001/jamainternmed.2020.3030"
  },
  {
    "type": "article-journal",
    "id": "oaqFxV4W",
    "author": [
      {
        "family": "Abella",
        "given": "Benjamin S."
      },
      {
        "family": "Jolkovsky",
        "given": "Eliana L."
      },
      {
        "family": "Biney",
        "given": "Barbara T."
      },
      {
        "family": "Uspal",
        "given": "Julie E."
      },
      {
        "family": "Hyman",
        "given": "Matthew C."
      },
      {
        "family": "Frank",
        "given": "Ian"
      },
      {
        "family": "Hensley",
        "given": "Scott E."
      },
      {
        "family": "Gill",
        "given": "Saar"
      },
      {
        "family": "Vogl",
        "given": "Dan T."
      },
      {
        "family": "Maillard",
        "given": "Ivan"
      },
      {
        "family": "Babushok",
        "given": "Daria V."
      },
      {
        "family": "Huang",
        "given": "Alexander C."
      },
      {
        "family": "Nasta",
        "given": "Sunita D."
      },
      {
        "family": "Walsh",
        "given": "Jennifer C."
      },
      {
        "family": "Wiletyo",
        "given": "E. Paul"
      },
      {
        "family": "Gimotty",
        "given": "Phyllis A."
      },
      {
        "family": "Milone",
        "given": "Michael C."
      },
      {
        "family": "Amaravadi",
        "given": "Ravi K."
      },
      {
        "literal": "Prevention and Treatment of COVID-19 With Hydroxychloroquine (PATCH) Investigators"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          2,
          1
        ]
      ]
    },
    "container-title": "JAMA Internal Medicine",
    "DOI": "10.1001/jamainternmed.2020.6319",
    "volume": "181",
    "issue": "2",
    "page": "195",
    "publisher": "American Medical Association (AMA)",
    "title": "Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers",
    "URL": "https://doi.org/ghd6nj",
    "PMCID": "PMC7527945",
    "PMID": "33001138",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1001/jamainternmed.2020.6319\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: oaqFxV4W"
  },
  {
    "type": "article-journal",
    "id": "ueLoJJY7",
    "author": [
      {
        "family": "Chen",
        "given": "Yuanjing"
      },
      {
        "family": "Li",
        "given": "Ka"
      },
      {
        "family": "Pu",
        "given": "Hongshan"
      },
      {
        "family": "Wu",
        "given": "Taixiang"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2011,
          3,
          16
        ]
      ]
    },
    "container-title": "Cochrane Database of Systematic Reviews",
    "DOI": "10.1002/14651858.cd007720.pub2",
    "publisher": "Wiley",
    "title": "Corticosteroids for pneumonia",
    "URL": "https://doi.org/cvc92x",
    "PMID": "21412908",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1002/14651858.cd007720.pub2"
  },
  {
    "type": "article-journal",
    "id": "Xh7pYr41",
    "author": [
      {
        "family": "Stern",
        "given": "Anat"
      },
      {
        "family": "Skalsky",
        "given": "Keren"
      },
      {
        "family": "Avni",
        "given": "Tomer"
      },
      {
        "family": "Carrara",
        "given": "Elena"
      },
      {
        "family": "Leibovici",
        "given": "Leonard"
      },
      {
        "family": "Paul",
        "given": "Mical"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          12,
          13
        ]
      ]
    },
    "container-title": "Cochrane Database of Systematic Reviews",
    "DOI": "10.1002/14651858.cd007720.pub3",
    "publisher": "Wiley",
    "title": "Corticosteroids for pneumonia",
    "URL": "https://doi.org/gc9cdk",
    "PMCID": "PMC6486210",
    "PMID": "29236286",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1002/14651858.cd007720.pub3"
  },
  {
    "type": "article-journal",
    "id": "rQNzKxRd",
    "author": [
      {
        "family": "Helal",
        "given": "Gouda Kamel"
      },
      {
        "family": "Gad",
        "given": "Magdy Abdelmawgoud"
      },
      {
        "family": "Abd-Ellah",
        "given": "Mohamed Fahmy"
      },
      {
        "family": "Eid",
        "given": "Mahmoud Saied"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2016,
          12
        ]
      ]
    },
    "container-title": "Journal of Medical Virology",
    "DOI": "10.1002/jmv.24575",
    "volume": "88",
    "issue": "12",
    "page": "2170-2178",
    "publisher": "Wiley",
    "title": "Hydroxychloroquine augments early virological response to pegylated interferon plus ribavirin in genotype-4 chronic hepatitis C patients",
    "URL": "https://doi.org/f889nt",
    "PMCID": "PMC7167065",
    "PMID": "27183377",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1002/jmv.24575\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: rQNzKxRd"
  },
  {
    "type": "article-journal",
    "id": "Sh1FwWps",
    "author": [
      {
        "family": "Lung",
        "given": "Jrhau"
      },
      {
        "family": "Lin",
        "given": "Yu‐Shih"
      },
      {
        "family": "Yang",
        "given": "Yao‐Hsu"
      },
      {
        "family": "Chou",
        "given": "Yu‐Lun"
      },
      {
        "family": "Shu",
        "given": "Li‐Hsin"
      },
      {
        "family": "Cheng",
        "given": "Yu‐Ching"
      },
      {
        "family": "Liu",
        "given": "Hung Te"
      },
      {
        "family": "Wu",
        "given": "Ching‐Yuan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          18
        ]
      ]
    },
    "container-title": "Journal of Medical Virology",
    "DOI": "10.1002/jmv.25761",
    "volume": "92",
    "issue": "6",
    "page": "693-697",
    "publisher": "Wiley",
    "title": "The potential chemical structure of anti‐SARS‐CoV‐2 RNA‐dependent RNA polymerase",
    "URL": "https://doi.org/ggp6fm",
    "PMID": "32167173",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1002/jmv.25761\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: Sh1FwWps"
  },
  {
    "type": "article-journal",
    "id": "kAKKkMAW",
    "author": [
      {
        "family": "Rajendran",
        "given": "Karthick"
      },
      {
        "family": "Krishnasamy",
        "given": "Narayanasamy"
      },
      {
        "family": "Rangarajan",
        "given": "Jayanthi"
      },
      {
        "family": "Rathinam",
        "given": "Jeyalalitha"
      },
      {
        "family": "Natarajan",
        "given": "Murugan"
      },
      {
        "family": "Ramachandran",
        "given": "Arunkumar"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          5,
          12
        ]
      ]
    },
    "container-title": "Journal of Medical Virology",
    "DOI": "10.1002/jmv.25961",
    "volume": "92",
    "issue": "9",
    "page": "1475-1483",
    "publisher": "Wiley",
    "title": "Convalescent plasma transfusion for the treatment of COVID‐19: Systematic review",
    "URL": "https://doi.org/ggv3gx",
    "PMCID": "PMC7267113",
    "PMID": "32356910",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1002/jmv.25961"
  },
  {
    "type": "article-journal",
    "id": "ZZ2cNql8",
    "author": [
      {
        "family": "Hashimoto",
        "given": "Kenji"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          1,
          5
        ]
      ]
    },
    "container-title": "European Archives of Psychiatry and Clinical Neuroscience",
    "DOI": "10.1007/s00406-020-01231-x",
    "volume": "271",
    "issue": "2",
    "page": "249-258",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor",
    "URL": "https://doi.org/ghth6q",
    "PMCID": "PMC7785036",
    "PMID": "33403480",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1007/s00406-020-01231-x"
  },
  {
    "type": "article-journal",
    "id": "17fxIsLBV",
    "author": [
      {
        "family": "Mikami",
        "given": "Katsunaka"
      },
      {
        "family": "Suzuki",
        "given": "Masaru"
      },
      {
        "family": "Kitagawa",
        "given": "Hiroshi"
      },
      {
        "family": "Kawakami",
        "given": "Masaki"
      },
      {
        "family": "Hirota",
        "given": "Nobuaki"
      },
      {
        "family": "Yamaguchi",
        "given": "Hiromichi"
      },
      {
        "family": "Narumoto",
        "given": "Osamu"
      },
      {
        "family": "Kichikawa",
        "given": "Yoshiko"
      },
      {
        "family": "Kawai",
        "given": "Makoto"
      },
      {
        "family": "Tashimo",
        "given": "Hiroyuki"
      },
      {
        "family": "Arai",
        "given": "Hidenori"
      },
      {
        "family": "Horiuchi",
        "given": "Tadashi"
      },
      {
        "family": "Sakamoto",
        "given": "Yoshio"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2007,
          8,
          21
        ]
      ]
    },
    "container-title": "Lung",
    "DOI": "10.1007/s00408-007-9020-3",
    "volume": "185",
    "issue": "5",
    "page": "249-255",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Efficacy of Corticosteroids in the Treatment of Community-Acquired Pneumonia Requiring Hospitalization",
    "URL": "https://doi.org/fk5f5d",
    "PMID": "17710485",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1007/s00408-007-9020-3"
  },
  {
    "type": "article-journal",
    "id": "LIqxTdN",
    "author": [
      {
        "family": "Scheller",
        "given": "Jürgen"
      },
      {
        "family": "Rose-John",
        "given": "Stefan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2006,
          5,
          31
        ]
      ]
    },
    "container-title": "Medical Microbiology and Immunology",
    "DOI": "10.1007/s00430-006-0019-9",
    "volume": "195",
    "issue": "4",
    "page": "173-183",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Interleukin-6 and its receptor: from bench to bedside",
    "URL": "https://doi.org/ck8xch",
    "PMID": "16741736",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1007/s00430-006-0019-9\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: LIqxTdN"
  },
  {
    "type": "article-journal",
    "id": "15rGJX7Hl",
    "author": [
      {
        "family": "Dabbous",
        "given": "Hany M."
      },
      {
        "family": "Abd-Elsalam",
        "given": "Sherief"
      },
      {
        "family": "El-Sayed",
        "given": "Manal H."
      },
      {
        "family": "Sherief",
        "given": "Ahmed F."
      },
      {
        "family": "Ebeid",
        "given": "Fatma F. S."
      },
      {
        "family": "El Ghafar",
        "given": "Mohamed Samir Abd"
      },
      {
        "family": "Soliman",
        "given": "Shaimaa"
      },
      {
        "family": "Elbahnasawy",
        "given": "Mohamed"
      },
      {
        "family": "Badawi",
        "given": "Rehab"
      },
      {
        "family": "Tageldin",
        "given": "Mohamed Awad"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          1,
          25
        ]
      ]
    },
    "container-title": "Archives of Virology",
    "DOI": "10.1007/s00705-021-04956-9",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study",
    "URL": "https://doi.org/ghx874",
    "PMCID": "PMC7829645",
    "PMID": "33492523",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1007/s00705-021-04956-9\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 15rGJX7Hl"
  },
  {
    "type": "article-journal",
    "id": "M1ZtcbRp",
    "author": [
      {
        "family": "Fujii",
        "given": "Takeshi"
      },
      {
        "family": "Iwamoto",
        "given": "Aikichi"
      },
      {
        "family": "Nakamura",
        "given": "Tetsuya"
      },
      {
        "family": "Iwamoto",
        "given": "Aikichi"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2004
        ]
      ]
    },
    "container-title": "Journal of Infection and Chemotherapy",
    "DOI": "10.1007/s10156-003-0296-9",
    "volume": "10",
    "issue": "1",
    "page": "1-7",
    "publisher": "Elsevier BV",
    "title": "Current concepts in SARS treatment",
    "URL": "https://doi.org/dpmxk2",
    "PMCID": "PMC7088022",
    "PMID": "14991510",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1007/s10156-003-0296-9"
  },
  {
    "type": "article-journal",
    "id": "17EErh01r",
    "author": [
      {
        "family": "Azad",
        "given": "Gajendra Kumar"
      },
      {
        "family": "Tomar",
        "given": "Raghuvir S."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2014,
          5,
          28
        ]
      ]
    },
    "container-title": "Molecular Biology Reports",
    "DOI": "10.1007/s11033-014-3417-x",
    "volume": "41",
    "issue": "8",
    "page": "4865-4879",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways",
    "URL": "https://doi.org/f6cnq3",
    "PMID": "24867080",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1007/s11033-014-3417-x\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 17EErh01r"
  },
  {
    "type": "article-journal",
    "id": "XfOTPQPJ",
    "author": [
      {
        "family": "Ren",
        "given": "Zhilin"
      },
      {
        "family": "Yan",
        "given": "Liming"
      },
      {
        "family": "Zhang",
        "given": "Ning"
      },
      {
        "family": "Guo",
        "given": "Yu"
      },
      {
        "family": "Yang",
        "given": "Cheng"
      },
      {
        "family": "Lou",
        "given": "Zhiyong"
      },
      {
        "family": "Rao",
        "given": "Zihe"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2013,
          4,
          3
        ]
      ]
    },
    "container-title": "Protein & Cell",
    "DOI": "10.1007/s13238-013-2841-3",
    "volume": "4",
    "issue": "4",
    "page": "248-250",
    "publisher": "Springer Science and Business Media LLC",
    "title": "The newly emerged SARS-Like coronavirus HCoV-EMC also has an “Achilles’ heel”: current effective inhibitor targeting a 3C-like protease",
    "URL": "https://doi.org/ggr7vh",
    "PMCID": "PMC4875521",
    "PMID": "23549610",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1007/s13238-013-2841-3\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: XfOTPQPJ"
  },
  {
    "type": "article-journal",
    "id": "hFGjQQN8",
    "author": [
      {
        "family": "Sperber",
        "given": "Kirk"
      },
      {
        "family": "Louie",
        "given": "Michael"
      },
      {
        "family": "Kraus",
        "given": "Thomas"
      },
      {
        "family": "Proner",
        "given": "Jacqueline"
      },
      {
        "family": "Sapira",
        "given": "Erica"
      },
      {
        "family": "Lin",
        "given": "Su"
      },
      {
        "family": "Stecher",
        "given": "Vera"
      },
      {
        "family": "Mayer",
        "given": "Lloyd"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1995,
          7
        ]
      ]
    },
    "container-title": "Clinical Therapeutics",
    "DOI": "10.1016/0149-2918(95)80039-5",
    "volume": "17",
    "issue": "4",
    "page": "622-636",
    "publisher": "Elsevier BV",
    "title": "Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1",
    "URL": "https://doi.org/cq2hx9",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/0149-2918(95)80039-5\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: hFGjQQN8"
  },
  {
    "type": "chapter",
    "id": "1ETGa7JyL",
    "author": [
      {
        "family": "Zabirowicz",
        "given": "Eric S."
      },
      {
        "family": "Gan",
        "given": "Tong J."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019
        ]
      ]
    },
    "DOI": "10.1016/b978-0-323-48110-6.00034-x",
    "page": "671-692",
    "publisher": "Elsevier BV",
    "title": "Pharmacology of Postoperative Nausea and Vomiting",
    "URL": "https://doi.org/ghfkjw",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/b978-0-323-48110-6.00034-x\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 1ETGa7JyL"
  },
  {
    "type": "article-journal",
    "id": "FT3Nw9xJ",
    "author": [
      {
        "family": "Lin",
        "given": "Kai"
      },
      {
        "family": "Gallay",
        "given": "Philippe"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2013,
          7
        ]
      ]
    },
    "container-title": "Antiviral Research",
    "DOI": "10.1016/j.antiviral.2013.03.020",
    "volume": "99",
    "issue": "1",
    "page": "68-77",
    "publisher": "Elsevier BV",
    "title": "Curing a viral infection by targeting the host: The example of cyclophilin inhibitors",
    "URL": "https://doi.org/f4237c",
    "PMCID": "PMC4332838",
    "PMID": "23578729",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.antiviral.2013.03.020\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: FT3Nw9xJ"
  },
  {
    "type": "article-journal",
    "id": "f7csoyEu",
    "author": [
      {
        "family": "Zhou",
        "given": "Yanchen"
      },
      {
        "family": "Vedantham",
        "given": "Punitha"
      },
      {
        "family": "Lu",
        "given": "Kai"
      },
      {
        "family": "Agudelo",
        "given": "Juliet"
      },
      {
        "family": "Carrion",
        "given": "Ricardo"
      },
      {
        "family": "Nunneley",
        "given": "Jerritt W."
      },
      {
        "family": "Barnard",
        "given": "Dale"
      },
      {
        "family": "Pöhlmann",
        "given": "Stefan"
      },
      {
        "family": "McKerrow",
        "given": "James H."
      },
      {
        "family": "Renslo",
        "given": "Adam R."
      },
      {
        "family": "Simmons",
        "given": "Graham"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2015,
          4
        ]
      ]
    },
    "container-title": "Antiviral Research",
    "DOI": "10.1016/j.antiviral.2015.01.011",
    "volume": "116",
    "page": "76-84",
    "publisher": "Elsevier BV",
    "title": "Protease inhibitors targeting coronavirus and filovirus entry",
    "URL": "https://doi.org/ggr984",
    "PMCID": "PMC4774534",
    "PMID": "25666761",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.antiviral.2015.01.011\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: f7csoyEu"
  },
  {
    "type": "article-journal",
    "id": "KVTUgJqr",
    "author": [
      {
        "family": "van Doremalen",
        "given": "Neeltje"
      },
      {
        "family": "Falzarano",
        "given": "Darryl"
      },
      {
        "family": "Ying",
        "given": "Tianlei"
      },
      {
        "family": "de Wit",
        "given": "Emmie"
      },
      {
        "family": "Bushmaker",
        "given": "Trenton"
      },
      {
        "family": "Feldmann",
        "given": "Friederike"
      },
      {
        "family": "Okumura",
        "given": "Atsushi"
      },
      {
        "family": "Wang",
        "given": "Yanping"
      },
      {
        "family": "Scott",
        "given": "Dana P."
      },
      {
        "family": "Hanley",
        "given": "Patrick W."
      },
      {
        "family": "Feldmann",
        "given": "Heinz"
      },
      {
        "family": "Dimitrov",
        "given": "Dimiter S."
      },
      {
        "family": "Munster",
        "given": "Vincent J."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          7
        ]
      ]
    },
    "container-title": "Antiviral Research",
    "DOI": "10.1016/j.antiviral.2017.03.025",
    "volume": "143",
    "page": "30-37",
    "publisher": "Elsevier BV",
    "title": "Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets",
    "URL": "https://doi.org/gbh5c2",
    "PMCID": "PMC6957253",
    "PMID": "28389142",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/j.antiviral.2017.03.025"
  },
  {
    "type": "article-journal",
    "id": "MPJdSF1p",
    "author": [
      {
        "family": "Seley-Radtke",
        "given": "Katherine L."
      },
      {
        "family": "Yates",
        "given": "Mary K."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          6
        ]
      ]
    },
    "container-title": "Antiviral Research",
    "DOI": "10.1016/j.antiviral.2018.04.004",
    "volume": "154",
    "page": "66-86",
    "publisher": "Elsevier BV",
    "title": "The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold",
    "URL": "https://doi.org/gdpn35",
    "PMCID": "PMC6396324",
    "PMID": "29649496",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.antiviral.2018.04.004\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: MPJdSF1p"
  },
  {
    "type": "article-journal",
    "id": "rL8owM5Y",
    "author": [
      {
        "family": "Erkan",
        "given": "Doruk"
      },
      {
        "family": "Aguiar",
        "given": "Cassyanne L."
      },
      {
        "family": "Andrade",
        "given": "Danieli"
      },
      {
        "family": "Cohen",
        "given": "Hannah"
      },
      {
        "family": "Cuadrado",
        "given": "Maria J."
      },
      {
        "family": "Danowski",
        "given": "Adriana"
      },
      {
        "family": "Levy",
        "given": "Roger A."
      },
      {
        "family": "Ortel",
        "given": "Thomas L."
      },
      {
        "family": "Rahman",
        "given": "Anisur"
      },
      {
        "family": "Salmon",
        "given": "Jane E."
      },
      {
        "family": "Tektonidou",
        "given": "Maria G."
      },
      {
        "family": "Willis",
        "given": "Rohan"
      },
      {
        "family": "Lockshin",
        "given": "Michael D."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2014,
          6
        ]
      ]
    },
    "container-title": "Autoimmunity Reviews",
    "DOI": "10.1016/j.autrev.2014.01.053",
    "volume": "13",
    "issue": "6",
    "page": "685-696",
    "publisher": "Elsevier BV",
    "title": "14th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends",
    "URL": "https://doi.org/ggp8r8",
    "PMID": "24468415",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.autrev.2014.01.053\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: rL8owM5Y"
  },
  {
    "type": "article-journal",
    "id": "7d1TnpE3",
    "author": [
      {
        "family": "Rocha-Pereira",
        "given": "J."
      },
      {
        "family": "Jochmans",
        "given": "D."
      },
      {
        "family": "Dallmeier",
        "given": "K."
      },
      {
        "family": "Leyssen",
        "given": "P."
      },
      {
        "family": "Nascimento",
        "given": "M.S.J."
      },
      {
        "family": "Neyts",
        "given": "J."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2012,
          8
        ]
      ]
    },
    "container-title": "Biochemical and Biophysical Research Communications",
    "DOI": "10.1016/j.bbrc.2012.07.034",
    "volume": "424",
    "issue": "4",
    "page": "777-780",
    "publisher": "Elsevier BV",
    "title": "Favipiravir (T-705) inhibits in vitro norovirus replication",
    "URL": "https://doi.org/f369j7",
    "PMID": "22809499",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.bbrc.2012.07.034\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 7d1TnpE3"
  },
  {
    "type": "article-journal",
    "id": "hkzKw8NQ",
    "author": [
      {
        "family": "Deb",
        "given": "Paroma"
      },
      {
        "family": "Molla",
        "given": "Md. Maruf Ahmed"
      },
      {
        "family": "Saif-Ur-Rahman",
        "given": "K.M."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          4
        ]
      ]
    },
    "container-title": "Biosafety and Health",
    "DOI": "10.1016/j.bsheal.2021.02.001",
    "volume": "3",
    "issue": "2",
    "page": "87-91",
    "publisher": "Elsevier BV",
    "title": "An update to monoclonal antibody as therapeutic option against COVID-19",
    "URL": "https://doi.org/gh4m7h",
    "PMCID": "PMC7872849",
    "PMID": "33585808",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/j.bsheal.2021.02.001"
  },
  {
    "type": "article-journal",
    "id": "15l3di3Wj",
    "author": [
      {
        "family": "Hoffmann",
        "given": "Markus"
      },
      {
        "family": "Kleine-Weber",
        "given": "Hannah"
      },
      {
        "family": "Schroeder",
        "given": "Simon"
      },
      {
        "family": "Krüger",
        "given": "Nadine"
      },
      {
        "family": "Herrler",
        "given": "Tanja"
      },
      {
        "family": "Erichsen",
        "given": "Sandra"
      },
      {
        "family": "Schiergens",
        "given": "Tobias S."
      },
      {
        "family": "Herrler",
        "given": "Georg"
      },
      {
        "family": "Wu",
        "given": "Nai-Huei"
      },
      {
        "family": "Nitsche",
        "given": "Andreas"
      },
      {
        "family": "Müller",
        "given": "Marcel A."
      },
      {
        "family": "Drosten",
        "given": "Christian"
      },
      {
        "family": "Pöhlmann",
        "given": "Stefan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4
        ]
      ]
    },
    "container-title": "Cell",
    "DOI": "10.1016/j.cell.2020.02.052",
    "volume": "181",
    "issue": "2",
    "page": "271-280.e8",
    "publisher": "Elsevier BV",
    "title": "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor",
    "URL": "https://doi.org/ggnq74",
    "PMCID": "PMC7102627",
    "PMID": "32142651",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.cell.2020.02.052\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 15l3di3Wj"
  },
  {
    "type": "article-journal",
    "id": "qcVbT0w4",
    "author": [
      {
        "family": "Walls",
        "given": "Alexandra C."
      },
      {
        "family": "Park",
        "given": "Young-Jun"
      },
      {
        "family": "Tortorici",
        "given": "M. Alejandra"
      },
      {
        "family": "Wall",
        "given": "Abigail"
      },
      {
        "family": "McGuire",
        "given": "Andrew T."
      },
      {
        "family": "Veesler",
        "given": "David"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4
        ]
      ]
    },
    "container-title": "Cell",
    "DOI": "10.1016/j.cell.2020.02.058",
    "volume": "181",
    "issue": "2",
    "page": "281-292.e6",
    "publisher": "Elsevier BV",
    "title": "Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein",
    "URL": "https://doi.org/dpvh",
    "PMCID": "PMC7102599",
    "PMID": "32155444",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.cell.2020.02.058\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: qcVbT0w4"
  },
  {
    "type": "article-journal",
    "id": "15kk2xRrj",
    "author": [
      {
        "family": "Dittmar",
        "given": "Mark"
      },
      {
        "family": "Lee",
        "given": "Jae Seung"
      },
      {
        "family": "Whig",
        "given": "Kanupriya"
      },
      {
        "family": "Segrist",
        "given": "Elisha"
      },
      {
        "family": "Li",
        "given": "Minghua"
      },
      {
        "family": "Kamalia",
        "given": "Brinda"
      },
      {
        "family": "Castellana",
        "given": "Lauren"
      },
      {
        "family": "Ayyanathan",
        "given": "Kasirajan"
      },
      {
        "family": "Cardenas-Diaz",
        "given": "Fabian L."
      },
      {
        "family": "Morrisey",
        "given": "Edward E."
      },
      {
        "family": "Truitt",
        "given": "Rachel"
      },
      {
        "family": "Yang",
        "given": "Wenli"
      },
      {
        "family": "Jurado",
        "given": "Kellie"
      },
      {
        "family": "Samby",
        "given": "Kirandeep"
      },
      {
        "family": "Ramage",
        "given": "Holly"
      },
      {
        "family": "Schultz",
        "given": "David C."
      },
      {
        "family": "Cherry",
        "given": "Sara"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          4
        ]
      ]
    },
    "container-title": "Cell Reports",
    "DOI": "10.1016/j.celrep.2021.108959",
    "volume": "35",
    "issue": "1",
    "page": "108959",
    "publisher": "Elsevier BV",
    "title": "Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2",
    "URL": "https://doi.org/gj3v44",
    "PMCID": "PMC7985926",
    "PMID": "33811811",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/j.celrep.2021.108959"
  },
  {
    "type": "article-journal",
    "id": "p0tzgJvA",
    "author": [
      {
        "family": "Radbel",
        "given": "Jared"
      },
      {
        "family": "Narayanan",
        "given": "Navaneeth"
      },
      {
        "family": "Bhatt",
        "given": "Pinki J."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          7
        ]
      ]
    },
    "container-title": "Chest",
    "DOI": "10.1016/j.chest.2020.04.024",
    "volume": "158",
    "issue": "1",
    "page": "e15-e19",
    "publisher": "Elsevier BV",
    "title": "Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome",
    "URL": "https://doi.org/ggtxvs",
    "PMCID": "PMC7195070",
    "PMID": "32343968",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.chest.2020.04.024\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: p0tzgJvA"
  },
  {
    "type": "article-journal",
    "id": "Wt9vgKLY",
    "author": [
      {
        "family": "Price",
        "given": "Christina C."
      },
      {
        "family": "Altice",
        "given": "Frederick L."
      },
      {
        "family": "Shyr",
        "given": "Yu"
      },
      {
        "family": "Koff",
        "given": "Alan"
      },
      {
        "family": "Pischel",
        "given": "Lauren"
      },
      {
        "family": "Goshua",
        "given": "George"
      },
      {
        "family": "Azar",
        "given": "Marwan M."
      },
      {
        "family": "Mcmanus",
        "given": "Dayna"
      },
      {
        "family": "Chen",
        "given": "Sheau-Chiann"
      },
      {
        "family": "Gleeson",
        "given": "Shana E."
      },
      {
        "family": "Britto",
        "given": "Clemente J."
      },
      {
        "family": "Azmy",
        "given": "Veronica"
      },
      {
        "family": "Kaman",
        "given": "Kelsey"
      },
      {
        "family": "Gaston",
        "given": "David C."
      },
      {
        "family": "Davis",
        "given": "Matthew"
      },
      {
        "family": "Burrello",
        "given": "Trisha"
      },
      {
        "family": "Harris",
        "given": "Zachary"
      },
      {
        "family": "Villanueva",
        "given": "Merceditas S."
      },
      {
        "family": "Aoun-Barakat",
        "given": "Lydia"
      },
      {
        "family": "Kang",
        "given": "Insoo"
      },
      {
        "family": "Seropian",
        "given": "Stuart"
      },
      {
        "family": "Chupp",
        "given": "Geoffrey"
      },
      {
        "family": "Bucala",
        "given": "Richard"
      },
      {
        "family": "Kaminski",
        "given": "Naftali"
      },
      {
        "family": "Lee",
        "given": "Alfred I."
      },
      {
        "family": "LoRusso",
        "given": "Patricia Mucci"
      },
      {
        "family": "Topal",
        "given": "Jeffrey E."
      },
      {
        "family": "Dela Cruz",
        "given": "Charles"
      },
      {
        "family": "Malinis",
        "given": "Maricar"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          10
        ]
      ]
    },
    "container-title": "Chest",
    "DOI": "10.1016/j.chest.2020.06.006",
    "volume": "158",
    "issue": "4",
    "page": "1397-1408",
    "publisher": "Elsevier BV",
    "title": "Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019",
    "URL": "https://doi.org/gg2789",
    "PMCID": "PMC7831876",
    "PMID": "32553536",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.chest.2020.06.006\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: Wt9vgKLY"
  },
  {
    "type": "article-journal",
    "id": "1FtcInMeU",
    "author": [
      {
        "family": "Liu",
        "given": "Zhuoming"
      },
      {
        "family": "VanBlargan",
        "given": "Laura A."
      },
      {
        "family": "Bloyet",
        "given": "Louis-Marie"
      },
      {
        "family": "Rothlauf",
        "given": "Paul W."
      },
      {
        "family": "Chen",
        "given": "Rita E."
      },
      {
        "family": "Stumpf",
        "given": "Spencer"
      },
      {
        "family": "Zhao",
        "given": "Haiyan"
      },
      {
        "family": "Errico",
        "given": "John M."
      },
      {
        "family": "Theel",
        "given": "Elitza S."
      },
      {
        "family": "Liebeskind",
        "given": "Mariel J."
      },
      {
        "family": "Alford",
        "given": "Brynn"
      },
      {
        "family": "Buchser",
        "given": "William J."
      },
      {
        "family": "Ellebedy",
        "given": "Ali H."
      },
      {
        "family": "Fremont",
        "given": "Daved H."
      },
      {
        "family": "Diamond",
        "given": "Michael S."
      },
      {
        "family": "Whelan",
        "given": "Sean P.J."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          3
        ]
      ]
    },
    "container-title": "Cell Host & Microbe",
    "DOI": "10.1016/j.chom.2021.01.014",
    "volume": "29",
    "issue": "3",
    "page": "477-488.e4",
    "publisher": "Elsevier BV",
    "title": "Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization",
    "URL": "https://doi.org/gh4m7j",
    "PMCID": "PMC7839837",
    "PMID": "33535027",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/j.chom.2021.01.014"
  },
  {
    "type": "article-journal",
    "id": "1ALDN7rfe",
    "author": [
      {
        "family": "Shire",
        "given": "Steven J"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2009,
          12
        ]
      ]
    },
    "container-title": "Current Opinion in Biotechnology",
    "DOI": "10.1016/j.copbio.2009.10.006",
    "volume": "20",
    "issue": "6",
    "page": "708-714",
    "publisher": "Elsevier BV",
    "title": "Formulation and manufacturability of biologics",
    "URL": "https://doi.org/cjk8p6",
    "PMID": "19880308",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.copbio.2009.10.006\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 1ALDN7rfe"
  },
  {
    "type": "article-journal",
    "id": "jMzODpwS",
    "author": [
      {
        "family": "Barnes",
        "given": "Mark A."
      },
      {
        "family": "Carson",
        "given": "Monica J."
      },
      {
        "family": "Nair",
        "given": "Meera G."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2015,
          4
        ]
      ]
    },
    "container-title": "Cytokine",
    "DOI": "10.1016/j.cyto.2015.01.008",
    "volume": "72",
    "issue": "2",
    "page": "210-219",
    "publisher": "Elsevier BV",
    "title": "Non-traditional cytokines: How catecholamines and adipokines influence macrophages in immunity, metabolism and the central nervous system",
    "URL": "https://doi.org/f65c59",
    "PMCID": "PMC4590987",
    "PMID": "25703786",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.cyto.2015.01.008\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: jMzODpwS"
  },
  {
    "type": "article-journal",
    "id": "1BxkPZYnj",
    "author": [
      {
        "family": "Garbers",
        "given": "Christoph"
      },
      {
        "family": "Hermanns",
        "given": "Heike M."
      },
      {
        "family": "Schaper",
        "given": "Fred"
      },
      {
        "family": "Müller-Newen",
        "given": "Gerhard"
      },
      {
        "family": "Grötzinger",
        "given": "Joachim"
      },
      {
        "family": "Rose-John",
        "given": "Stefan"
      },
      {
        "family": "Scheller",
        "given": "Jürgen"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2012,
          6
        ]
      ]
    },
    "container-title": "Cytokine & Growth Factor Reviews",
    "DOI": "10.1016/j.cytogfr.2012.04.001",
    "volume": "23",
    "issue": "3",
    "page": "85-97",
    "publisher": "Elsevier BV",
    "title": "Plasticity and cross-talk of Interleukin 6-type cytokines",
    "URL": "https://doi.org/f3z743",
    "PMID": "22595692",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.cytogfr.2012.04.001\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 1BxkPZYnj"
  },
  {
    "type": "article-journal",
    "id": "12nqESooA",
    "author": [
      {
        "family": "Parvathaneni",
        "given": "Vineela"
      },
      {
        "family": "Kulkarni",
        "given": "Nishant S."
      },
      {
        "family": "Muth",
        "given": "Aaron"
      },
      {
        "family": "Gupta",
        "given": "Vivek"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          10
        ]
      ]
    },
    "container-title": "Drug Discovery Today",
    "DOI": "10.1016/j.drudis.2019.06.014",
    "volume": "24",
    "issue": "10",
    "page": "2076-2085",
    "publisher": "Elsevier BV",
    "title": "Drug repurposing: a promising tool to accelerate the drug discovery process",
    "URL": "https://doi.org/gj3v46",
    "PMID": "31238113",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/j.drudis.2019.06.014"
  },
  {
    "type": "article-journal",
    "id": "f3z5LF0J",
    "author": [
      {
        "family": "Villoutreix",
        "given": "Bruno O."
      },
      {
        "family": "Beaune",
        "given": "Philippe H."
      },
      {
        "family": "Tamouza",
        "given": "Ryad"
      },
      {
        "family": "Krishnamoorthy",
        "given": "Rajagopal"
      },
      {
        "family": "Leboyer",
        "given": "Marion"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          8
        ]
      ]
    },
    "container-title": "Drug Discovery Today",
    "DOI": "10.1016/j.drudis.2020.06.022",
    "volume": "25",
    "issue": "8",
    "page": "1287-1290",
    "publisher": "Elsevier BV",
    "title": "Prevention of COVID-19 by drug repurposing: rationale from drugs prescribed for mental disorders",
    "URL": "https://doi.org/gjkv82",
    "PMCID": "PMC7315962",
    "PMID": "32593662",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/j.drudis.2020.06.022"
  },
  {
    "type": "article-journal",
    "id": "luPHOS0m",
    "author": [
      {
        "family": "Capra",
        "given": "Ruggero"
      },
      {
        "family": "De Rossi",
        "given": "Nicola"
      },
      {
        "family": "Mattioli",
        "given": "Flavia"
      },
      {
        "family": "Romanelli",
        "given": "Giuseppe"
      },
      {
        "family": "Scarpazza",
        "given": "Cristina"
      },
      {
        "family": "Sormani",
        "given": "Maria Pia"
      },
      {
        "family": "Cossi",
        "given": "Stefania"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          6
        ]
      ]
    },
    "container-title": "European Journal of Internal Medicine",
    "DOI": "10.1016/j.ejim.2020.05.009",
    "volume": "76",
    "page": "31-35",
    "publisher": "Elsevier BV",
    "title": "Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia",
    "URL": "https://doi.org/ggx4fm",
    "PMCID": "PMC7219361",
    "PMID": "32405160",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.ejim.2020.05.009\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: luPHOS0m"
  },
  {
    "type": "article-journal",
    "id": "1EjFnlgU8",
    "author": [
      {
        "family": "Noreen",
        "given": "Sobia"
      },
      {
        "family": "Maqbool",
        "given": "Irsah"
      },
      {
        "family": "Madni",
        "given": "Asadullah"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          3
        ]
      ]
    },
    "container-title": "European Journal of Pharmacology",
    "DOI": "10.1016/j.ejphar.2021.173854",
    "volume": "894",
    "page": "173854",
    "publisher": "Elsevier BV",
    "title": "Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic",
    "URL": "https://doi.org/gj4qgn",
    "PMCID": "PMC7836247",
    "PMID": "33428898",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/j.ejphar.2021.173854"
  },
  {
    "type": "article-journal",
    "id": "APU0cUZz",
    "author": [
      {
        "family": "Lou",
        "given": "Yan"
      },
      {
        "family": "Liu",
        "given": "Lin"
      },
      {
        "family": "Yao",
        "given": "Hangping"
      },
      {
        "family": "Hu",
        "given": "Xingjiang"
      },
      {
        "family": "Su",
        "given": "Junwei"
      },
      {
        "family": "Xu",
        "given": "Kaijin"
      },
      {
        "family": "Luo",
        "given": "Rui"
      },
      {
        "family": "Yang",
        "given": "Xi"
      },
      {
        "family": "He",
        "given": "Lingjuan"
      },
      {
        "family": "Lu",
        "given": "Xiaoyang"
      },
      {
        "family": "Zhao",
        "given": "Qingwei"
      },
      {
        "family": "Liang",
        "given": "Tingbo"
      },
      {
        "family": "Qiu",
        "given": "Yunqing"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          2
        ]
      ]
    },
    "container-title": "European Journal of Pharmaceutical Sciences",
    "DOI": "10.1016/j.ejps.2020.105631",
    "volume": "157",
    "page": "105631",
    "publisher": "Elsevier BV",
    "title": "Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial",
    "URL": "https://doi.org/ghx88n",
    "PMCID": "PMC7585719",
    "PMID": "33115675",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.ejps.2020.105631\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: APU0cUZz"
  },
  {
    "type": "article-journal",
    "id": "13Oz7yRPx",
    "author": [
      {
        "family": "Cai",
        "given": "Qingxian"
      },
      {
        "family": "Yang",
        "given": "Minghui"
      },
      {
        "family": "Liu",
        "given": "Dongjing"
      },
      {
        "family": "Chen",
        "given": "Jun"
      },
      {
        "family": "Shu",
        "given": "Dan"
      },
      {
        "family": "Xia",
        "given": "Junxia"
      },
      {
        "family": "Liao",
        "given": "Xuejiao"
      },
      {
        "family": "Gu",
        "given": "Yuanbo"
      },
      {
        "family": "Cai",
        "given": "Qiue"
      },
      {
        "family": "Yang",
        "given": "Yang"
      },
      {
        "family": "Shen",
        "given": "Chenguang"
      },
      {
        "family": "Li",
        "given": "Xiaohe"
      },
      {
        "family": "Peng",
        "given": "Ling"
      },
      {
        "family": "Huang",
        "given": "Deliang"
      },
      {
        "family": "Zhang",
        "given": "Jing"
      },
      {
        "family": "Zhang",
        "given": "Shurong"
      },
      {
        "family": "Wang",
        "given": "Fuxiang"
      },
      {
        "family": "Liu",
        "given": "Jiaye"
      },
      {
        "family": "Chen",
        "given": "Li"
      },
      {
        "family": "Chen",
        "given": "Shuyan"
      },
      {
        "family": "Wang",
        "given": "Zhaoqin"
      },
      {
        "family": "Zhang",
        "given": "Zheng"
      },
      {
        "family": "Cao",
        "given": "Ruiyuan"
      },
      {
        "family": "Zhong",
        "given": "Wu"
      },
      {
        "family": "Liu",
        "given": "Yingxia"
      },
      {
        "family": "Liu",
        "given": "Lei"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          10
        ]
      ]
    },
    "container-title": "Engineering",
    "DOI": "10.1016/j.eng.2020.03.007",
    "volume": "6",
    "issue": "10",
    "page": "1192-1198",
    "publisher": "Elsevier BV",
    "title": "Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study",
    "URL": "https://doi.org/ggpprd",
    "PMID": "32346491",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.eng.2020.03.007\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 13Oz7yRPx"
  },
  {
    "type": "article-journal",
    "id": "wy3S7Cpa",
    "author": [
      {
        "family": "Roden",
        "given": "Dan M."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2008,
          8
        ]
      ]
    },
    "container-title": "Heart Rhythm",
    "DOI": "10.1016/j.hrthm.2008.05.008",
    "volume": "5",
    "issue": "8",
    "page": "1213-1215",
    "publisher": "Elsevier BV",
    "title": "Keep the QT interval: It is a reliable predictor of ventricular arrhythmias",
    "URL": "https://doi.org/d5rchx",
    "PMCID": "PMC3212752",
    "PMID": "18675237",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.hrthm.2008.05.008\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: wy3S7Cpa"
  },
  {
    "type": "article-journal",
    "id": "ovHLMvCi",
    "author": [
      {
        "family": "Gautret",
        "given": "Philippe"
      },
      {
        "family": "Lagier",
        "given": "Jean-Christophe"
      },
      {
        "family": "Parola",
        "given": "Philippe"
      },
      {
        "family": "Hoang",
        "given": "Van Thuan"
      },
      {
        "family": "Meddeb",
        "given": "Line"
      },
      {
        "family": "Mailhe",
        "given": "Morgane"
      },
      {
        "family": "Doudier",
        "given": "Barbara"
      },
      {
        "family": "Courjon",
        "given": "Johan"
      },
      {
        "family": "Giordanengo",
        "given": "Valérie"
      },
      {
        "family": "Vieira",
        "given": "Vera Esteves"
      },
      {
        "family": "Tissot Dupont",
        "given": "Hervé"
      },
      {
        "family": "Honoré",
        "given": "Stéphane"
      },
      {
        "family": "Colson",
        "given": "Philippe"
      },
      {
        "family": "Chabrière",
        "given": "Eric"
      },
      {
        "family": "La Scola",
        "given": "Bernard"
      },
      {
        "family": "Rolain",
        "given": "Jean-Marc"
      },
      {
        "family": "Brouqui",
        "given": "Philippe"
      },
      {
        "family": "Raoult",
        "given": "Didier"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          7
        ]
      ]
    },
    "container-title": "International Journal of Antimicrobial Agents",
    "DOI": "10.1016/j.ijantimicag.2020.105949",
    "volume": "56",
    "issue": "1",
    "page": "105949",
    "publisher": "Elsevier BV",
    "title": "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial",
    "URL": "https://doi.org/dp7d",
    "PMCID": "PMC7102549",
    "PMID": "32205204",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.ijantimicag.2020.105949\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: ovHLMvCi"
  },
  {
    "type": "article-journal",
    "id": "kO7WRULi",
    "author": [
      {
        "family": "Tong",
        "given": "Song"
      },
      {
        "family": "Su",
        "given": "Yuan"
      },
      {
        "family": "Yu",
        "given": "Yuan"
      },
      {
        "family": "Wu",
        "given": "Chuangyan"
      },
      {
        "family": "Chen",
        "given": "Jiuling"
      },
      {
        "family": "Wang",
        "given": "Sihua"
      },
      {
        "family": "Jiang",
        "given": "Jinjun"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          9
        ]
      ]
    },
    "container-title": "International Journal of Antimicrobial Agents",
    "DOI": "10.1016/j.ijantimicag.2020.106114",
    "volume": "56",
    "issue": "3",
    "page": "106114",
    "publisher": "Elsevier BV",
    "title": "Ribavirin therapy for severe COVID-19: a retrospective cohort study",
    "URL": "https://doi.org/gg5w75",
    "PMCID": "PMC7377772",
    "PMID": "32712334",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/j.ijantimicag.2020.106114"
  },
  {
    "type": "article-journal",
    "id": "tnF7yB6H",
    "author": [
      {
        "family": "Sun",
        "given": "Zhen-Yu J."
      },
      {
        "family": "Oh",
        "given": "Kyoung Joon"
      },
      {
        "family": "Kim",
        "given": "Mikyung"
      },
      {
        "family": "Yu",
        "given": "Jessica"
      },
      {
        "family": "Brusic",
        "given": "Vladimir"
      },
      {
        "family": "Song",
        "given": "Likai"
      },
      {
        "family": "Qiao",
        "given": "Zhisong"
      },
      {
        "family": "Wang",
        "given": "Jia-huai"
      },
      {
        "family": "Wagner",
        "given": "Gerhard"
      },
      {
        "family": "Reinherz",
        "given": "Ellis L."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2008,
          1
        ]
      ]
    },
    "container-title": "Immunity",
    "DOI": "10.1016/j.immuni.2007.11.018",
    "volume": "28",
    "issue": "1",
    "page": "52-63",
    "publisher": "Elsevier BV",
    "title": "HIV-1 Broadly Neutralizing Antibody Extracts Its Epitope from a Kinked gp41 Ectodomain Region on the Viral Membrane",
    "URL": "https://doi.org/ftw7t3",
    "PMID": "18191596",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/j.immuni.2007.11.018"
  },
  {
    "type": "article-journal",
    "id": "LtFtUo2P",
    "author": [
      {
        "family": "Spiegel",
        "given": "Martin"
      },
      {
        "family": "Pichlmair",
        "given": "Andreas"
      },
      {
        "family": "Mühlberger",
        "given": "Elke"
      },
      {
        "family": "Haller",
        "given": "Otto"
      },
      {
        "family": "Weber",
        "given": "Friedemann"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2004,
          7
        ]
      ]
    },
    "container-title": "Journal of Clinical Virology",
    "DOI": "10.1016/j.jcv.2003.11.013",
    "volume": "30",
    "issue": "3",
    "page": "211-213",
    "publisher": "Elsevier BV",
    "title": "The antiviral effect of interferon-beta against SARS-Coronavirus is not mediated by MxA protein",
    "URL": "https://doi.org/cmc3ds",
    "PMID": "15135736",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.jcv.2003.11.013\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: LtFtUo2P"
  },
  {
    "type": "article-journal",
    "id": "hvOwSJvK",
    "author": [
      {
        "family": "Hassoun",
        "given": "Ali"
      },
      {
        "family": "Thottacherry",
        "given": "Elizabeth Dilip"
      },
      {
        "family": "Muklewicz",
        "given": "Justin"
      },
      {
        "family": "Aziz",
        "given": "Qurrat-ul-ain"
      },
      {
        "family": "Edwards",
        "given": "Jonathan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          7
        ]
      ]
    },
    "container-title": "Journal of Clinical Virology",
    "DOI": "10.1016/j.jcv.2020.104443",
    "volume": "128",
    "page": "104443",
    "publisher": "Elsevier BV",
    "title": "Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19",
    "URL": "https://doi.org/ggx359",
    "PMCID": "PMC7229471",
    "PMID": "32425661",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.jcv.2020.104443\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: hvOwSJvK"
  },
  {
    "type": "article-journal",
    "id": "15K1BCAlx",
    "author": [
      {
        "family": "Yin-Chun Yam",
        "given": "Loretta"
      },
      {
        "family": "Chun-Wing Lau",
        "given": "Arthur"
      },
      {
        "family": "Yuk-Lin Lai",
        "given": "Florence"
      },
      {
        "family": "Shung",
        "given": "Edwina"
      },
      {
        "family": "Chan",
        "given": "Jane"
      },
      {
        "family": "Wong",
        "given": "Vivian"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2007,
          1
        ]
      ]
    },
    "container-title": "Journal of Infection",
    "DOI": "10.1016/j.jinf.2006.01.005",
    "volume": "54",
    "issue": "1",
    "page": "28-39",
    "publisher": "Elsevier BV",
    "title": "Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong",
    "URL": "https://doi.org/dffg65",
    "PMCID": "PMC7112522",
    "PMID": "16542729",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/j.jinf.2006.01.005"
  },
  {
    "type": "article-journal",
    "id": "18KmvBOFr",
    "author": [
      {
        "family": "Molina",
        "given": "J.M."
      },
      {
        "family": "Delaugerre",
        "given": "C."
      },
      {
        "family": "Le Goff",
        "given": "J."
      },
      {
        "family": "Mela-Lima",
        "given": "B."
      },
      {
        "family": "Ponscarme",
        "given": "D."
      },
      {
        "family": "Goldwirt",
        "given": "L."
      },
      {
        "family": "de Castro",
        "given": "N."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          6
        ]
      ]
    },
    "container-title": "Médecine et Maladies Infectieuses",
    "DOI": "10.1016/j.medmal.2020.03.006",
    "volume": "50",
    "issue": "4",
    "page": "384",
    "publisher": "Elsevier BV",
    "title": "No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection",
    "URL": "https://doi.org/ggqzrb",
    "PMID": "32240719",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.medmal.2020.03.006\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 18KmvBOFr"
  },
  {
    "type": "article-journal",
    "id": "17hgtBpcV",
    "author": [
      {
        "family": "Klopfenstein",
        "given": "T."
      },
      {
        "family": "Zayet",
        "given": "S."
      },
      {
        "family": "Lohse",
        "given": "A."
      },
      {
        "family": "Balblanc",
        "given": "J.-C."
      },
      {
        "family": "Badie",
        "given": "J."
      },
      {
        "family": "Royer",
        "given": "P.-Y."
      },
      {
        "family": "Toko",
        "given": "L."
      },
      {
        "family": "Mezher",
        "given": "C."
      },
      {
        "family": "Kadiane-Oussou",
        "given": "N.J."
      },
      {
        "family": "Bossert",
        "given": "M."
      },
      {
        "family": "Bozgan",
        "given": "A.-M."
      },
      {
        "family": "Charpentier",
        "given": "A."
      },
      {
        "family": "Roux",
        "given": "M.-F."
      },
      {
        "family": "Contreras",
        "given": "R."
      },
      {
        "family": "Mazurier",
        "given": "I."
      },
      {
        "family": "Dussert",
        "given": "P."
      },
      {
        "family": "Gendrin",
        "given": "V."
      },
      {
        "family": "Conrozier",
        "given": "T."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          8
        ]
      ]
    },
    "container-title": "Médecine et Maladies Infectieuses",
    "DOI": "10.1016/j.medmal.2020.05.001",
    "volume": "50",
    "issue": "5",
    "page": "397-400",
    "publisher": "Elsevier BV",
    "title": "Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients",
    "URL": "https://doi.org/ggvz45",
    "PMCID": "PMC7202806",
    "PMID": "32387320",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.medmal.2020.05.001\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 17hgtBpcV"
  },
  {
    "type": "article-journal",
    "id": "fYBqSPGl",
    "author": [
      {
        "family": "Kuleshov",
        "given": "Maxim V."
      },
      {
        "family": "Stein",
        "given": "Daniel J."
      },
      {
        "family": "Clarke",
        "given": "Daniel J.B."
      },
      {
        "family": "Kropiwnicki",
        "given": "Eryk"
      },
      {
        "family": "Jagodnik",
        "given": "Kathleen M."
      },
      {
        "family": "Bartal",
        "given": "Alon"
      },
      {
        "family": "Evangelista",
        "given": "John E."
      },
      {
        "family": "Hom",
        "given": "Jason"
      },
      {
        "family": "Cheng",
        "given": "Minxuan"
      },
      {
        "family": "Bailey",
        "given": "Allison"
      },
      {
        "family": "Zhou",
        "given": "Abigail"
      },
      {
        "family": "Ferguson",
        "given": "Laura B."
      },
      {
        "family": "Lachmann",
        "given": "Alexander"
      },
      {
        "family": "Ma'ayan",
        "given": "Avi"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          9
        ]
      ]
    },
    "container-title": "Patterns",
    "DOI": "10.1016/j.patter.2020.100090",
    "volume": "1",
    "issue": "6",
    "page": "100090",
    "publisher": "Elsevier BV",
    "title": "The COVID-19 Drug and Gene Set Library",
    "URL": "https://doi.org/gg56f3",
    "PMCID": "PMC7381899",
    "PMID": "32838343",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/j.patter.2020.100090"
  },
  {
    "type": "article-journal",
    "id": "h4reluu",
    "author": [
      {
        "family": "Cortegiani",
        "given": "A."
      },
      {
        "family": "Ippolito",
        "given": "M."
      },
      {
        "family": "Greco",
        "given": "M."
      },
      {
        "family": "Granone",
        "given": "V."
      },
      {
        "family": "Protti",
        "given": "A."
      },
      {
        "family": "Gregoretti",
        "given": "C."
      },
      {
        "family": "Giarratano",
        "given": "A."
      },
      {
        "family": "Einav",
        "given": "S."
      },
      {
        "family": "Cecconi",
        "given": "M."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          1
        ]
      ]
    },
    "container-title": "Pulmonology",
    "DOI": "10.1016/j.pulmoe.2020.07.003",
    "volume": "27",
    "issue": "1",
    "page": "52-66",
    "publisher": "Elsevier BV",
    "title": "Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review",
    "URL": "https://doi.org/gg5xv3",
    "PMCID": "PMC7369580",
    "PMID": "32713784",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.pulmoe.2020.07.003\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: h4reluu"
  },
  {
    "type": "article-journal",
    "id": "1FTnvyZlf",
    "author": [
      {
        "family": "Pelegrin",
        "given": "Mireia"
      },
      {
        "family": "Naranjo-Gomez",
        "given": "Mar"
      },
      {
        "family": "Piechaczyk",
        "given": "Marc"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2015,
          10
        ]
      ]
    },
    "container-title": "Trends in Microbiology",
    "DOI": "10.1016/j.tim.2015.07.005",
    "volume": "23",
    "issue": "10",
    "page": "653-665",
    "publisher": "Elsevier BV",
    "title": "Antiviral Monoclonal Antibodies: Can They Be More Than Simple Neutralizing Agents?",
    "URL": "https://doi.org/f7vzrf",
    "PMCID": "PMC7127033",
    "PMID": "26433697",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.tim.2015.07.005\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 1FTnvyZlf"
  },
  {
    "type": "article-journal",
    "id": "1BgpXRivf",
    "author": [
      {
        "family": "Mercorelli",
        "given": "Beatrice"
      },
      {
        "family": "Palù",
        "given": "Giorgio"
      },
      {
        "family": "Loregian",
        "given": "Arianna"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          10
        ]
      ]
    },
    "container-title": "Trends in Microbiology",
    "DOI": "10.1016/j.tim.2018.04.004",
    "volume": "26",
    "issue": "10",
    "page": "865-876",
    "publisher": "Elsevier BV",
    "title": "Drug Repurposing for Viral Infectious Diseases: How Far Are We?",
    "URL": "https://doi.org/gfbp3h",
    "PMCID": "PMC7126639",
    "PMID": "29759926",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/j.tim.2018.04.004"
  },
  {
    "type": "article-journal",
    "id": "161Tg5PUW",
    "author": [
      {
        "family": "Turner",
        "given": "Anthony J"
      },
      {
        "family": "Hiscox",
        "given": "Julian A"
      },
      {
        "family": "Hooper",
        "given": "Nigel M"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2004,
          6
        ]
      ]
    },
    "container-title": "Trends in Pharmacological Sciences",
    "DOI": "10.1016/j.tips.2004.04.001",
    "volume": "25",
    "issue": "6",
    "page": "291-294",
    "publisher": "Elsevier BV",
    "title": "ACE2: from vasopeptidase to SARS virus receptor",
    "URL": "https://doi.org/dn77dn",
    "PMCID": "PMC7119032",
    "PMID": "15165741",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/j.tips.2004.04.001"
  },
  {
    "type": "article-journal",
    "id": "19R52ruRw",
    "author": [
      {
        "family": "Renn",
        "given": "Alex"
      },
      {
        "family": "Fu",
        "given": "Ying"
      },
      {
        "family": "Hu",
        "given": "Xin"
      },
      {
        "family": "Hall",
        "given": "Matthew D."
      },
      {
        "family": "Simeonov",
        "given": "Anton"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          11
        ]
      ]
    },
    "container-title": "Trends in Pharmacological Sciences",
    "DOI": "10.1016/j.tips.2020.07.004",
    "volume": "41",
    "issue": "11",
    "page": "815-829",
    "publisher": "Elsevier BV",
    "title": "Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2",
    "URL": "https://doi.org/gg72sv",
    "PMCID": "PMC7572790",
    "PMID": "32829936",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/j.tips.2020.07.004"
  },
  {
    "type": "article-journal",
    "id": "1BBiGYn1K",
    "author": [
      {
        "family": "Mohs",
        "given": "Richard C."
      },
      {
        "family": "Greig",
        "given": "Nigel H."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          11
        ]
      ]
    },
    "container-title": "Alzheimer's & Dementia: Translational Research & Clinical Interventions",
    "DOI": "10.1016/j.trci.2017.10.005",
    "volume": "3",
    "issue": "4",
    "page": "651-657",
    "publisher": "Wiley",
    "title": "Drug discovery and development: Role of basic biological research",
    "URL": "https://doi.org/gf92kj",
    "PMCID": "PMC5725284",
    "PMID": "29255791",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/j.trci.2017.10.005"
  },
  {
    "type": "article-journal",
    "id": "NtlqU5Jy",
    "author": [
      {
        "family": "He",
        "given": "Yuxian"
      },
      {
        "family": "Li",
        "given": "Jingjing"
      },
      {
        "family": "Du",
        "given": "Lanying"
      },
      {
        "family": "Yan",
        "given": "Xuxia"
      },
      {
        "family": "Hu",
        "given": "Guangan"
      },
      {
        "family": "Zhou",
        "given": "Yusen"
      },
      {
        "family": "Jiang",
        "given": "Shibo"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2006,
          6
        ]
      ]
    },
    "container-title": "Vaccine",
    "DOI": "10.1016/j.vaccine.2006.04.054",
    "volume": "24",
    "issue": "26",
    "page": "5498-5508",
    "publisher": "Elsevier BV",
    "title": "Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: Revealing the critical antigenic determinants in inactivated SARS-CoV vaccine",
    "URL": "https://doi.org/b99b68",
    "PMCID": "PMC7115380",
    "PMID": "16725238",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/j.vaccine.2006.04.054"
  },
  {
    "type": "article-journal",
    "id": "Nfu9kiae",
    "author": [
      {
        "family": "DeDiego",
        "given": "Marta L."
      },
      {
        "family": "Nieto-Torres",
        "given": "Jose L."
      },
      {
        "family": "Jimenez-Guardeño",
        "given": "Jose M."
      },
      {
        "family": "Regla-Nava",
        "given": "Jose A."
      },
      {
        "family": "Castaño-Rodriguez",
        "given": "Carlos"
      },
      {
        "family": "Fernandez-Delgado",
        "given": "Raul"
      },
      {
        "family": "Usera",
        "given": "Fernando"
      },
      {
        "family": "Enjuanes",
        "given": "Luis"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2014,
          12
        ]
      ]
    },
    "container-title": "Virus Research",
    "DOI": "10.1016/j.virusres.2014.07.024",
    "volume": "194",
    "page": "124-137",
    "publisher": "Elsevier BV",
    "title": "Coronavirus virulence genes with main focus on SARS-CoV envelope gene",
    "URL": "https://doi.org/f6wm24",
    "PMCID": "PMC4261026",
    "PMID": "25093995",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.virusres.2014.07.024\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: Nfu9kiae"
  },
  {
    "type": "article-journal",
    "id": "9rA6s6Qp",
    "author": [
      {
        "family": "Dimitrov",
        "given": "Dimiter S"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2003,
          12
        ]
      ]
    },
    "container-title": "Cell",
    "DOI": "10.1016/s0092-8674(03)00976-0",
    "volume": "115",
    "issue": "6",
    "page": "652-653",
    "publisher": "Elsevier BV",
    "title": "The Secret Life of ACE2 as a Receptor for the SARS Virus",
    "URL": "https://doi.org/d85vmw",
    "PMCID": "PMC7133233",
    "PMID": "14675530",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/s0092-8674(03)00976-0"
  },
  {
    "type": "article-journal",
    "id": "gmWrMKlb",
    "author": [
      {
        "family": "Nicholls",
        "given": "John M"
      },
      {
        "family": "Poon",
        "given": "Leo LM"
      },
      {
        "family": "Lee",
        "given": "Kam C"
      },
      {
        "family": "Ng",
        "given": "Wai F"
      },
      {
        "family": "Lai",
        "given": "Sik T"
      },
      {
        "family": "Leung",
        "given": "Chung Y"
      },
      {
        "family": "Chu",
        "given": "Chung M"
      },
      {
        "family": "Hui",
        "given": "Pak K"
      },
      {
        "family": "Mak",
        "given": "Kong L"
      },
      {
        "family": "Lim",
        "given": "Wilna"
      },
      {
        "family": "Yan",
        "given": "Kin W"
      },
      {
        "family": "Chan",
        "given": "Kwok H"
      },
      {
        "family": "Tsang",
        "given": "Ngai C"
      },
      {
        "family": "Guan",
        "given": "Yi"
      },
      {
        "family": "Yuen",
        "given": "Kwok Y"
      },
      {
        "family": "Malik Peiris",
        "given": "JS"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2003,
          5
        ]
      ]
    },
    "container-title": "The Lancet",
    "DOI": "10.1016/s0140-6736(03)13413-7",
    "volume": "361",
    "issue": "9371",
    "page": "1773-1778",
    "publisher": "Elsevier BV",
    "title": "Lung pathology of fatal severe acute respiratory syndrome",
    "URL": "https://doi.org/c8mmbg",
    "PMCID": "PMC7112492",
    "PMID": "12781536",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/s0140-6736(03)13413-7"
  },
  {
    "type": "article-journal",
    "id": "1Fqilxaum",
    "author": [
      {
        "family": "Lu",
        "given": "Roujian"
      },
      {
        "family": "Zhao",
        "given": "Xiang"
      },
      {
        "family": "Li",
        "given": "Juan"
      },
      {
        "family": "Niu",
        "given": "Peihua"
      },
      {
        "family": "Yang",
        "given": "Bo"
      },
      {
        "family": "Wu",
        "given": "Honglong"
      },
      {
        "family": "Wang",
        "given": "Wenling"
      },
      {
        "family": "Song",
        "given": "Hao"
      },
      {
        "family": "Huang",
        "given": "Baoying"
      },
      {
        "family": "Zhu",
        "given": "Na"
      },
      {
        "family": "Bi",
        "given": "Yuhai"
      },
      {
        "family": "Ma",
        "given": "Xuejun"
      },
      {
        "family": "Zhan",
        "given": "Faxian"
      },
      {
        "family": "Wang",
        "given": "Liang"
      },
      {
        "family": "Hu",
        "given": "Tao"
      },
      {
        "family": "Zhou",
        "given": "Hong"
      },
      {
        "family": "Hu",
        "given": "Zhenhong"
      },
      {
        "family": "Zhou",
        "given": "Weimin"
      },
      {
        "family": "Zhao",
        "given": "Li"
      },
      {
        "family": "Chen",
        "given": "Jing"
      },
      {
        "family": "Meng",
        "given": "Yao"
      },
      {
        "family": "Wang",
        "given": "Ji"
      },
      {
        "family": "Lin",
        "given": "Yang"
      },
      {
        "family": "Yuan",
        "given": "Jianying"
      },
      {
        "family": "Xie",
        "given": "Zhihao"
      },
      {
        "family": "Ma",
        "given": "Jinmin"
      },
      {
        "family": "Liu",
        "given": "William J"
      },
      {
        "family": "Wang",
        "given": "Dayan"
      },
      {
        "family": "Xu",
        "given": "Wenbo"
      },
      {
        "family": "Holmes",
        "given": "Edward C"
      },
      {
        "family": "Gao",
        "given": "George F"
      },
      {
        "family": "Wu",
        "given": "Guizhen"
      },
      {
        "family": "Chen",
        "given": "Weijun"
      },
      {
        "family": "Shi",
        "given": "Weifeng"
      },
      {
        "family": "Tan",
        "given": "Wenjie"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2
        ]
      ]
    },
    "container-title": "The Lancet",
    "DOI": "10.1016/s0140-6736(20)30251-8",
    "volume": "395",
    "issue": "10224",
    "page": "565-574",
    "publisher": "Elsevier BV",
    "title": "Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding",
    "URL": "https://doi.org/ggjr43",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/s0140-6736(20)30251-8\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 1Fqilxaum"
  },
  {
    "type": "article-journal",
    "id": "uCns3aFw",
    "author": [
      {
        "family": "Richardson",
        "given": "Peter"
      },
      {
        "family": "Griffin",
        "given": "Ivan"
      },
      {
        "family": "Tucker",
        "given": "Catherine"
      },
      {
        "family": "Smith",
        "given": "Dan"
      },
      {
        "family": "Oechsle",
        "given": "Olly"
      },
      {
        "family": "Phelan",
        "given": "Anne"
      },
      {
        "family": "Rawling",
        "given": "Michael"
      },
      {
        "family": "Savory",
        "given": "Edward"
      },
      {
        "family": "Stebbing",
        "given": "Justin"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2
        ]
      ]
    },
    "container-title": "The Lancet",
    "DOI": "10.1016/s0140-6736(20)30304-4",
    "volume": "395",
    "issue": "10223",
    "page": "e30-e31",
    "publisher": "Elsevier BV",
    "title": "Baricitinib as potential treatment for 2019-nCoV acute respiratory disease",
    "URL": "https://doi.org/ggnrsx",
    "PMCID": "PMC7137985",
    "PMID": "32032529",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/s0140-6736(20)30304-4\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: uCns3aFw"
  },
  {
    "type": "article-journal",
    "id": "Ji2fchyS",
    "author": [
      {
        "family": "Russell",
        "given": "Clark D"
      },
      {
        "family": "Millar",
        "given": "Jonathan E"
      },
      {
        "family": "Baillie",
        "given": "J Kenneth"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2
        ]
      ]
    },
    "container-title": "The Lancet",
    "DOI": "10.1016/s0140-6736(20)30317-2",
    "volume": "395",
    "issue": "10223",
    "page": "473-475",
    "publisher": "Elsevier BV",
    "title": "Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury",
    "URL": "https://doi.org/ggks86",
    "PMCID": "PMC7134694",
    "PMID": "32043983",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/s0140-6736(20)30317-2\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: Ji2fchyS"
  },
  {
    "type": "article-journal",
    "id": "xndHds7d",
    "author": [
      {
        "family": "Shang",
        "given": "Lianhan"
      },
      {
        "family": "Zhao",
        "given": "Jianping"
      },
      {
        "family": "Hu",
        "given": "Yi"
      },
      {
        "family": "Du",
        "given": "Ronghui"
      },
      {
        "family": "Cao",
        "given": "Bin"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2
        ]
      ]
    },
    "container-title": "The Lancet",
    "DOI": "10.1016/s0140-6736(20)30361-5",
    "volume": "395",
    "issue": "10225",
    "page": "683-684",
    "publisher": "Elsevier BV",
    "title": "On the use of corticosteroids for 2019-nCoV pneumonia",
    "URL": "https://doi.org/ggq356",
    "PMCID": "PMC7159292",
    "PMID": "32122468",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/s0140-6736(20)30361-5\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: xndHds7d"
  },
  {
    "type": "article-journal",
    "id": "10THxyeCg",
    "author": [
      {
        "family": "Zhou",
        "given": "Fei"
      },
      {
        "family": "Yu",
        "given": "Ting"
      },
      {
        "family": "Du",
        "given": "Ronghui"
      },
      {
        "family": "Fan",
        "given": "Guohui"
      },
      {
        "family": "Liu",
        "given": "Ying"
      },
      {
        "family": "Liu",
        "given": "Zhibo"
      },
      {
        "family": "Xiang",
        "given": "Jie"
      },
      {
        "family": "Wang",
        "given": "Yeming"
      },
      {
        "family": "Song",
        "given": "Bin"
      },
      {
        "family": "Gu",
        "given": "Xiaoying"
      },
      {
        "family": "Guan",
        "given": "Lulu"
      },
      {
        "family": "Wei",
        "given": "Yuan"
      },
      {
        "family": "Li",
        "given": "Hui"
      },
      {
        "family": "Wu",
        "given": "Xudong"
      },
      {
        "family": "Xu",
        "given": "Jiuyang"
      },
      {
        "family": "Tu",
        "given": "Shengjin"
      },
      {
        "family": "Zhang",
        "given": "Yi"
      },
      {
        "family": "Chen",
        "given": "Hua"
      },
      {
        "family": "Cao",
        "given": "Bin"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3
        ]
      ]
    },
    "container-title": "The Lancet",
    "DOI": "10.1016/s0140-6736(20)30566-3",
    "volume": "395",
    "issue": "10229",
    "page": "1054-1062",
    "publisher": "Elsevier BV",
    "title": "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study",
    "URL": "https://doi.org/ggnxb3",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/s0140-6736(20)30566-3\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 10THxyeCg"
  },
  {
    "type": "article-journal",
    "id": "3HdlV9Vf",
    "author": [
      {
        "family": "Mehta",
        "given": "Puja"
      },
      {
        "family": "McAuley",
        "given": "Daniel F"
      },
      {
        "family": "Brown",
        "given": "Michael"
      },
      {
        "family": "Sanchez",
        "given": "Emilie"
      },
      {
        "family": "Tattersall",
        "given": "Rachel S"
      },
      {
        "family": "Manson",
        "given": "Jessica J"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3
        ]
      ]
    },
    "container-title": "The Lancet",
    "DOI": "10.1016/s0140-6736(20)30628-0",
    "volume": "395",
    "issue": "10229",
    "page": "1033-1034",
    "publisher": "Elsevier BV",
    "title": "COVID-19: consider cytokine storm syndromes and immunosuppression",
    "URL": "https://doi.org/ggnzmc",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/s0140-6736(20)30628-0\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 3HdlV9Vf"
  },
  {
    "type": "article-journal",
    "id": "suHq6Qnm",
    "author": [
      {
        "family": "Ritchie",
        "given": "Andrew I"
      },
      {
        "family": "Singanayagam",
        "given": "Aran"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4
        ]
      ]
    },
    "container-title": "The Lancet",
    "DOI": "10.1016/s0140-6736(20)30691-7",
    "volume": "395",
    "issue": "10230",
    "page": "1111",
    "publisher": "Elsevier BV",
    "title": "Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?",
    "URL": "https://doi.org/ggq8hs",
    "PMCID": "PMC7138169",
    "PMID": "32220278",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/s0140-6736(20)30691-7\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: suHq6Qnm"
  },
  {
    "type": "article-journal",
    "id": "1BApBNHvd",
    "author": [
      {
        "family": "Mehra",
        "given": "Mandeep R"
      },
      {
        "family": "Desai",
        "given": "Sapan S"
      },
      {
        "family": "Ruschitzka",
        "given": "Frank"
      },
      {
        "family": "Patel",
        "given": "Amit N"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          5
        ]
      ]
    },
    "container-title": "The Lancet",
    "DOI": "10.1016/s0140-6736(20)31180-6",
    "page": "S0140673620311806",
    "publisher": "Elsevier BV",
    "title": "RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis",
    "URL": "https://doi.org/ggwzsb",
    "PMCID": "PMC7255293",
    "PMID": "32450107",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/s0140-6736(20)31180-6\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 1BApBNHvd"
  },
  {
    "type": "article-journal",
    "id": "11FsxWalS",
    "author": [
      {
        "family": "Mehra",
        "given": "Mandeep R"
      },
      {
        "family": "Ruschitzka",
        "given": "Frank"
      },
      {
        "family": "Patel",
        "given": "Amit N"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          6
        ]
      ]
    },
    "container-title": "The Lancet",
    "DOI": "10.1016/s0140-6736(20)31324-6",
    "volume": "395",
    "issue": "10240",
    "page": "1820",
    "publisher": "Elsevier BV",
    "title": "Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis",
    "URL": "https://doi.org/ggzqng",
    "PMCID": "PMC7274621",
    "PMID": "32511943",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/s0140-6736(20)31324-6\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 11FsxWalS"
  },
  {
    "type": "article-journal",
    "id": "fTWlYlvp",
    "author": [
      {
        "family": "Horby",
        "given": "Peter W"
      },
      {
        "family": "Mafham",
        "given": "Marion"
      },
      {
        "family": "Bell",
        "given": "Jennifer L"
      },
      {
        "family": "Linsell",
        "given": "Louise"
      },
      {
        "family": "Staplin",
        "given": "Natalie"
      },
      {
        "family": "Emberson",
        "given": "Jonathan"
      },
      {
        "family": "Palfreeman",
        "given": "Adrian"
      },
      {
        "family": "Raw",
        "given": "Jason"
      },
      {
        "family": "Elmahi",
        "given": "Einas"
      },
      {
        "family": "Prudon",
        "given": "Benjamin"
      },
      {
        "family": "Green",
        "given": "Christopher"
      },
      {
        "family": "Carley",
        "given": "Simon"
      },
      {
        "family": "Chadwick",
        "given": "David"
      },
      {
        "family": "Davies",
        "given": "Matthew"
      },
      {
        "family": "Wise",
        "given": "Matthew P"
      },
      {
        "family": "Baillie",
        "given": "J Kenneth"
      },
      {
        "family": "Chappell",
        "given": "Lucy C"
      },
      {
        "family": "Faust",
        "given": "Saul N"
      },
      {
        "family": "Jaki",
        "given": "Thomas"
      },
      {
        "family": "Jefferey",
        "given": "Katie"
      },
      {
        "family": "Lim",
        "given": "Wei Shen"
      },
      {
        "family": "Montgomery",
        "given": "Alan"
      },
      {
        "family": "Rowan",
        "given": "Kathryn"
      },
      {
        "family": "Juszczak",
        "given": "Edmund"
      },
      {
        "family": "Haynes",
        "given": "Richard"
      },
      {
        "family": "Landray",
        "given": "Martin J"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          10
        ]
      ]
    },
    "container-title": "The Lancet",
    "DOI": "10.1016/s0140-6736(20)32013-4",
    "volume": "396",
    "issue": "10259",
    "page": "1345-1352",
    "publisher": "Elsevier BV",
    "title": "Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial",
    "URL": "https://doi.org/fnx2",
    "PMCID": "PMC7535623",
    "PMID": "33031764",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/s0140-6736(20)32013-4\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: fTWlYlvp"
  },
  {
    "type": "article-journal",
    "id": "sUAAY1me",
    "author": [
      {
        "family": "Greenhalgh",
        "given": "Trisha"
      },
      {
        "family": "Jimenez",
        "given": "Jose L"
      },
      {
        "family": "Prather",
        "given": "Kimberly A"
      },
      {
        "family": "Tufekci",
        "given": "Zeynep"
      },
      {
        "family": "Fisman",
        "given": "David"
      },
      {
        "family": "Schooley",
        "given": "Robert"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          5
        ]
      ]
    },
    "container-title": "The Lancet",
    "DOI": "10.1016/s0140-6736(21)00869-2",
    "volume": "397",
    "issue": "10285",
    "page": "1603-1605",
    "publisher": "Elsevier BV",
    "title": "Ten scientific reasons in support of airborne transmission of SARS-CoV-2",
    "URL": "https://doi.org/gjqmvq",
    "PMCID": "PMC8049599",
    "PMID": "33865497",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/s0140-6736(21)00869-2"
  },
  {
    "type": "article-journal",
    "id": "U1nCE851",
    "author": [
      {
        "family": "Dong",
        "given": "Ensheng"
      },
      {
        "family": "Du",
        "given": "Hongru"
      },
      {
        "family": "Gardner",
        "given": "Lauren"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          5
        ]
      ]
    },
    "container-title": "The Lancet Infectious Diseases",
    "DOI": "10.1016/s1473-3099(20)30120-1",
    "volume": "20",
    "issue": "5",
    "page": "533-534",
    "publisher": "Elsevier BV",
    "title": "An interactive web-based dashboard to track COVID-19 in real time",
    "URL": "https://doi.org/ggnsjk",
    "PMCID": "PMC7159018",
    "PMID": "32087114",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/s1473-3099(20)30120-1"
  },
  {
    "type": "article-journal",
    "id": "WF7ymA4m",
    "author": [
      {
        "family": "Stebbing",
        "given": "Justin"
      },
      {
        "family": "Phelan",
        "given": "Anne"
      },
      {
        "family": "Griffin",
        "given": "Ivan"
      },
      {
        "family": "Tucker",
        "given": "Catherine"
      },
      {
        "family": "Oechsle",
        "given": "Olly"
      },
      {
        "family": "Smith",
        "given": "Dan"
      },
      {
        "family": "Richardson",
        "given": "Peter"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4
        ]
      ]
    },
    "container-title": "The Lancet Infectious Diseases",
    "DOI": "10.1016/s1473-3099(20)30132-8",
    "volume": "20",
    "issue": "4",
    "page": "400-402",
    "publisher": "Elsevier BV",
    "title": "COVID-19: combining antiviral and anti-inflammatory treatments",
    "URL": "https://doi.org/dph5",
    "PMCID": "PMC7158903",
    "PMID": "32113509",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/s1473-3099(20)30132-8\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: WF7ymA4m"
  },
  {
    "type": "article-journal",
    "id": "f52YwpY3",
    "author": [
      {
        "family": "Chen",
        "given": "Long"
      },
      {
        "family": "Xiong",
        "given": "Jing"
      },
      {
        "family": "Bao",
        "given": "Lei"
      },
      {
        "family": "Shi",
        "given": "Yuan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4
        ]
      ]
    },
    "container-title": "The Lancet Infectious Diseases",
    "DOI": "10.1016/s1473-3099(20)30141-9",
    "volume": "20",
    "issue": "4",
    "page": "398-400",
    "publisher": "Elsevier BV",
    "title": "Convalescent plasma as a potential therapy for COVID-19",
    "URL": "https://doi.org/ggqr7s",
    "PMCID": "PMC7128218",
    "PMID": "32113510",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/s1473-3099(20)30141-9"
  },
  {
    "type": "article-journal",
    "id": "cw5j7x80",
    "author": [
      {
        "family": "Goldman",
        "given": "Emanuel"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          8
        ]
      ]
    },
    "container-title": "The Lancet Infectious Diseases",
    "DOI": "10.1016/s1473-3099(20)30561-2",
    "volume": "20",
    "issue": "8",
    "page": "892-893",
    "publisher": "Elsevier BV",
    "title": "Exaggerated risk of transmission of COVID-19 by fomites",
    "URL": "https://doi.org/gg6br7",
    "PMCID": "PMC7333993",
    "PMID": "32628907",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/s1473-3099(20)30561-2\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: cw5j7x80"
  },
  {
    "type": "article-journal",
    "id": "qwlYY6jn",
    "author": [
      {
        "family": "Pilkington",
        "given": "Victoria"
      },
      {
        "family": "Pepperrell",
        "given": "Toby"
      },
      {
        "family": "Hill",
        "given": "Andrew"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4
        ]
      ]
    },
    "container-title": "Journal of Virus Eradication",
    "DOI": "10.1016/s2055-6640(20)30016-9",
    "volume": "6",
    "issue": "2",
    "page": "45-51",
    "publisher": "Elsevier BV",
    "title": "A review of the safety of favipiravir – a potential treatment in the COVID-19 pandemic?",
    "URL": "https://doi.org/ftgm",
    "PMCID": "PMC7331506",
    "PMID": "32405421",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/s2055-6640(20)30016-9\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: qwlYY6jn"
  },
  {
    "type": "article-journal",
    "id": "1DUXbHUEW",
    "author": [
      {
        "family": "Villar",
        "given": "Jesús"
      },
      {
        "family": "Ferrando",
        "given": "Carlos"
      },
      {
        "family": "Martínez",
        "given": "Domingo"
      },
      {
        "family": "Ambrós",
        "given": "Alfonso"
      },
      {
        "family": "Muñoz",
        "given": "Tomás"
      },
      {
        "family": "Soler",
        "given": "Juan A"
      },
      {
        "family": "Aguilar",
        "given": "Gerardo"
      },
      {
        "family": "Alba",
        "given": "Francisco"
      },
      {
        "family": "González-Higueras",
        "given": "Elena"
      },
      {
        "family": "Conesa",
        "given": "Luís A"
      },
      {
        "family": "Martín-Rodríguez",
        "given": "Carmen"
      },
      {
        "family": "Díaz-Domínguez",
        "given": "Francisco J"
      },
      {
        "family": "Serna-Grande",
        "given": "Pablo"
      },
      {
        "family": "Rivas",
        "given": "Rosana"
      },
      {
        "family": "Ferreres",
        "given": "José"
      },
      {
        "family": "Belda",
        "given": "Javier"
      },
      {
        "family": "Capilla",
        "given": "Lucía"
      },
      {
        "family": "Tallet",
        "given": "Alec"
      },
      {
        "family": "Añón",
        "given": "José M"
      },
      {
        "family": "Fernández",
        "given": "Rosa L"
      },
      {
        "family": "González-Martín",
        "given": "Jesús M"
      },
      {
        "family": "Aguilar",
        "given": "Gerardo"
      },
      {
        "family": "Alba",
        "given": "Francisco"
      },
      {
        "family": "Álvarez",
        "given": "Julián"
      },
      {
        "family": "Ambrós",
        "given": "Alfonso"
      },
      {
        "family": "Añón",
        "given": "José M."
      },
      {
        "family": "Asensio",
        "given": "María J."
      },
      {
        "family": "Belda",
        "given": "Javier"
      },
      {
        "family": "Blanco",
        "given": "Jesús"
      },
      {
        "family": "Blasco",
        "given": "Marisa"
      },
      {
        "family": "Cachafeiro",
        "given": "Lucia"
      },
      {
        "family": "del Campo",
        "given": "Rafael"
      },
      {
        "family": "Capilla",
        "given": "Lucía"
      },
      {
        "family": "Carbonell",
        "given": "José A."
      },
      {
        "family": "Carbonell",
        "given": "Nieves"
      },
      {
        "family": "Cariñena",
        "given": "Agustín"
      },
      {
        "family": "Carriedo",
        "given": "Demetrio"
      },
      {
        "family": "Chico",
        "given": "Mario"
      },
      {
        "family": "Conesa",
        "given": "Luís A."
      },
      {
        "family": "Corpas",
        "given": "Ruth"
      },
      {
        "family": "Cuervo",
        "given": "Javier"
      },
      {
        "family": "Díaz-Domínguez",
        "given": "Francisco J."
      },
      {
        "family": "Domínguez-Antelo",
        "given": "Cristina"
      },
      {
        "family": "Fernández",
        "given": "Lorena"
      },
      {
        "family": "Fernández",
        "given": "Rosa L."
      },
      {
        "family": "Ferrando",
        "given": "Carlos"
      },
      {
        "family": "Ferreres",
        "given": "José"
      },
      {
        "family": "Gamboa",
        "given": "Eneritz"
      },
      {
        "family": "González-Higueras",
        "given": "Elena"
      },
      {
        "family": "González-Luengo",
        "given": "Raúl I."
      },
      {
        "family": "González-Martín",
        "given": "Jesús M."
      },
      {
        "family": "Martínez",
        "given": "Domingo"
      },
      {
        "family": "Martín-Rodríguez",
        "given": "Carmen"
      },
      {
        "family": "Muñoz",
        "given": "Tomás"
      },
      {
        "family": "Ortiz Díaz-Miguel",
        "given": "Ramón"
      },
      {
        "family": "Pérez-González",
        "given": "Raquel"
      },
      {
        "family": "Prieto",
        "given": "Ana M."
      },
      {
        "family": "Prieto",
        "given": "Isidro"
      },
      {
        "family": "Rivas",
        "given": "Rosana"
      },
      {
        "family": "Rojas-Viguera",
        "given": "Leticia"
      },
      {
        "family": "Romera",
        "given": "Miguel A."
      },
      {
        "family": "Sánchez-Ballesteros",
        "given": "Jesús"
      },
      {
        "family": "Segura",
        "given": "José M."
      },
      {
        "family": "Serna-Grande",
        "given": "Pablo"
      },
      {
        "family": "Serrano",
        "given": "Ainhoa"
      },
      {
        "family": "Solano",
        "given": "Rosario"
      },
      {
        "family": "Soler",
        "given": "Juan A."
      },
      {
        "family": "Soro",
        "given": "Marina"
      },
      {
        "family": "Tallet",
        "given": "Alec"
      },
      {
        "family": "Villar",
        "given": "Jesús"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3
        ]
      ]
    },
    "container-title": "The Lancet Respiratory Medicine",
    "DOI": "10.1016/s2213-2600(19)30417-5",
    "volume": "8",
    "issue": "3",
    "page": "267-276",
    "publisher": "Elsevier BV",
    "title": "Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial",
    "URL": "https://doi.org/ggpxzc",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/s2213-2600(19)30417-5\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 1DUXbHUEW"
  },
  {
    "type": "article-journal",
    "id": "WhuiEHlo",
    "author": [
      {
        "family": "Reddy",
        "given": "Kiran"
      },
      {
        "family": "O'Kane",
        "given": "Cecilia"
      },
      {
        "family": "McAuley",
        "given": "Daniel"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3
        ]
      ]
    },
    "container-title": "The Lancet Respiratory Medicine",
    "DOI": "10.1016/s2213-2600(20)30048-5",
    "volume": "8",
    "issue": "3",
    "page": "220-222",
    "publisher": "Elsevier BV",
    "title": "Corticosteroids in acute respiratory distress syndrome: a step forward, but more evidence is needed",
    "URL": "https://doi.org/gcv2",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/s2213-2600(20)30048-5"
  },
  {
    "type": "article-journal",
    "id": "TytQ90Bl",
    "author": [
      {
        "family": "Matthay",
        "given": "Michael A"
      },
      {
        "family": "Thompson",
        "given": "B Taylor"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          12
        ]
      ]
    },
    "container-title": "The Lancet Respiratory Medicine",
    "DOI": "10.1016/s2213-2600(20)30503-8",
    "volume": "8",
    "issue": "12",
    "page": "1170-1172",
    "publisher": "Elsevier BV",
    "title": "Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties",
    "URL": "https://doi.org/ftk4",
    "PMCID": "PMC7598750",
    "PMID": "33129421",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/s2213-2600(20)30503-8"
  },
  {
    "type": "article-journal",
    "id": "qFDbLzcP",
    "author": [
      {
        "family": "Monk",
        "given": "Phillip D"
      },
      {
        "family": "Marsden",
        "given": "Richard J"
      },
      {
        "family": "Tear",
        "given": "Victoria J"
      },
      {
        "family": "Brookes",
        "given": "Jody"
      },
      {
        "family": "Batten",
        "given": "Toby N"
      },
      {
        "family": "Mankowski",
        "given": "Marcin"
      },
      {
        "family": "Gabbay",
        "given": "Felicity J"
      },
      {
        "family": "Davies",
        "given": "Donna E"
      },
      {
        "family": "Holgate",
        "given": "Stephen T"
      },
      {
        "family": "Ho",
        "given": "Ling-Pei"
      },
      {
        "family": "Clark",
        "given": "Tristan"
      },
      {
        "family": "Djukanovic",
        "given": "Ratko"
      },
      {
        "family": "Wilkinson",
        "given": "Tom M A"
      },
      {
        "family": "Crooks",
        "given": "Michael G"
      },
      {
        "family": "Dosanjh",
        "given": "Davinder PS"
      },
      {
        "family": "Siddiqui",
        "given": "Salman"
      },
      {
        "family": "Rahman",
        "given": "Najib M"
      },
      {
        "family": "Smith",
        "given": "Jacklyn A"
      },
      {
        "family": "Horsley",
        "given": "Alexander"
      },
      {
        "family": "Harrison",
        "given": "Timothy W"
      },
      {
        "family": "Saralaya",
        "given": "Dinesh"
      },
      {
        "family": "McGarvey",
        "given": "Lorcan"
      },
      {
        "family": "Watson",
        "given": "Alastair"
      },
      {
        "family": "Foster",
        "given": "Edmund"
      },
      {
        "family": "Fleet",
        "given": "Adam"
      },
      {
        "family": "Singh",
        "given": "Dave"
      },
      {
        "family": "Hemmings",
        "given": "Sophie"
      },
      {
        "family": "Aitken",
        "given": "Sandra"
      },
      {
        "family": "Dudley",
        "given": "Sarah"
      },
      {
        "family": "Beegan",
        "given": "Rona"
      },
      {
        "family": "Thompson",
        "given": "Angela"
      },
      {
        "family": "Rodrigues",
        "given": "Pedro MB"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          2
        ]
      ]
    },
    "container-title": "The Lancet Respiratory Medicine",
    "DOI": "10.1016/s2213-2600(20)30511-7",
    "volume": "9",
    "issue": "2",
    "page": "196-206",
    "publisher": "Elsevier BV",
    "title": "Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial",
    "URL": "https://doi.org/ghjzm4",
    "PMCID": "PMC7836724",
    "PMID": "33189161",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/s2213-2600(20)30511-7"
  },
  {
    "type": "article-journal",
    "id": "11hbhD5Rk",
    "author": [
      {
        "family": "Peiffer-Smadja",
        "given": "Nathan"
      },
      {
        "family": "Yazdanpanah",
        "given": "Yazdan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          2
        ]
      ]
    },
    "container-title": "The Lancet Respiratory Medicine",
    "DOI": "10.1016/s2213-2600(20)30523-3",
    "volume": "9",
    "issue": "2",
    "page": "122-123",
    "publisher": "Elsevier BV",
    "title": "Nebulised interferon beta-1a for patients with COVID-19",
    "URL": "https://doi.org/ftmj",
    "PMCID": "PMC7833737",
    "PMID": "33189160",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/s2213-2600(20)30523-3"
  },
  {
    "type": "article-journal",
    "id": "IRuDYZRB",
    "author": [
      {
        "family": "Cohen",
        "given": "Jordana B"
      },
      {
        "family": "Hanff",
        "given": "Thomas C"
      },
      {
        "family": "William",
        "given": "Preethi"
      },
      {
        "family": "Sweitzer",
        "given": "Nancy"
      },
      {
        "family": "Rosado-Santander",
        "given": "Nelson R"
      },
      {
        "family": "Medina",
        "given": "Carola"
      },
      {
        "family": "Rodriguez-Mori",
        "given": "Juan E"
      },
      {
        "family": "Renna",
        "given": "Nicolás"
      },
      {
        "family": "Chang",
        "given": "Tara I"
      },
      {
        "family": "Corrales-Medina",
        "given": "Vicente"
      },
      {
        "family": "Andrade-Villanueva",
        "given": "Jaime F"
      },
      {
        "family": "Barbagelata",
        "given": "Alejandro"
      },
      {
        "family": "Cristodulo-Cortez",
        "given": "Roberto"
      },
      {
        "family": "Díaz-Cucho",
        "given": "Omar A"
      },
      {
        "family": "Spaak",
        "given": "Jonas"
      },
      {
        "family": "Alfonso",
        "given": "Carlos E"
      },
      {
        "family": "Valdivia-Vega",
        "given": "Renzo"
      },
      {
        "family": "Villavicencio-Carranza",
        "given": "Mirko"
      },
      {
        "family": "Ayala-García",
        "given": "Ricardo J"
      },
      {
        "family": "Castro-Callirgos",
        "given": "Carlos A"
      },
      {
        "family": "González-Hernández",
        "given": "Luz A"
      },
      {
        "family": "Bernales-Salas",
        "given": "Eduardo F"
      },
      {
        "family": "Coacalla-Guerra",
        "given": "Johanna C"
      },
      {
        "family": "Salinas-Herrera",
        "given": "Cynthia D"
      },
      {
        "family": "Nicolosi",
        "given": "Liliana"
      },
      {
        "family": "Basconcel",
        "given": "Mauro"
      },
      {
        "family": "Byrd",
        "given": "James B"
      },
      {
        "family": "Sharkoski",
        "given": "Tiffany"
      },
      {
        "family": "Bendezú-Huasasquiche",
        "given": "Luis E"
      },
      {
        "family": "Chittams",
        "given": "Jesse"
      },
      {
        "family": "Edmonston",
        "given": "Daniel L"
      },
      {
        "family": "Vasquez",
        "given": "Charles R"
      },
      {
        "family": "Chirinos",
        "given": "Julio A"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          3
        ]
      ]
    },
    "container-title": "The Lancet Respiratory Medicine",
    "DOI": "10.1016/s2213-2600(20)30558-0",
    "volume": "9",
    "issue": "3",
    "page": "275-284",
    "publisher": "Elsevier BV",
    "title": "Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial",
    "URL": "https://doi.org/fvgt",
    "PMCID": "PMC7832152",
    "PMID": "33422263",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/s2213-2600(20)30558-0"
  },
  {
    "type": "article-journal",
    "id": "1E4Qx2UqB",
    "author": [
      {
        "family": "Brotherton",
        "given": "Helen"
      },
      {
        "family": "Usuf",
        "given": "Effua"
      },
      {
        "family": "Nadjm",
        "given": "Behzad"
      },
      {
        "family": "Forrest",
        "given": "Karen"
      },
      {
        "family": "Bojang",
        "given": "Kalifa"
      },
      {
        "family": "Samateh",
        "given": "Ahmadou Lamin"
      },
      {
        "family": "Bittaye",
        "given": "Mustapha"
      },
      {
        "family": "Roberts",
        "given": "Charles AP"
      },
      {
        "family": "d'Alessandro",
        "given": "Umberto"
      },
      {
        "family": "Roca",
        "given": "Anna"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          9
        ]
      ]
    },
    "container-title": "The Lancet Global Health",
    "DOI": "10.1016/s2214-109x(20)30318-1",
    "volume": "8",
    "issue": "9",
    "page": "e1125-e1126",
    "publisher": "Elsevier BV",
    "title": "Dexamethasone for COVID-19: data needed from randomised clinical trials in Africa",
    "URL": "https://doi.org/gg42kx",
    "PMCID": "PMC7833918",
    "PMID": "32679038",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1016/s2214-109x(20)30318-1"
  },
  {
    "type": "article-journal",
    "id": "ayc7zYqi",
    "author": [
      {
        "family": "Guaraldi",
        "given": "Giovanni"
      },
      {
        "family": "Meschiari",
        "given": "Marianna"
      },
      {
        "family": "Cozzi-Lepri",
        "given": "Alessandro"
      },
      {
        "family": "Milic",
        "given": "Jovana"
      },
      {
        "family": "Tonelli",
        "given": "Roberto"
      },
      {
        "family": "Menozzi",
        "given": "Marianna"
      },
      {
        "family": "Franceschini",
        "given": "Erica"
      },
      {
        "family": "Cuomo",
        "given": "Gianluca"
      },
      {
        "family": "Orlando",
        "given": "Gabriella"
      },
      {
        "family": "Borghi",
        "given": "Vanni"
      },
      {
        "family": "Santoro",
        "given": "Antonella"
      },
      {
        "family": "Di Gaetano",
        "given": "Margherita"
      },
      {
        "family": "Puzzolante",
        "given": "Cinzia"
      },
      {
        "family": "Carli",
        "given": "Federica"
      },
      {
        "family": "Bedini",
        "given": "Andrea"
      },
      {
        "family": "Corradi",
        "given": "Luca"
      },
      {
        "family": "Fantini",
        "given": "Riccardo"
      },
      {
        "family": "Castaniere",
        "given": "Ivana"
      },
      {
        "family": "Tabbì",
        "given": "Luca"
      },
      {
        "family": "Girardis",
        "given": "Massimo"
      },
      {
        "family": "Tedeschi",
        "given": "Sara"
      },
      {
        "family": "Giannella",
        "given": "Maddalena"
      },
      {
        "family": "Bartoletti",
        "given": "Michele"
      },
      {
        "family": "Pascale",
        "given": "Renato"
      },
      {
        "family": "Dolci",
        "given": "Giovanni"
      },
      {
        "family": "Brugioni",
        "given": "Lucio"
      },
      {
        "family": "Pietrangelo",
        "given": "Antonello"
      },
      {
        "family": "Cossarizza",
        "given": "Andrea"
      },
      {
        "family": "Pea",
        "given": "Federico"
      },
      {
        "family": "Clini",
        "given": "Enrico"
      },
      {
        "family": "Salvarani",
        "given": "Carlo"
      },
      {
        "family": "Massari",
        "given": "Marco"
      },
      {
        "family": "Viale",
        "given": "Pier Luigi"
      },
      {
        "family": "Mussini",
        "given": "Cristina"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          8
        ]
      ]
    },
    "container-title": "The Lancet Rheumatology",
    "DOI": "10.1016/s2665-9913(20)30173-9",
    "volume": "2",
    "issue": "8",
    "page": "e474-e484",
    "publisher": "Elsevier BV",
    "title": "Tocilizumab in patients with severe COVID-19: a retrospective cohort study",
    "URL": "https://doi.org/d2pk",
    "PMCID": "PMC7314456",
    "PMID": "32835257",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1016/s2665-9913(20)30173-9\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: ayc7zYqi"
  },
  {
    "type": "article-journal",
    "id": "q0TqfpEr",
    "author": [
      {
        "family": "Khan",
        "given": "M. Omar F."
      },
      {
        "family": "Lee",
        "given": "Henry J."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2008,
          12,
          10
        ]
      ]
    },
    "container-title": "Chemical Reviews",
    "DOI": "10.1021/cr068203e",
    "volume": "108",
    "issue": "12",
    "page": "5131-5145",
    "publisher": "American Chemical Society (ACS)",
    "title": "Synthesis and Pharmacology of Anti-Inflammatory Steroidal Antedrugs",
    "URL": "https://doi.org/cmkrtc",
    "PMCID": "PMC2650492",
    "PMID": "19035773",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1021/cr068203e\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: q0TqfpEr"
  },
  {
    "type": "article-journal",
    "id": "KQ7uhAaa",
    "author": [
      {
        "family": "Arth",
        "given": "Glen E."
      },
      {
        "family": "Johnston",
        "given": "David B. R."
      },
      {
        "family": "Fried",
        "given": "John"
      },
      {
        "family": "Spooncer",
        "given": "William W."
      },
      {
        "family": "Hoff",
        "given": "Dale R."
      },
      {
        "family": "Sarett",
        "given": "Lewis H."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2002,
          5,
          1
        ]
      ]
    },
    "container-title": "Journal of the American Chemical Society",
    "DOI": "10.1021/ja01545a061",
    "volume": "80",
    "issue": "12",
    "page": "3160-3161",
    "publisher": "American Chemical Society (ACS)",
    "title": "16-METHYLATED STEROIDS. I. 16α-METHYLATED ANALOGS OF CORTISONE, A NEW GROUP OF ANTI-INFLAMMATORY STEROIDS",
    "URL": "https://doi.org/cj5c82",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1021/ja01545a061\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: KQ7uhAaa"
  },
  {
    "type": "article-journal",
    "id": "Cd5uMaAr",
    "author": [
      {
        "family": "Biot",
        "given": "Christophe"
      },
      {
        "family": "Daher",
        "given": "Wassim"
      },
      {
        "family": "Chavain",
        "given": "Natascha"
      },
      {
        "family": "Fandeur",
        "given": "Thierry"
      },
      {
        "family": "Khalife",
        "given": "Jamal"
      },
      {
        "family": "Dive",
        "given": "Daniel"
      },
      {
        "family": "De Clercq",
        "given": "Erik"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2006,
          5
        ]
      ]
    },
    "container-title": "Journal of Medicinal Chemistry",
    "DOI": "10.1021/jm0601856",
    "volume": "49",
    "issue": "9",
    "page": "2845-2849",
    "publisher": "American Chemical Society (ACS)",
    "title": "Design and Synthesis of Hydroxyferroquine Derivatives with Antimalarial and Antiviral Activities",
    "URL": "https://doi.org/db4n83",
    "PMID": "16640347",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1021/jm0601856\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: Cd5uMaAr"
  },
  {
    "type": "article-journal",
    "id": "6IJxPIQd",
    "author": [
      {
        "family": "Pushpakom",
        "given": "Sudeep"
      },
      {
        "family": "Iorio",
        "given": "Francesco"
      },
      {
        "family": "Eyers",
        "given": "Patrick A."
      },
      {
        "family": "Escott",
        "given": "K. Jane"
      },
      {
        "family": "Hopper",
        "given": "Shirley"
      },
      {
        "family": "Wells",
        "given": "Andrew"
      },
      {
        "family": "Doig",
        "given": "Andrew"
      },
      {
        "family": "Guilliams",
        "given": "Tim"
      },
      {
        "family": "Latimer",
        "given": "Joanna"
      },
      {
        "family": "McNamee",
        "given": "Christine"
      },
      {
        "family": "Norris",
        "given": "Alan"
      },
      {
        "family": "Sanseau",
        "given": "Philippe"
      },
      {
        "family": "Cavalla",
        "given": "David"
      },
      {
        "family": "Pirmohamed",
        "given": "Munir"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          10,
          12
        ]
      ]
    },
    "container-title": "Nature Reviews Drug Discovery",
    "DOI": "10.1038/nrd.2018.168",
    "volume": "18",
    "issue": "1",
    "page": "41-58",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Drug repurposing: progress, challenges and recommendations",
    "URL": "https://doi.org/gfrbsz",
    "PMID": "30310233",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1038/nrd.2018.168"
  },
  {
    "type": "article-journal",
    "id": "G5NJrE75",
    "author": [
      {
        "family": "de Wit",
        "given": "Emmie"
      },
      {
        "family": "van Doremalen",
        "given": "Neeltje"
      },
      {
        "family": "Falzarano",
        "given": "Darryl"
      },
      {
        "family": "Munster",
        "given": "Vincent J."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2016,
          6,
          27
        ]
      ]
    },
    "container-title": "Nature Reviews Microbiology",
    "DOI": "10.1038/nrmicro.2016.81",
    "volume": "14",
    "issue": "8",
    "page": "523-534",
    "publisher": "Springer Science and Business Media LLC",
    "title": "SARS and MERS: recent insights into emerging coronaviruses",
    "URL": "https://doi.org/f8v5cv",
    "PMCID": "PMC7097822",
    "PMID": "27344959",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1038/nrmicro.2016.81\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: G5NJrE75"
  },
  {
    "type": "article-journal",
    "id": "Rmu8ZB9w",
    "author": [
      {
        "family": "Li",
        "given": "Huan"
      },
      {
        "family": "Chen",
        "given": "Chongxiang"
      },
      {
        "family": "Hu",
        "given": "Fang"
      },
      {
        "family": "Wang",
        "given": "Jiaojiao"
      },
      {
        "family": "Zhao",
        "given": "Qingyu"
      },
      {
        "family": "Gale",
        "given": "Robert Peter"
      },
      {
        "family": "Liang",
        "given": "Yang"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          5,
          5
        ]
      ]
    },
    "container-title": "Leukemia",
    "DOI": "10.1038/s41375-020-0848-3",
    "volume": "34",
    "issue": "6",
    "page": "1503-1511",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis",
    "URL": "https://doi.org/ggv2rb",
    "PMCID": "PMC7199650",
    "PMID": "32372026",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1038/s41375-020-0848-3"
  },
  {
    "type": "article-journal",
    "id": "19dEKfvUE",
    "author": [
      {
        "family": "Zhou",
        "given": "Wei"
      },
      {
        "family": "Liu",
        "given": "Yisi"
      },
      {
        "family": "Tian",
        "given": "Dongdong"
      },
      {
        "family": "Wang",
        "given": "Cheng"
      },
      {
        "family": "Wang",
        "given": "Sa"
      },
      {
        "family": "Cheng",
        "given": "Jing"
      },
      {
        "family": "Hu",
        "given": "Ming"
      },
      {
        "family": "Fang",
        "given": "Minghao"
      },
      {
        "family": "Gao",
        "given": "Yue"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          21
        ]
      ]
    },
    "container-title": "Signal Transduction and Targeted Therapy",
    "DOI": "10.1038/s41392-020-0127-9",
    "volume": "5",
    "issue": "1",
    "page": "18",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia",
    "URL": "https://doi.org/ggqr84",
    "PMCID": "PMC7035340",
    "PMID": "32296012",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1038/s41392-020-0127-9\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 19dEKfvUE"
  },
  {
    "type": "article-journal",
    "id": "u87rwxD8",
    "author": [
      {
        "family": "Shi",
        "given": "Yufang"
      },
      {
        "family": "Wang",
        "given": "Ying"
      },
      {
        "family": "Shao",
        "given": "Changshun"
      },
      {
        "family": "Huang",
        "given": "Jianan"
      },
      {
        "family": "Gan",
        "given": "Jianhe"
      },
      {
        "family": "Huang",
        "given": "Xiaoping"
      },
      {
        "family": "Bucci",
        "given": "Enrico"
      },
      {
        "family": "Piacentini",
        "given": "Mauro"
      },
      {
        "family": "Ippolito",
        "given": "Giuseppe"
      },
      {
        "family": "Melino",
        "given": "Gerry"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          23
        ]
      ]
    },
    "container-title": "Cell Death & Differentiation",
    "DOI": "10.1038/s41418-020-0530-3",
    "volume": "27",
    "issue": "5",
    "page": "1451-1454",
    "publisher": "Springer Science and Business Media LLC",
    "title": "COVID-19 infection: the perspectives on immune responses",
    "URL": "https://doi.org/ggq8td",
    "PMCID": "PMC7091918",
    "PMID": "32205856",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1038/s41418-020-0530-3"
  },
  {
    "type": "article-journal",
    "id": "IhdcvbzC",
    "author": [
      {
        "family": "Wang",
        "given": "Manli"
      },
      {
        "family": "Cao",
        "given": "Ruiyuan"
      },
      {
        "family": "Zhang",
        "given": "Leike"
      },
      {
        "family": "Yang",
        "given": "Xinglou"
      },
      {
        "family": "Liu",
        "given": "Jia"
      },
      {
        "family": "Xu",
        "given": "Mingyue"
      },
      {
        "family": "Shi",
        "given": "Zhengli"
      },
      {
        "family": "Hu",
        "given": "Zhihong"
      },
      {
        "family": "Zhong",
        "given": "Wu"
      },
      {
        "family": "Xiao",
        "given": "Gengfu"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          4
        ]
      ]
    },
    "container-title": "Cell Research",
    "DOI": "10.1038/s41422-020-0282-0",
    "volume": "30",
    "issue": "3",
    "page": "269-271",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro",
    "URL": "https://doi.org/ggkbsg",
    "PMCID": "PMC7054408",
    "PMID": "32020029",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1038/s41422-020-0282-0\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: IhdcvbzC"
  },
  {
    "type": "article-journal",
    "id": "j3rGUH1f",
    "author": [
      {
        "family": "Schrezenmeier",
        "given": "Eva"
      },
      {
        "family": "Dörner",
        "given": "Thomas"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          7
        ]
      ]
    },
    "container-title": "Nature Reviews Rheumatology",
    "DOI": "10.1038/s41584-020-0372-x",
    "volume": "16",
    "issue": "3",
    "page": "155-166",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology",
    "URL": "https://doi.org/ggzjnh",
    "PMID": "32034323",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1038/s41584-020-0372-x\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: j3rGUH1f"
  },
  {
    "type": "article-journal",
    "id": "4Sja6dIz",
    "author": [
      {
        "family": "Jin",
        "given": "Zhenming"
      },
      {
        "family": "Du",
        "given": "Xiaoyu"
      },
      {
        "family": "Xu",
        "given": "Yechun"
      },
      {
        "family": "Deng",
        "given": "Yongqiang"
      },
      {
        "family": "Liu",
        "given": "Meiqin"
      },
      {
        "family": "Zhao",
        "given": "Yao"
      },
      {
        "family": "Zhang",
        "given": "Bing"
      },
      {
        "family": "Li",
        "given": "Xiaofeng"
      },
      {
        "family": "Zhang",
        "given": "Leike"
      },
      {
        "family": "Peng",
        "given": "Chao"
      },
      {
        "family": "Duan",
        "given": "Yinkai"
      },
      {
        "family": "Yu",
        "given": "Jing"
      },
      {
        "family": "Wang",
        "given": "Lin"
      },
      {
        "family": "Yang",
        "given": "Kailin"
      },
      {
        "family": "Liu",
        "given": "Fengjiang"
      },
      {
        "family": "Jiang",
        "given": "Rendi"
      },
      {
        "family": "Yang",
        "given": "Xinglou"
      },
      {
        "family": "You",
        "given": "Tian"
      },
      {
        "family": "Liu",
        "given": "Xiaoce"
      },
      {
        "family": "Yang",
        "given": "Xiuna"
      },
      {
        "family": "Bai",
        "given": "Fang"
      },
      {
        "family": "Liu",
        "given": "Hong"
      },
      {
        "family": "Liu",
        "given": "Xiang"
      },
      {
        "family": "Guddat",
        "given": "Luke W."
      },
      {
        "family": "Xu",
        "given": "Wenqing"
      },
      {
        "family": "Xiao",
        "given": "Gengfu"
      },
      {
        "family": "Qin",
        "given": "Chengfeng"
      },
      {
        "family": "Shi",
        "given": "Zhengli"
      },
      {
        "family": "Jiang",
        "given": "Hualiang"
      },
      {
        "family": "Rao",
        "given": "Zihe"
      },
      {
        "family": "Yang",
        "given": "Haitao"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4,
          9
        ]
      ]
    },
    "container-title": "Nature",
    "DOI": "10.1038/s41586-020-2223-y",
    "volume": "582",
    "issue": "7811",
    "page": "289-293",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors",
    "URL": "https://doi.org/ggrp42",
    "PMID": "32272481",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1038/s41586-020-2223-y\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 4Sja6dIz"
  },
  {
    "type": "article-journal",
    "id": "YigWg7xu",
    "author": [
      {
        "family": "Pinto",
        "given": "Dora"
      },
      {
        "family": "Park",
        "given": "Young-Jun"
      },
      {
        "family": "Beltramello",
        "given": "Martina"
      },
      {
        "family": "Walls",
        "given": "Alexandra C."
      },
      {
        "family": "Tortorici",
        "given": "M. Alejandra"
      },
      {
        "family": "Bianchi",
        "given": "Siro"
      },
      {
        "family": "Jaconi",
        "given": "Stefano"
      },
      {
        "family": "Culap",
        "given": "Katja"
      },
      {
        "family": "Zatta",
        "given": "Fabrizia"
      },
      {
        "family": "De Marco",
        "given": "Anna"
      },
      {
        "family": "Peter",
        "given": "Alessia"
      },
      {
        "family": "Guarino",
        "given": "Barbara"
      },
      {
        "family": "Spreafico",
        "given": "Roberto"
      },
      {
        "family": "Cameroni",
        "given": "Elisabetta"
      },
      {
        "family": "Case",
        "given": "James Brett"
      },
      {
        "family": "Chen",
        "given": "Rita E."
      },
      {
        "family": "Havenar-Daughton",
        "given": "Colin"
      },
      {
        "family": "Snell",
        "given": "Gyorgy"
      },
      {
        "family": "Telenti",
        "given": "Amalio"
      },
      {
        "family": "Virgin",
        "given": "Herbert W."
      },
      {
        "family": "Lanzavecchia",
        "given": "Antonio"
      },
      {
        "family": "Diamond",
        "given": "Michael S."
      },
      {
        "family": "Fink",
        "given": "Katja"
      },
      {
        "family": "Veesler",
        "given": "David"
      },
      {
        "family": "Corti",
        "given": "Davide"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          5,
          18
        ]
      ]
    },
    "container-title": "Nature",
    "DOI": "10.1038/s41586-020-2349-y",
    "volume": "583",
    "issue": "7815",
    "page": "290-295",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody",
    "URL": "https://doi.org/dv4x",
    "PMID": "32422645",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1038/s41586-020-2349-y"
  },
  {
    "type": "article-journal",
    "id": "1EEloBjzn",
    "author": [
      {
        "family": "Rose-John",
        "given": "S"
      },
      {
        "family": "Heinrich",
        "given": "P C"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1994,
          6,
          1
        ]
      ]
    },
    "container-title": "Biochemical Journal",
    "DOI": "10.1042/bj3000281",
    "volume": "300",
    "issue": "2",
    "page": "281-290",
    "publisher": "Portland Press Ltd.",
    "title": "Soluble receptors for cytokines and growth factors: generation and biological function",
    "URL": "https://doi.org/ggqmgd",
    "PMCID": "PMC1138158",
    "PMID": "8002928",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1042/bj3000281\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 1EEloBjzn"
  },
  {
    "type": "article-journal",
    "id": "wNXTNffA",
    "author": [
      {
        "family": "Pasin",
        "given": "Laura"
      },
      {
        "family": "Navalesi",
        "given": "Paolo"
      },
      {
        "family": "Zangrillo",
        "given": "Alberto"
      },
      {
        "family": "Kuzovlev",
        "given": "Artem"
      },
      {
        "family": "Likhvantsev",
        "given": "Valery"
      },
      {
        "family": "Hajjar",
        "given": "Ludhmila Abrahão"
      },
      {
        "family": "Fresilli",
        "given": "Stefano"
      },
      {
        "family": "Lacerda",
        "given": "Marcus Vinicius Guimaraes"
      },
      {
        "family": "Landoni",
        "given": "Giovanni"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          2
        ]
      ]
    },
    "container-title": "Journal of Cardiothoracic and Vascular Anesthesia",
    "DOI": "10.1053/j.jvca.2020.11.057",
    "volume": "35",
    "issue": "2",
    "page": "578-584",
    "publisher": "Elsevier BV",
    "title": "Corticosteroids for Patients With Coronavirus Disease 2019 (COVID-19) With Different Disease Severity: A Meta-Analysis of Randomized Clinical Trials",
    "URL": "https://doi.org/ghzkp9",
    "PMCID": "PMC7698829",
    "PMID": "33298370",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1053/j.jvca.2020.11.057"
  },
  {
    "type": "article-journal",
    "id": "8OnbWuhF",
    "author": [
      {
        "family": "Zhang",
        "given": "Yan"
      },
      {
        "family": "Xiao",
        "given": "Meng"
      },
      {
        "family": "Zhang",
        "given": "Shulan"
      },
      {
        "family": "Xia",
        "given": "Peng"
      },
      {
        "family": "Cao",
        "given": "Wei"
      },
      {
        "family": "Jiang",
        "given": "Wei"
      },
      {
        "family": "Chen",
        "given": "Huan"
      },
      {
        "family": "Ding",
        "given": "Xin"
      },
      {
        "family": "Zhao",
        "given": "Hua"
      },
      {
        "family": "Zhang",
        "given": "Hongmin"
      },
      {
        "family": "Wang",
        "given": "Chunyao"
      },
      {
        "family": "Zhao",
        "given": "Jing"
      },
      {
        "family": "Sun",
        "given": "Xuefeng"
      },
      {
        "family": "Tian",
        "given": "Ran"
      },
      {
        "family": "Wu",
        "given": "Wei"
      },
      {
        "family": "Wu",
        "given": "Dong"
      },
      {
        "family": "Ma",
        "given": "Jie"
      },
      {
        "family": "Chen",
        "given": "Yu"
      },
      {
        "family": "Zhang",
        "given": "Dong"
      },
      {
        "family": "Xie",
        "given": "Jing"
      },
      {
        "family": "Yan",
        "given": "Xiaowei"
      },
      {
        "family": "Zhou",
        "given": "Xiang"
      },
      {
        "family": "Liu",
        "given": "Zhengyin"
      },
      {
        "family": "Wang",
        "given": "Jinglan"
      },
      {
        "family": "Du",
        "given": "Bin"
      },
      {
        "family": "Qin",
        "given": "Yan"
      },
      {
        "family": "Gao",
        "given": "Peng"
      },
      {
        "family": "Qin",
        "given": "Xuzhen"
      },
      {
        "family": "Xu",
        "given": "Yingchun"
      },
      {
        "family": "Zhang",
        "given": "Wen"
      },
      {
        "family": "Li",
        "given": "Taisheng"
      },
      {
        "family": "Zhang",
        "given": "Fengchun"
      },
      {
        "family": "Zhao",
        "given": "Yongqiang"
      },
      {
        "family": "Li",
        "given": "Yongzhe"
      },
      {
        "family": "Zhang",
        "given": "Shuyang"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4,
          23
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmc2007575",
    "volume": "382",
    "issue": "17",
    "page": "e38",
    "publisher": "Massachusetts Medical Society",
    "title": "Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19",
    "URL": "https://doi.org/ggrgz7",
    "PMCID": "PMC7161262",
    "PMID": "32268022",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1056/nejmc2007575\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 8OnbWuhF"
  },
  {
    "type": "article-journal",
    "id": "3GIXDhwz",
    "author": [
      {
        "family": "Mehra",
        "given": "Mandeep R."
      },
      {
        "family": "Desai",
        "given": "Sapan S."
      },
      {
        "family": "Kuy",
        "given": "SreyRam"
      },
      {
        "family": "Henry",
        "given": "Timothy D."
      },
      {
        "family": "Patel",
        "given": "Amit N."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          6,
          25
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmc2021225",
    "volume": "382",
    "issue": "26",
    "page": "2582-2582",
    "publisher": "Massachusetts Medical Society",
    "title": "Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.",
    "URL": "https://doi.org/ggzkpj",
    "PMCID": "PMC7274164",
    "PMID": "32501665",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1056/nejmc2021225"
  },
  {
    "type": "article-journal",
    "id": "xM0IhxIr",
    "author": [
      {
        "family": "Harrington",
        "given": "David P."
      },
      {
        "family": "Baden",
        "given": "Lindsey R."
      },
      {
        "family": "Hogan",
        "given": "Joseph W."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          12,
          2
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejme2034294",
    "page": "NEJMe2034294",
    "publisher": "Massachusetts Medical Society",
    "title": "A Large, Simple Trial Leading to Complex Questions",
    "URL": "https://doi.org/ghnhnx",
    "PMCID": "PMC7727323",
    "PMID": "33264557",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1056/nejme2034294\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: xM0IhxIr"
  },
  {
    "type": "article-journal",
    "id": "V6tUK1F0",
    "issued": {
      "date-parts": [
        [
          2006,
          4,
          20
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmoa051693",
    "volume": "354",
    "issue": "16",
    "page": "1671-1684",
    "publisher": "Massachusetts Medical Society",
    "title": "Efficacy and Safety of Corticosteroids for Persistent Acute Respiratory Distress Syndrome",
    "URL": "https://doi.org/c3sfcb",
    "PMID": "16625008",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1056/nejmoa051693"
  },
  {
    "type": "article-journal",
    "id": "7Ee6Sz9l",
    "author": [
      {
        "family": "Zaki",
        "given": "Ali M."
      },
      {
        "family": "van Boheemen",
        "given": "Sander"
      },
      {
        "family": "Bestebroer",
        "given": "Theo M."
      },
      {
        "family": "Osterhaus",
        "given": "Albert D.M.E."
      },
      {
        "family": "Fouchier",
        "given": "Ron A.M."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2012,
          11,
          8
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmoa1211721",
    "volume": "367",
    "issue": "19",
    "page": "1814-1820",
    "publisher": "Massachusetts Medical Society",
    "title": "Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia",
    "URL": "https://doi.org/f4czx5",
    "PMID": "23075143",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1056/nejmoa1211721\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 7Ee6Sz9l"
  },
  {
    "type": "article-journal",
    "id": "gnfviuGp",
    "author": [
      {
        "family": "Mulangu",
        "given": "Sabue"
      },
      {
        "family": "Dodd",
        "given": "Lori E."
      },
      {
        "family": "Davey",
        "given": "Richard T."
      },
      {
        "family": "Tshiani Mbaya",
        "given": "Olivier"
      },
      {
        "family": "Proschan",
        "given": "Michael"
      },
      {
        "family": "Mukadi",
        "given": "Daniel"
      },
      {
        "family": "Lusakibanza Manzo",
        "given": "Mariano"
      },
      {
        "family": "Nzolo",
        "given": "Didier"
      },
      {
        "family": "Tshomba Oloma",
        "given": "Antoine"
      },
      {
        "family": "Ibanda",
        "given": "Augustin"
      },
      {
        "family": "Ali",
        "given": "Rosine"
      },
      {
        "family": "Coulibaly",
        "given": "Sinaré"
      },
      {
        "family": "Levine",
        "given": "Adam C."
      },
      {
        "family": "Grais",
        "given": "Rebecca"
      },
      {
        "family": "Diaz",
        "given": "Janet"
      },
      {
        "family": "Lane",
        "given": "H. Clifford"
      },
      {
        "family": "Muyembe-Tamfum",
        "given": "Jean-Jacques"
      },
      {
        "family": "the PALM Writing Group"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          12,
          12
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmoa1910993",
    "volume": "381",
    "issue": "24",
    "page": "2293-2303",
    "publisher": "Massachusetts Medical Society",
    "title": "A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics",
    "URL": "https://doi.org/ggqmx4",
    "PMID": "31774950",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1056/nejmoa1910993\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: gnfviuGp"
  },
  {
    "type": "article-journal",
    "id": "gleq16qf",
    "author": [
      {
        "family": "Holshue",
        "given": "Michelle L."
      },
      {
        "family": "DeBolt",
        "given": "Chas"
      },
      {
        "family": "Lindquist",
        "given": "Scott"
      },
      {
        "family": "Lofy",
        "given": "Kathy H."
      },
      {
        "family": "Wiesman",
        "given": "John"
      },
      {
        "family": "Bruce",
        "given": "Hollianne"
      },
      {
        "family": "Spitters",
        "given": "Christopher"
      },
      {
        "family": "Ericson",
        "given": "Keith"
      },
      {
        "family": "Wilkerson",
        "given": "Sara"
      },
      {
        "family": "Tural",
        "given": "Ahmet"
      },
      {
        "family": "Diaz",
        "given": "George"
      },
      {
        "family": "Cohn",
        "given": "Amanda"
      },
      {
        "family": "Fox",
        "given": "LeAnne"
      },
      {
        "family": "Patel",
        "given": "Anita"
      },
      {
        "family": "Gerber",
        "given": "Susan I."
      },
      {
        "family": "Kim",
        "given": "Lindsay"
      },
      {
        "family": "Tong",
        "given": "Suxiang"
      },
      {
        "family": "Lu",
        "given": "Xiaoyan"
      },
      {
        "family": "Lindstrom",
        "given": "Steve"
      },
      {
        "family": "Pallansch",
        "given": "Mark A."
      },
      {
        "family": "Weldon",
        "given": "William C."
      },
      {
        "family": "Biggs",
        "given": "Holly M."
      },
      {
        "family": "Uyeki",
        "given": "Timothy M."
      },
      {
        "family": "Pillai",
        "given": "Satish K."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          5
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmoa2001191",
    "volume": "382",
    "issue": "10",
    "page": "929-936",
    "publisher": "Massachusetts Medical Society",
    "title": "First Case of 2019 Novel Coronavirus in the United States",
    "URL": "https://doi.org/ggjvr6",
    "PMCID": "PMC7092802",
    "PMID": "32004427",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1056/nejmoa2001191\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: gleq16qf"
  },
  {
    "type": "article-journal",
    "id": "16zLDIOyk",
    "author": [
      {
        "family": "Grein",
        "given": "Jonathan"
      },
      {
        "family": "Ohmagari",
        "given": "Norio"
      },
      {
        "family": "Shin",
        "given": "Daniel"
      },
      {
        "family": "Diaz",
        "given": "George"
      },
      {
        "family": "Asperges",
        "given": "Erika"
      },
      {
        "family": "Castagna",
        "given": "Antonella"
      },
      {
        "family": "Feldt",
        "given": "Torsten"
      },
      {
        "family": "Green",
        "given": "Gary"
      },
      {
        "family": "Green",
        "given": "Margaret L."
      },
      {
        "family": "Lescure",
        "given": "François-Xavier"
      },
      {
        "family": "Nicastri",
        "given": "Emanuele"
      },
      {
        "family": "Oda",
        "given": "Rentaro"
      },
      {
        "family": "Yo",
        "given": "Kikuo"
      },
      {
        "family": "Quiros-Roldan",
        "given": "Eugenia"
      },
      {
        "family": "Studemeister",
        "given": "Alex"
      },
      {
        "family": "Redinski",
        "given": "John"
      },
      {
        "family": "Ahmed",
        "given": "Seema"
      },
      {
        "family": "Bernett",
        "given": "Jorge"
      },
      {
        "family": "Chelliah",
        "given": "Daniel"
      },
      {
        "family": "Chen",
        "given": "Danny"
      },
      {
        "family": "Chihara",
        "given": "Shingo"
      },
      {
        "family": "Cohen",
        "given": "Stuart H."
      },
      {
        "family": "Cunningham",
        "given": "Jennifer"
      },
      {
        "family": "D’Arminio Monforte",
        "given": "Antonella"
      },
      {
        "family": "Ismail",
        "given": "Saad"
      },
      {
        "family": "Kato",
        "given": "Hideaki"
      },
      {
        "family": "Lapadula",
        "given": "Giuseppe"
      },
      {
        "family": "L’Her",
        "given": "Erwan"
      },
      {
        "family": "Maeno",
        "given": "Toshitaka"
      },
      {
        "family": "Majumder",
        "given": "Sumit"
      },
      {
        "family": "Massari",
        "given": "Marco"
      },
      {
        "family": "Mora-Rillo",
        "given": "Marta"
      },
      {
        "family": "Mutoh",
        "given": "Yoshikazu"
      },
      {
        "family": "Nguyen",
        "given": "Duc"
      },
      {
        "family": "Verweij",
        "given": "Ewa"
      },
      {
        "family": "Zoufaly",
        "given": "Alexander"
      },
      {
        "family": "Osinusi",
        "given": "Anu O."
      },
      {
        "family": "DeZure",
        "given": "Adam"
      },
      {
        "family": "Zhao",
        "given": "Yang"
      },
      {
        "family": "Zhong",
        "given": "Lijie"
      },
      {
        "family": "Chokkalingam",
        "given": "Anand"
      },
      {
        "family": "Elboudwarej",
        "given": "Emon"
      },
      {
        "family": "Telep",
        "given": "Laura"
      },
      {
        "family": "Timbs",
        "given": "Leighann"
      },
      {
        "family": "Henne",
        "given": "Ilana"
      },
      {
        "family": "Sellers",
        "given": "Scott"
      },
      {
        "family": "Cao",
        "given": "Huyen"
      },
      {
        "family": "Tan",
        "given": "Susanna K."
      },
      {
        "family": "Winterbourne",
        "given": "Lucinda"
      },
      {
        "family": "Desai",
        "given": "Polly"
      },
      {
        "family": "Mera",
        "given": "Robertino"
      },
      {
        "family": "Gaggar",
        "given": "Anuj"
      },
      {
        "family": "Myers",
        "given": "Robert P."
      },
      {
        "family": "Brainard",
        "given": "Diana M."
      },
      {
        "family": "Childs",
        "given": "Richard"
      },
      {
        "family": "Flanigan",
        "given": "Timothy"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          6,
          11
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmoa2007016",
    "volume": "382",
    "issue": "24",
    "page": "2327-2336",
    "publisher": "Massachusetts Medical Society",
    "title": "Compassionate Use of Remdesivir for Patients with Severe Covid-19",
    "URL": "https://doi.org/ggrm99",
    "PMCID": "PMC7169476",
    "PMID": "32275812",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1056/nejmoa2007016\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 16zLDIOyk"
  },
  {
    "type": "article-journal",
    "id": "10q7vcaWw",
    "author": [
      {
        "family": "Mehra",
        "given": "Mandeep R."
      },
      {
        "family": "Desai",
        "given": "Sapan S."
      },
      {
        "family": "Kuy",
        "given": "SreyRam"
      },
      {
        "family": "Henry",
        "given": "Timothy D."
      },
      {
        "family": "Patel",
        "given": "Amit N."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          6,
          18
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmoa2007621",
    "volume": "382",
    "issue": "25",
    "page": "e102",
    "publisher": "Massachusetts Medical Society",
    "title": "Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19",
    "URL": "https://doi.org/ggtp6v",
    "PMCID": "PMC7206931",
    "PMID": "32356626",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1056/nejmoa2007621\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 10q7vcaWw"
  },
  {
    "type": "article-journal",
    "id": "DtpdBrgt",
    "author": [
      {
        "family": "Beigel",
        "given": "John H."
      },
      {
        "family": "Tomashek",
        "given": "Kay M."
      },
      {
        "family": "Dodd",
        "given": "Lori E."
      },
      {
        "family": "Mehta",
        "given": "Aneesh K."
      },
      {
        "family": "Zingman",
        "given": "Barry S."
      },
      {
        "family": "Kalil",
        "given": "Andre C."
      },
      {
        "family": "Hohmann",
        "given": "Elizabeth"
      },
      {
        "family": "Chu",
        "given": "Helen Y."
      },
      {
        "family": "Luetkemeyer",
        "given": "Annie"
      },
      {
        "family": "Kline",
        "given": "Susan"
      },
      {
        "family": "Lopez de Castilla",
        "given": "Diego"
      },
      {
        "family": "Finberg",
        "given": "Robert W."
      },
      {
        "family": "Dierberg",
        "given": "Kerry"
      },
      {
        "family": "Tapson",
        "given": "Victor"
      },
      {
        "family": "Hsieh",
        "given": "Lanny"
      },
      {
        "family": "Patterson",
        "given": "Thomas F."
      },
      {
        "family": "Paredes",
        "given": "Roger"
      },
      {
        "family": "Sweeney",
        "given": "Daniel A."
      },
      {
        "family": "Short",
        "given": "William R."
      },
      {
        "family": "Touloumi",
        "given": "Giota"
      },
      {
        "family": "Lye",
        "given": "David Chien"
      },
      {
        "family": "Ohmagari",
        "given": "Norio"
      },
      {
        "family": "Oh",
        "given": "Myoung-don"
      },
      {
        "family": "Ruiz-Palacios",
        "given": "Guillermo M."
      },
      {
        "family": "Benfield",
        "given": "Thomas"
      },
      {
        "family": "Fätkenheuer",
        "given": "Gerd"
      },
      {
        "family": "Kortepeter",
        "given": "Mark G."
      },
      {
        "family": "Atmar",
        "given": "Robert L."
      },
      {
        "family": "Creech",
        "given": "C. Buddy"
      },
      {
        "family": "Lundgren",
        "given": "Jens"
      },
      {
        "family": "Babiker",
        "given": "Abdel G."
      },
      {
        "family": "Pett",
        "given": "Sarah"
      },
      {
        "family": "Neaton",
        "given": "James D."
      },
      {
        "family": "Burgess",
        "given": "Timothy H."
      },
      {
        "family": "Bonnett",
        "given": "Tyler"
      },
      {
        "family": "Green",
        "given": "Michelle"
      },
      {
        "family": "Makowski",
        "given": "Mat"
      },
      {
        "family": "Osinusi",
        "given": "Anu"
      },
      {
        "family": "Nayak",
        "given": "Seema"
      },
      {
        "family": "Lane",
        "given": "H. Clifford"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          11,
          5
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmoa2007764",
    "volume": "383",
    "issue": "19",
    "page": "1813-1826",
    "publisher": "Massachusetts Medical Society",
    "title": "Remdesivir for the Treatment of Covid-19 — Final Report",
    "URL": "https://doi.org/dwkd",
    "PMCID": "PMC7262788",
    "PMID": "32445440",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1056/nejmoa2007764\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: DtpdBrgt"
  },
  {
    "type": "article-journal",
    "id": "w5y1LWUR",
    "author": [
      {
        "family": "Goldman",
        "given": "Jason D."
      },
      {
        "family": "Lye",
        "given": "David C.B."
      },
      {
        "family": "Hui",
        "given": "David S."
      },
      {
        "family": "Marks",
        "given": "Kristen M."
      },
      {
        "family": "Bruno",
        "given": "Raffaele"
      },
      {
        "family": "Montejano",
        "given": "Rocio"
      },
      {
        "family": "Spinner",
        "given": "Christoph D."
      },
      {
        "family": "Galli",
        "given": "Massimo"
      },
      {
        "family": "Ahn",
        "given": "Mi-Young"
      },
      {
        "family": "Nahass",
        "given": "Ronald G."
      },
      {
        "family": "Chen",
        "given": "Yao-Shen"
      },
      {
        "family": "SenGupta",
        "given": "Devi"
      },
      {
        "family": "Hyland",
        "given": "Robert H."
      },
      {
        "family": "Osinusi",
        "given": "Anu O."
      },
      {
        "family": "Cao",
        "given": "Huyen"
      },
      {
        "family": "Blair",
        "given": "Christiana"
      },
      {
        "family": "Wei",
        "given": "Xuelian"
      },
      {
        "family": "Gaggar",
        "given": "Anuj"
      },
      {
        "family": "Brainard",
        "given": "Diana M."
      },
      {
        "family": "Towner",
        "given": "William J."
      },
      {
        "family": "Muñoz",
        "given": "Jose"
      },
      {
        "family": "Mullane",
        "given": "Kathleen M."
      },
      {
        "family": "Marty",
        "given": "Francisco M."
      },
      {
        "family": "Tashima",
        "given": "Karen T."
      },
      {
        "family": "Diaz",
        "given": "George"
      },
      {
        "family": "Subramanian",
        "given": "Aruna"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          11,
          5
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmoa2015301",
    "volume": "383",
    "issue": "19",
    "page": "1827-1837",
    "publisher": "Massachusetts Medical Society",
    "title": "Remdesivir for 5 or 10 Days in Patients with Severe Covid-19",
    "URL": "https://doi.org/ggz7qv",
    "PMCID": "PMC7377062",
    "PMID": "32459919",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1056/nejmoa2015301\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: w5y1LWUR"
  },
  {
    "type": "article-journal",
    "id": "NiVdIN7Z",
    "author": [
      {
        "family": "Boulware",
        "given": "David R."
      },
      {
        "family": "Pullen",
        "given": "Matthew F."
      },
      {
        "family": "Bangdiwala",
        "given": "Ananta S."
      },
      {
        "family": "Pastick",
        "given": "Katelyn A."
      },
      {
        "family": "Lofgren",
        "given": "Sarah M."
      },
      {
        "family": "Okafor",
        "given": "Elizabeth C."
      },
      {
        "family": "Skipper",
        "given": "Caleb P."
      },
      {
        "family": "Nascene",
        "given": "Alanna A."
      },
      {
        "family": "Nicol",
        "given": "Melanie R."
      },
      {
        "family": "Abassi",
        "given": "Mahsa"
      },
      {
        "family": "Engen",
        "given": "Nicole W."
      },
      {
        "family": "Cheng",
        "given": "Matthew P."
      },
      {
        "family": "LaBar",
        "given": "Derek"
      },
      {
        "family": "Lother",
        "given": "Sylvain A."
      },
      {
        "family": "MacKenzie",
        "given": "Lauren J."
      },
      {
        "family": "Drobot",
        "given": "Glen"
      },
      {
        "family": "Marten",
        "given": "Nicole"
      },
      {
        "family": "Zarychanski",
        "given": "Ryan"
      },
      {
        "family": "Kelly",
        "given": "Lauren E."
      },
      {
        "family": "Schwartz",
        "given": "Ilan S."
      },
      {
        "family": "McDonald",
        "given": "Emily G."
      },
      {
        "family": "Rajasingham",
        "given": "Radha"
      },
      {
        "family": "Lee",
        "given": "Todd C."
      },
      {
        "family": "Hullsiek",
        "given": "Kathy H."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          8,
          6
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmoa2016638",
    "volume": "383",
    "issue": "6",
    "page": "517-525",
    "publisher": "Massachusetts Medical Society",
    "title": "A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19",
    "URL": "https://doi.org/dxkv",
    "PMCID": "PMC7289276",
    "PMID": "32492293",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1056/nejmoa2016638\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: NiVdIN7Z"
  },
  {
    "type": "article-journal",
    "id": "H3C2PalE",
    "author": [
      {
        "literal": "The RECOVERY Collaborative Group"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          7,
          17
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmoa2021436",
    "page": "NEJMoa2021436",
    "publisher": "Massachusetts Medical Society",
    "title": "Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report",
    "URL": "https://doi.org/gg5c8p",
    "PMCID": "PMC7383595",
    "PMID": "32678530",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1056/nejmoa2021436\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: H3C2PalE"
  },
  {
    "type": "article-journal",
    "id": "KwFZyfFx",
    "author": [
      {
        "literal": "The RECOVERY Collaborative Group"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          11,
          19
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmoa2022926",
    "volume": "383",
    "issue": "21",
    "page": "2030-2040",
    "publisher": "Massachusetts Medical Society",
    "title": "Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19",
    "URL": "https://doi.org/ghd8c7",
    "PMCID": "PMC7556338",
    "PMID": "33031652",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1056/nejmoa2022926\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: KwFZyfFx"
  },
  {
    "type": "article-journal",
    "id": "jShm9uhy",
    "author": [
      {
        "literal": "WHO Solidarity Trial Consortium"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          12,
          2
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmoa2023184",
    "page": "NEJMoa2023184",
    "publisher": "Massachusetts Medical Society",
    "title": "Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results",
    "URL": "https://doi.org/ghnhnw",
    "PMCID": "PMC7727327",
    "PMID": "33264556",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1056/nejmoa2023184\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: jShm9uhy"
  },
  {
    "type": "article-journal",
    "id": "3qsYQAdF",
    "author": [
      {
        "family": "Rosas",
        "given": "Ivan O."
      },
      {
        "family": "Bräu",
        "given": "Norbert"
      },
      {
        "family": "Waters",
        "given": "Michael"
      },
      {
        "family": "Go",
        "given": "Ronaldo C."
      },
      {
        "family": "Hunter",
        "given": "Bradley D."
      },
      {
        "family": "Bhagani",
        "given": "Sanjay"
      },
      {
        "family": "Skiest",
        "given": "Daniel"
      },
      {
        "family": "Aziz",
        "given": "Mariam S."
      },
      {
        "family": "Cooper",
        "given": "Nichola"
      },
      {
        "family": "Douglas",
        "given": "Ivor S."
      },
      {
        "family": "Savic",
        "given": "Sinisa"
      },
      {
        "family": "Youngstein",
        "given": "Taryn"
      },
      {
        "family": "Del Sorbo",
        "given": "Lorenzo"
      },
      {
        "family": "Cubillo Gracian",
        "given": "Antonio"
      },
      {
        "family": "De La Zerda",
        "given": "David J."
      },
      {
        "family": "Ustianowski",
        "given": "Andrew"
      },
      {
        "family": "Bao",
        "given": "Min"
      },
      {
        "family": "Dimonaco",
        "given": "Sophie"
      },
      {
        "family": "Graham",
        "given": "Emily"
      },
      {
        "family": "Matharu",
        "given": "Balpreet"
      },
      {
        "family": "Spotswood",
        "given": "Helen"
      },
      {
        "family": "Tsai",
        "given": "Larry"
      },
      {
        "family": "Malhotra",
        "given": "Atul"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          4,
          22
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmoa2028700",
    "volume": "384",
    "issue": "16",
    "page": "1503-1516",
    "publisher": "Massachusetts Medical Society",
    "title": "Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia",
    "URL": "https://doi.org/gh5vk5",
    "PMCID": "PMC7953459",
    "PMID": "33631066",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1056/nejmoa2028700"
  },
  {
    "type": "article-journal",
    "id": "Cblh7jlS",
    "author": [
      {
        "family": "Chen",
        "given": "Peter"
      },
      {
        "family": "Nirula",
        "given": "Ajay"
      },
      {
        "family": "Heller",
        "given": "Barry"
      },
      {
        "family": "Gottlieb",
        "given": "Robert L."
      },
      {
        "family": "Boscia",
        "given": "Joseph"
      },
      {
        "family": "Morris",
        "given": "Jason"
      },
      {
        "family": "Huhn",
        "given": "Gregory"
      },
      {
        "family": "Cardona",
        "given": "Jose"
      },
      {
        "family": "Mocherla",
        "given": "Bharat"
      },
      {
        "family": "Stosor",
        "given": "Valentina"
      },
      {
        "family": "Shawa",
        "given": "Imad"
      },
      {
        "family": "Adams",
        "given": "Andrew C."
      },
      {
        "family": "Van Naarden",
        "given": "Jacob"
      },
      {
        "family": "Custer",
        "given": "Kenneth L."
      },
      {
        "family": "Shen",
        "given": "Lei"
      },
      {
        "family": "Durante",
        "given": "Michael"
      },
      {
        "family": "Oakley",
        "given": "Gerard"
      },
      {
        "family": "Schade",
        "given": "Andrew E."
      },
      {
        "family": "Sabo",
        "given": "Janelle"
      },
      {
        "family": "Patel",
        "given": "Dipak R."
      },
      {
        "family": "Klekotka",
        "given": "Paul"
      },
      {
        "family": "Skovronsky",
        "given": "Daniel M."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          1,
          21
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmoa2029849",
    "volume": "384",
    "issue": "3",
    "page": "229-237",
    "publisher": "Massachusetts Medical Society",
    "title": "SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19",
    "URL": "https://doi.org/fgtm",
    "PMCID": "PMC7646625",
    "PMID": "33113295",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1056/nejmoa2029849"
  },
  {
    "type": "article-journal",
    "id": "11XXNLZ90",
    "author": [
      {
        "family": "Salama",
        "given": "Carlos"
      },
      {
        "family": "Han",
        "given": "Jian"
      },
      {
        "family": "Yau",
        "given": "Linda"
      },
      {
        "family": "Reiss",
        "given": "William G."
      },
      {
        "family": "Kramer",
        "given": "Benjamin"
      },
      {
        "family": "Neidhart",
        "given": "Jeffrey D."
      },
      {
        "family": "Criner",
        "given": "Gerard J."
      },
      {
        "family": "Kaplan-Lewis",
        "given": "Emma"
      },
      {
        "family": "Baden",
        "given": "Rachel"
      },
      {
        "family": "Pandit",
        "given": "Lavannya"
      },
      {
        "family": "Cameron",
        "given": "Miriam L."
      },
      {
        "family": "Garcia-Diaz",
        "given": "Julia"
      },
      {
        "family": "Chávez",
        "given": "Victoria"
      },
      {
        "family": "Mekebeb-Reuter",
        "given": "Martha"
      },
      {
        "family": "Lima de Menezes",
        "given": "Ferdinando"
      },
      {
        "family": "Shah",
        "given": "Reena"
      },
      {
        "family": "González-Lara",
        "given": "Maria F."
      },
      {
        "family": "Assman",
        "given": "Beverly"
      },
      {
        "family": "Freedman",
        "given": "Jamie"
      },
      {
        "family": "Mohan",
        "given": "Shalini V."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          1,
          7
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmoa2030340",
    "volume": "384",
    "issue": "1",
    "page": "20-30",
    "publisher": "Massachusetts Medical Society",
    "title": "Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia",
    "URL": "https://doi.org/ghp8xc",
    "PMCID": "PMC7781101",
    "PMID": "33332779",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1056/nejmoa2030340"
  },
  {
    "type": "article-journal",
    "id": "11J6lIInT",
    "author": [
      {
        "family": "Joyner",
        "given": "Michael J."
      },
      {
        "family": "Carter",
        "given": "Rickey E."
      },
      {
        "family": "Senefeld",
        "given": "Jonathon W."
      },
      {
        "family": "Klassen",
        "given": "Stephen A."
      },
      {
        "family": "Mills",
        "given": "John R."
      },
      {
        "family": "Johnson",
        "given": "Patrick W."
      },
      {
        "family": "Theel",
        "given": "Elitza S."
      },
      {
        "family": "Wiggins",
        "given": "Chad C."
      },
      {
        "family": "Bruno",
        "given": "Katelyn A."
      },
      {
        "family": "Klompas",
        "given": "Allan M."
      },
      {
        "family": "Lesser",
        "given": "Elizabeth R."
      },
      {
        "family": "Kunze",
        "given": "Katie L."
      },
      {
        "family": "Sexton",
        "given": "Matthew A."
      },
      {
        "family": "Diaz Soto",
        "given": "Juan C."
      },
      {
        "family": "Baker",
        "given": "Sarah E."
      },
      {
        "family": "Shepherd",
        "given": "John R.A."
      },
      {
        "family": "van Helmond",
        "given": "Noud"
      },
      {
        "family": "Verdun",
        "given": "Nicole C."
      },
      {
        "family": "Marks",
        "given": "Peter"
      },
      {
        "family": "van Buskirk",
        "given": "Camille M."
      },
      {
        "family": "Winters",
        "given": "Jeffrey L."
      },
      {
        "family": "Stubbs",
        "given": "James R."
      },
      {
        "family": "Rea",
        "given": "Robert F."
      },
      {
        "family": "Hodge",
        "given": "David O."
      },
      {
        "family": "Herasevich",
        "given": "Vitaly"
      },
      {
        "family": "Whelan",
        "given": "Emily R."
      },
      {
        "family": "Clayburn",
        "given": "Andrew J."
      },
      {
        "family": "Larson",
        "given": "Kathryn F."
      },
      {
        "family": "Ripoll",
        "given": "Juan G."
      },
      {
        "family": "Andersen",
        "given": "Kylie J."
      },
      {
        "family": "Buras",
        "given": "Matthew R."
      },
      {
        "family": "Vogt",
        "given": "Matthew N.P."
      },
      {
        "family": "Dennis",
        "given": "Joshua J."
      },
      {
        "family": "Regimbal",
        "given": "Riley J."
      },
      {
        "family": "Bauer",
        "given": "Philippe R."
      },
      {
        "family": "Blair",
        "given": "Janis E."
      },
      {
        "family": "Paneth",
        "given": "Nigel S."
      },
      {
        "family": "Fairweather",
        "given": "DeLisa"
      },
      {
        "family": "Wright",
        "given": "R. Scott"
      },
      {
        "family": "Casadevall",
        "given": "Arturo"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          1,
          13
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmoa2031893",
    "page": "NEJMoa2031893",
    "publisher": "Massachusetts Medical Society",
    "title": "Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19",
    "URL": "https://doi.org/ghs26g",
    "PMCID": "PMC7821984",
    "PMID": "33523609",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1056/nejmoa2031893\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 11J6lIInT"
  },
  {
    "type": "article-journal",
    "id": "pDl6Q4UP",
    "author": [
      {
        "family": "Kalil",
        "given": "Andre C."
      },
      {
        "family": "Patterson",
        "given": "Thomas F."
      },
      {
        "family": "Mehta",
        "given": "Aneesh K."
      },
      {
        "family": "Tomashek",
        "given": "Kay M."
      },
      {
        "family": "Wolfe",
        "given": "Cameron R."
      },
      {
        "family": "Ghazaryan",
        "given": "Varduhi"
      },
      {
        "family": "Marconi",
        "given": "Vincent C."
      },
      {
        "family": "Ruiz-Palacios",
        "given": "Guillermo M."
      },
      {
        "family": "Hsieh",
        "given": "Lanny"
      },
      {
        "family": "Kline",
        "given": "Susan"
      },
      {
        "family": "Tapson",
        "given": "Victor"
      },
      {
        "family": "Iovine",
        "given": "Nicole M."
      },
      {
        "family": "Jain",
        "given": "Mamta K."
      },
      {
        "family": "Sweeney",
        "given": "Daniel A."
      },
      {
        "family": "El Sahly",
        "given": "Hana M."
      },
      {
        "family": "Branche",
        "given": "Angela R."
      },
      {
        "family": "Regalado Pineda",
        "given": "Justino"
      },
      {
        "family": "Lye",
        "given": "David C."
      },
      {
        "family": "Sandkovsky",
        "given": "Uriel"
      },
      {
        "family": "Luetkemeyer",
        "given": "Anne F."
      },
      {
        "family": "Cohen",
        "given": "Stuart H."
      },
      {
        "family": "Finberg",
        "given": "Robert W."
      },
      {
        "family": "Jackson",
        "given": "Patrick E.H."
      },
      {
        "family": "Taiwo",
        "given": "Babafemi"
      },
      {
        "family": "Paules",
        "given": "Catharine I."
      },
      {
        "family": "Arguinchona",
        "given": "Henry"
      },
      {
        "family": "Erdmann",
        "given": "Nathaniel"
      },
      {
        "family": "Ahuja",
        "given": "Neera"
      },
      {
        "family": "Frank",
        "given": "Maria"
      },
      {
        "family": "Oh",
        "given": "Myoung-don"
      },
      {
        "family": "Kim",
        "given": "Eu-Suk"
      },
      {
        "family": "Tan",
        "given": "Seow Y."
      },
      {
        "family": "Mularski",
        "given": "Richard A."
      },
      {
        "family": "Nielsen",
        "given": "Henrik"
      },
      {
        "family": "Ponce",
        "given": "Philip O."
      },
      {
        "family": "Taylor",
        "given": "Barbara S."
      },
      {
        "family": "Larson",
        "given": "LuAnn"
      },
      {
        "family": "Rouphael",
        "given": "Nadine G."
      },
      {
        "family": "Saklawi",
        "given": "Youssef"
      },
      {
        "family": "Cantos",
        "given": "Valeria D."
      },
      {
        "family": "Ko",
        "given": "Emily R."
      },
      {
        "family": "Engemann",
        "given": "John J."
      },
      {
        "family": "Amin",
        "given": "Alpesh N."
      },
      {
        "family": "Watanabe",
        "given": "Miki"
      },
      {
        "family": "Billings",
        "given": "Joanne"
      },
      {
        "family": "Elie",
        "given": "Marie-Carmelle"
      },
      {
        "family": "Davey",
        "given": "Richard T."
      },
      {
        "family": "Burgess",
        "given": "Timothy H."
      },
      {
        "family": "Ferreira",
        "given": "Jennifer"
      },
      {
        "family": "Green",
        "given": "Michelle"
      },
      {
        "family": "Makowski",
        "given": "Mat"
      },
      {
        "family": "Cardoso",
        "given": "Anabela"
      },
      {
        "family": "de Bono",
        "given": "Stephanie"
      },
      {
        "family": "Bonnett",
        "given": "Tyler"
      },
      {
        "family": "Proschan",
        "given": "Michael"
      },
      {
        "family": "Deye",
        "given": "Gregory A."
      },
      {
        "family": "Dempsey",
        "given": "Walla"
      },
      {
        "family": "Nayak",
        "given": "Seema U."
      },
      {
        "family": "Dodd",
        "given": "Lori E."
      },
      {
        "family": "Beigel",
        "given": "John H."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          12,
          11
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmoa2031994",
    "page": "NEJMoa2031994",
    "publisher": "Massachusetts Medical Society",
    "title": "Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19",
    "URL": "https://doi.org/ghpbd2",
    "PMCID": "PMC7745180",
    "PMID": "33306283",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1056/nejmoa2031994\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: pDl6Q4UP"
  },
  {
    "type": "article-journal",
    "id": "Mc2i06U",
    "author": [
      {
        "family": "Weinreich",
        "given": "David M."
      },
      {
        "family": "Sivapalasingam",
        "given": "Sumathi"
      },
      {
        "family": "Norton",
        "given": "Thomas"
      },
      {
        "family": "Ali",
        "given": "Shazia"
      },
      {
        "family": "Gao",
        "given": "Haitao"
      },
      {
        "family": "Bhore",
        "given": "Rafia"
      },
      {
        "family": "Musser",
        "given": "Bret J."
      },
      {
        "family": "Soo",
        "given": "Yuhwen"
      },
      {
        "family": "Rofail",
        "given": "Diana"
      },
      {
        "family": "Im",
        "given": "Joseph"
      },
      {
        "family": "Perry",
        "given": "Christina"
      },
      {
        "family": "Pan",
        "given": "Cynthia"
      },
      {
        "family": "Hosain",
        "given": "Romana"
      },
      {
        "family": "Mahmood",
        "given": "Adnan"
      },
      {
        "family": "Davis",
        "given": "John D."
      },
      {
        "family": "Turner",
        "given": "Kenneth C."
      },
      {
        "family": "Hooper",
        "given": "Andrea T."
      },
      {
        "family": "Hamilton",
        "given": "Jennifer D."
      },
      {
        "family": "Baum",
        "given": "Alina"
      },
      {
        "family": "Kyratsous",
        "given": "Christos A."
      },
      {
        "family": "Kim",
        "given": "Yunji"
      },
      {
        "family": "Cook",
        "given": "Amanda"
      },
      {
        "family": "Kampman",
        "given": "Wendy"
      },
      {
        "family": "Kohli",
        "given": "Anita"
      },
      {
        "family": "Sachdeva",
        "given": "Yessica"
      },
      {
        "family": "Graber",
        "given": "Ximena"
      },
      {
        "family": "Kowal",
        "given": "Bari"
      },
      {
        "family": "DiCioccio",
        "given": "Thomas"
      },
      {
        "family": "Stahl",
        "given": "Neil"
      },
      {
        "family": "Lipsich",
        "given": "Leah"
      },
      {
        "family": "Braunstein",
        "given": "Ned"
      },
      {
        "family": "Herman",
        "given": "Gary"
      },
      {
        "family": "Yancopoulos",
        "given": "George D."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          1,
          21
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmoa2035002",
    "volume": "384",
    "issue": "3",
    "page": "238-251",
    "publisher": "Massachusetts Medical Society",
    "title": "REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19",
    "URL": "https://doi.org/gh4sjh",
    "PMCID": "PMC7781102",
    "PMID": "33332778",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1056/nejmoa2035002"
  },
  {
    "type": "article-journal",
    "id": "coPH1YK8",
    "author": [
      {
        "family": "Wenzel",
        "given": "Richard P."
      },
      {
        "family": "Edmond",
        "given": "Michael B."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2003,
          5,
          15
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmp030072",
    "volume": "348",
    "issue": "20",
    "page": "1947-1948",
    "publisher": "Massachusetts Medical Society",
    "title": "Managing SARS amidst Uncertainty",
    "URL": "https://doi.org/ddkjnr",
    "PMID": "12748313",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1056/nejmp030072"
  },
  {
    "type": "article-journal",
    "id": "pbfxOvnK",
    "author": [
      {
        "family": "Byrd",
        "given": "J. Brian"
      },
      {
        "family": "Chertow",
        "given": "Glenn M."
      },
      {
        "family": "Bhalla",
        "given": "Vivek"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          4,
          25
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmp1901657",
    "volume": "380",
    "issue": "17",
    "page": "1589-1591",
    "publisher": "Massachusetts Medical Society",
    "title": "Hypertension Hot Potato — Anatomy of the Angiotensin-Receptor Blocker Recalls",
    "URL": "https://doi.org/ggvc7g",
    "PMCID": "PMC7066505",
    "PMID": "30865819",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1056/nejmp1901657\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: pbfxOvnK"
  },
  {
    "type": "article-journal",
    "id": "nCVMwr28",
    "author": [
      {
        "family": "Fajgenbaum",
        "given": "David C."
      },
      {
        "family": "June",
        "given": "Carl H."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          12,
          3
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmra2026131",
    "volume": "383",
    "issue": "23",
    "page": "2255-2273",
    "publisher": "Massachusetts Medical Society",
    "title": "Cytokine Storm",
    "URL": "https://doi.org/ghnhm7",
    "PMCID": "PMC7727315",
    "PMID": "33264547",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1056/nejmra2026131\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: nCVMwr28"
  },
  {
    "type": "article-journal",
    "id": "bj2feMy4",
    "author": [
      {
        "family": "Xu",
        "given": "Xiaoling"
      },
      {
        "family": "Han",
        "given": "Mingfeng"
      },
      {
        "family": "Li",
        "given": "Tiantian"
      },
      {
        "family": "Sun",
        "given": "Wei"
      },
      {
        "family": "Wang",
        "given": "Dongsheng"
      },
      {
        "family": "Fu",
        "given": "Binqing"
      },
      {
        "family": "Zhou",
        "given": "Yonggang"
      },
      {
        "family": "Zheng",
        "given": "Xiaohu"
      },
      {
        "family": "Yang",
        "given": "Yun"
      },
      {
        "family": "Li",
        "given": "Xiuyong"
      },
      {
        "family": "Zhang",
        "given": "Xiaohua"
      },
      {
        "family": "Pan",
        "given": "Aijun"
      },
      {
        "family": "Wei",
        "given": "Haiming"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          5,
          19
        ]
      ]
    },
    "abstract": "After analyzing the immune characteristics of patients with severe coronavirus disease 2019 (COVID-19), we have identified that pathogenic T cells and inflammatory monocytes with large amount of interleukin 6 secreting may incite the inflammatory storm, which may potentially be curbed through monoclonal antibody that targets the IL-6 pathways. Here, we aimed to assess the efficacy of tocilizumab in severe patients with COVID-19 and seek a therapeutic strategy. The patients diagnosed as severe or critical COVID-19 in The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital) and Anhui Fuyang Second People’s Hospital were given tocilizumab in addition to routine therapy between 5 and 14 February 2020. The changes of clinical manifestations, computerized tomography (CT) scan image, and laboratory examinations were retrospectively analyzed. Fever returned to normal on the first day, and other symptoms improved remarkably within a few days. Within 5 d after tocilizumab, 15 of the 20 patients (75.0%) had lowered their oxygen intake, and 1 patient needed no oxygen therapy. CT scans manifested that the lung lesion opacity absorbed in 19 patients (90.5%). The percentage of lymphocytes in peripheral blood, which decreased in 85.0% of patients (17/20) before treatment (mean, 15.52 ± 8.89%), returned to normal in 52.6% of patients (10/19) on the fifth day after treatment. Abnormally elevated C-reactive protein decreased significantly in 84.2% of patients (16/19). No obvious adverse reactions were observed. All patients have been discharged on average 15.1 d after giving tocilizumab. Preliminary data show that tocilizumab, which improved the clinical outcome immediately in severe and critical COVID-19 patients, is an effective treatment to reduce mortality.",
    "container-title": "Proceedings of the National Academy of Sciences",
    "DOI": "10.1073/pnas.2005615117",
    "volume": "117",
    "issue": "20",
    "page": "10970-10975",
    "publisher": "Proceedings of the National Academy of Sciences",
    "title": "Effective treatment of severe COVID-19 patients with tocilizumab",
    "URL": "https://doi.org/ggv3r3",
    "PMCID": "PMC7245089",
    "PMID": "32350134",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1073/pnas.2005615117\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: bj2feMy4"
  },
  {
    "type": "article-journal",
    "id": "YaxKcqq8",
    "author": [
      {
        "family": "Gordon",
        "given": "Calvin J."
      },
      {
        "family": "Tchesnokov",
        "given": "Egor P."
      },
      {
        "family": "Feng",
        "given": "Joy Y."
      },
      {
        "family": "Porter",
        "given": "Danielle P."
      },
      {
        "family": "Götte",
        "given": "Matthias"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4
        ]
      ]
    },
    "container-title": "Journal of Biological Chemistry",
    "DOI": "10.1074/jbc.ac120.013056",
    "volume": "295",
    "issue": "15",
    "page": "4773-4779",
    "publisher": "Elsevier BV",
    "title": "The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus",
    "URL": "https://doi.org/ggqm6x",
    "PMID": "32094225",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1074/jbc.ac120.013056\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: YaxKcqq8"
  },
  {
    "type": "article-journal",
    "id": "1BV8xlc5v",
    "author": [
      {
        "family": "Obeidat",
        "given": "Mohammad"
      },
      {
        "family": "Isaacson",
        "given": "Alexandra L"
      },
      {
        "family": "Chen",
        "given": "Stephanie J."
      },
      {
        "family": "Ivanovic",
        "given": "Marina"
      },
      {
        "family": "Holanda",
        "given": "Danniele"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          12,
          4
        ]
      ]
    },
    "container-title": "Ultrastructural Pathology",
    "DOI": "10.1080/01913123.2020.1850966",
    "volume": "44",
    "issue": "4-6",
    "page": "519-523",
    "publisher": "Informa UK Limited",
    "title": "Zebra-like bodies in COVID-19: is phospholipidosis evidence of hydroxychloroquine induced acute kidney injury?",
    "URL": "https://doi.org/gj3v6c",
    "PMID": "33274661",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1080/01913123.2020.1850966"
  },
  {
    "type": "article-journal",
    "id": "6Qlsbuqr",
    "author": [
      {
        "family": "Totura",
        "given": "Allison L."
      },
      {
        "family": "Bavari",
        "given": "Sina"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          3,
          8
        ]
      ]
    },
    "container-title": "Expert Opinion on Drug Discovery",
    "DOI": "10.1080/17460441.2019.1581171",
    "volume": "14",
    "issue": "4",
    "page": "397-412",
    "publisher": "Informa UK Limited",
    "title": "Broad-spectrum coronavirus antiviral drug discovery",
    "URL": "https://doi.org/gg74z5",
    "PMCID": "PMC7103675",
    "PMID": "30849247",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1080/17460441.2019.1581171\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 6Qlsbuqr"
  },
  {
    "type": "article-journal",
    "id": "cwbHiM1o",
    "author": [
      {
        "family": "Resch",
        "given": "Bernhard"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          6,
          12
        ]
      ]
    },
    "container-title": "Human Vaccines & Immunotherapeutics",
    "DOI": "10.1080/21645515.2017.1337614",
    "volume": "13",
    "issue": "9",
    "page": "2138-2149",
    "publisher": "Informa UK Limited",
    "title": "Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection",
    "URL": "https://doi.org/ggqbps",
    "PMCID": "PMC5612471",
    "PMID": "28605249",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1080/21645515.2017.1337614\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: cwbHiM1o"
  },
  {
    "type": "article-journal",
    "id": "KULxo48U",
    "author": [
      {
        "family": "Yuchun",
        "given": "Nie"
      },
      {
        "family": "Guangwen",
        "given": "Wang"
      },
      {
        "family": "Xuanling",
        "given": "Shi"
      },
      {
        "family": "Hong",
        "given": "Zhang"
      },
      {
        "family": "Yan",
        "given": "Qiu"
      },
      {
        "family": "Zhongping",
        "given": "He"
      },
      {
        "family": "Wei",
        "given": "Wang"
      },
      {
        "family": "Gewei",
        "given": "Lian"
      },
      {
        "family": "Xiaolei",
        "given": "Yin"
      },
      {
        "family": "Liying",
        "given": "Du"
      },
      {
        "family": "Lili",
        "given": "Ren"
      },
      {
        "family": "Jianwei",
        "given": "Wang"
      },
      {
        "family": "Xiong",
        "given": "He"
      },
      {
        "family": "Taisheng",
        "given": "Li"
      },
      {
        "family": "Hongkui",
        "given": "Deng"
      },
      {
        "family": "Mingxiao",
        "given": "Ding"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2004,
          9
        ]
      ]
    },
    "container-title": "The Journal of Infectious Diseases",
    "DOI": "10.1086/423286",
    "volume": "190",
    "issue": "6",
    "page": "1119-1126",
    "publisher": "Oxford University Press (OUP)",
    "title": "Neutralizing Antibodies in Patients with Severe Acute Respiratory Syndrome-Associated Coronavirus Infection",
    "URL": "https://doi.org/cgqj5b",
    "PMID": "15319862",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1086/423286\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: KULxo48U"
  },
  {
    "type": "article-journal",
    "id": "V2NNL2k2",
    "author": [
      {
        "family": "Challa",
        "given": "Anup P."
      },
      {
        "family": "Lavieri",
        "given": "Robert R."
      },
      {
        "family": "Lewis",
        "given": "Judith T."
      },
      {
        "family": "Zaleski",
        "given": "Nicole M."
      },
      {
        "family": "Shirey-Rice",
        "given": "Jana K."
      },
      {
        "family": "Harris",
        "given": "Paul A."
      },
      {
        "family": "Aronoff",
        "given": "David M."
      },
      {
        "family": "Pulley",
        "given": "Jill M."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          12,
          1
        ]
      ]
    },
    "container-title": "ASSAY and Drug Development Technologies",
    "DOI": "10.1089/adt.2019.950",
    "volume": "17",
    "issue": "8",
    "page": "352-363",
    "publisher": "Mary Ann Liebert Inc",
    "title": "Systematically Prioritizing Candidates in Genome-Based Drug Repurposing",
    "URL": "https://doi.org/gj3v6d",
    "PMCID": "PMC6921094",
    "PMID": "31769998",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1089/adt.2019.950"
  },
  {
    "type": "article-journal",
    "id": "sP4wQEiM",
    "author": [
      {
        "family": "Guarner",
        "given": "Jeannette"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4
        ]
      ]
    },
    "container-title": "American Journal of Clinical Pathology",
    "DOI": "10.1093/ajcp/aqaa029",
    "volume": "153",
    "issue": "4",
    "page": "420-421",
    "publisher": "Oxford University Press (OUP)",
    "title": "Three Emerging Coronaviruses in Two Decades",
    "URL": "https://doi.org/ggppq3",
    "PMCID": "PMC7109697",
    "PMID": "32053148",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1093/ajcp/aqaa029\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: sP4wQEiM"
  },
  {
    "type": "article-journal",
    "id": "V8fkkVZg",
    "author": [
      {
        "family": "Mitjà",
        "given": "Oriol"
      },
      {
        "family": "Corbacho-Monné",
        "given": "Marc"
      },
      {
        "family": "Ubals",
        "given": "Maria"
      },
      {
        "family": "Tebé",
        "given": "Cristian"
      },
      {
        "family": "Peñafiel",
        "given": "Judith"
      },
      {
        "family": "Tobias",
        "given": "Aurelio"
      },
      {
        "family": "Ballana",
        "given": "Ester"
      },
      {
        "family": "Alemany",
        "given": "Andrea"
      },
      {
        "family": "Riera-Martí",
        "given": "Núria"
      },
      {
        "family": "Pérez",
        "given": "Carla A"
      },
      {
        "family": "Suñer",
        "given": "Clara"
      },
      {
        "family": "Laporte",
        "given": "Pep"
      },
      {
        "family": "Admella",
        "given": "Pol"
      },
      {
        "family": "Mitjà",
        "given": "Jordi"
      },
      {
        "family": "Clua",
        "given": "Mireia"
      },
      {
        "family": "Bertran",
        "given": "Laia"
      },
      {
        "family": "Sarquella",
        "given": "Maria"
      },
      {
        "family": "Gavilán",
        "given": "Sergi"
      },
      {
        "family": "Ara",
        "given": "Jordi"
      },
      {
        "family": "Argimon",
        "given": "Josep M"
      },
      {
        "family": "Casabona",
        "given": "Jordi"
      },
      {
        "family": "Cuatrecasas",
        "given": "Gabriel"
      },
      {
        "family": "Cañadas",
        "given": "Paz"
      },
      {
        "family": "Elizalde-Torrent",
        "given": "Aleix"
      },
      {
        "family": "Fabregat",
        "given": "Robert"
      },
      {
        "family": "Farré",
        "given": "Magí"
      },
      {
        "family": "Forcada",
        "given": "Anna"
      },
      {
        "family": "Flores-Mateo",
        "given": "Gemma"
      },
      {
        "family": "Muntada",
        "given": "Esteve"
      },
      {
        "family": "Nadal",
        "given": "Núria"
      },
      {
        "family": "Narejos",
        "given": "Silvia"
      },
      {
        "family": "Nieto",
        "given": "Aroa"
      },
      {
        "family": "Prat",
        "given": "Nuria"
      },
      {
        "family": "Puig",
        "given": "Jordi"
      },
      {
        "family": "Quiñones",
        "given": "Carles"
      },
      {
        "family": "Reyes-Ureña",
        "given": "Juliana"
      },
      {
        "family": "Ramírez-Viaplana",
        "given": "Ferran"
      },
      {
        "family": "Ruiz",
        "given": "Lidia"
      },
      {
        "family": "Riveira-Muñoz",
        "given": "Eva"
      },
      {
        "family": "Sierra",
        "given": "Alba"
      },
      {
        "family": "Velasco",
        "given": "César"
      },
      {
        "family": "Vivanco-Hidalgo",
        "given": "Rosa Maria"
      },
      {
        "family": "Sentís",
        "given": "Alexis"
      },
      {
        "family": "G-Beiras",
        "given": "Camila"
      },
      {
        "family": "Clotet",
        "given": "Bonaventura"
      },
      {
        "family": "Vall-Mayans",
        "given": "Martí"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          7,
          16
        ]
      ]
    },
    "container-title": "Clinical Infectious Diseases",
    "DOI": "10.1093/cid/ciaa1009",
    "page": "ciaa1009",
    "publisher": "Oxford University Press (OUP)",
    "title": "Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled Trial",
    "URL": "https://doi.org/gg5f9x",
    "PMCID": "PMC7454406",
    "PMID": "32674126",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1093/cid/ciaa1009\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: V8fkkVZg"
  },
  {
    "type": "article-journal",
    "id": "32n9UEkQ",
    "author": [
      {
        "family": "Ivashchenko",
        "given": "Andrey A"
      },
      {
        "family": "Dmitriev",
        "given": "Kirill A"
      },
      {
        "family": "Vostokova",
        "given": "Natalia V"
      },
      {
        "family": "Azarova",
        "given": "Valeria N"
      },
      {
        "family": "Blinow",
        "given": "Andrew A"
      },
      {
        "family": "Egorova",
        "given": "Alina N"
      },
      {
        "family": "Gordeev",
        "given": "Ivan G"
      },
      {
        "family": "Ilin",
        "given": "Alexey P"
      },
      {
        "family": "Karapetian",
        "given": "Ruben N"
      },
      {
        "family": "Kravchenko",
        "given": "Dmitry V"
      },
      {
        "family": "Lomakin",
        "given": "Nikita V"
      },
      {
        "family": "Merkulova",
        "given": "Elena A"
      },
      {
        "family": "Papazova",
        "given": "Natalia A"
      },
      {
        "family": "Pavlikova",
        "given": "Elena P"
      },
      {
        "family": "Savchuk",
        "given": "Nikolay P"
      },
      {
        "family": "Simakina",
        "given": "Elena N"
      },
      {
        "family": "Sitdekov",
        "given": "Tagir A"
      },
      {
        "family": "Smolyarchuk",
        "given": "Elena A"
      },
      {
        "family": "Tikhomolova",
        "given": "Elena G"
      },
      {
        "family": "Yakubova",
        "given": "Elena V"
      },
      {
        "family": "Ivachtchenko",
        "given": "Alexandre V"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          8,
          9
        ]
      ]
    },
    "abstract": "In May 2020 the Russian Ministry of Health granted fast-track marketing authorization to RNA polymerase inhibitor AVIFAVIR (favipiravir) for the treatment of COVID-19 patients. In the pilot stage of Phase II/III clinical trial, AVIFAVIR enabled SARS-CoV-2 viral clearance in 62.5% of patients within 4 days, and was safe and well-tolerated.",
    "container-title": "Clinical Infectious Diseases",
    "DOI": "10.1093/cid/ciaa1176",
    "page": "ciaa1176",
    "publisher": "Oxford University Press (OUP)",
    "title": "AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial",
    "URL": "https://doi.org/ghx9c2",
    "PMCID": "PMC7454388",
    "PMID": "32770240",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1093/cid/ciaa1176\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 32n9UEkQ"
  },
  {
    "type": "article-journal",
    "id": "1GBsnkeLK",
    "author": [
      {
        "family": "Yao",
        "given": "Xueting"
      },
      {
        "family": "Ye",
        "given": "Fei"
      },
      {
        "family": "Zhang",
        "given": "Miao"
      },
      {
        "family": "Cui",
        "given": "Cheng"
      },
      {
        "family": "Huang",
        "given": "Baoying"
      },
      {
        "family": "Niu",
        "given": "Peihua"
      },
      {
        "family": "Liu",
        "given": "Xu"
      },
      {
        "family": "Zhao",
        "given": "Li"
      },
      {
        "family": "Dong",
        "given": "Erdan"
      },
      {
        "family": "Song",
        "given": "Chunli"
      },
      {
        "family": "Zhan",
        "given": "Siyan"
      },
      {
        "family": "Lu",
        "given": "Roujian"
      },
      {
        "family": "Li",
        "given": "Haiyan"
      },
      {
        "family": "Tan",
        "given": "Wenjie"
      },
      {
        "family": "Liu",
        "given": "Dongyang"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          8,
          1
        ]
      ]
    },
    "container-title": "Clinical Infectious Diseases",
    "DOI": "10.1093/cid/ciaa237",
    "volume": "71",
    "issue": "15",
    "page": "732-739",
    "publisher": "Oxford University Press (OUP)",
    "title": "In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)",
    "URL": "https://doi.org/ggpx7z",
    "PMCID": "PMC7108130",
    "PMID": "32150618",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1093/cid/ciaa237\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 1GBsnkeLK"
  },
  {
    "type": "article-journal",
    "id": "17xTGqKp2",
    "author": [
      {
        "family": "Kreutz",
        "given": "Reinhold"
      },
      {
        "family": "Algharably",
        "given": "Engi Abd El-Hady"
      },
      {
        "family": "Azizi",
        "given": "Michel"
      },
      {
        "family": "Dobrowolski",
        "given": "Piotr"
      },
      {
        "family": "Guzik",
        "given": "Tomasz"
      },
      {
        "family": "Januszewicz",
        "given": "Andrzej"
      },
      {
        "family": "Persu",
        "given": "Alexandre"
      },
      {
        "family": "Prejbisz",
        "given": "Aleksander"
      },
      {
        "family": "Riemer",
        "given": "Thomas Günther"
      },
      {
        "family": "Wang",
        "given": "Ji-Guang"
      },
      {
        "family": "Burnier",
        "given": "Michel"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          8,
          1
        ]
      ]
    },
    "abstract": "Systemic arterial hypertension (referred to as hypertension herein) is a major risk factor of mortality worldwide, and its importance is further emphasized in the context of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection referred to as COVID-19. Patients with severe COVID-19 infections commonly are older and have a history of hypertension. Almost 75% of patients who have died in the pandemic in Italy had hypertension. This raised multiple questions regarding a more severe course of COVID-19 in relation to hypertension itself as well as its treatment with renin–angiotensin system (RAS) blockers, e.g. angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs). We provide a critical review on the relationship of hypertension, RAS, and risk of lung injury. We demonstrate lack of sound evidence that hypertension per se is an independent risk factor for COVID-19. Interestingly, ACEIs and ARBs may be associated with lower incidence and/or improved outcome in patients with lower respiratory tract infections. We also review in detail the molecular mechanisms linking the RAS to lung damage and the potential clinical impact of treatment with RAS blockers in patients with COVID-19 and a high cardiovascular and renal risk. This is related to the role of angiotensin-converting enzyme 2 (ACE2) for SARS-CoV-2 entry into cells, and expression of ACE2 in the lung, cardiovascular system, kidney, and other tissues. In summary, a critical review of available evidence does not support a deleterious effect of RAS blockers in COVID-19 infections. Therefore, there is currently no reason to discontinue RAS blockers in stable patients facing the COVID-19 pandemic.",
    "container-title": "Cardiovascular Research",
    "DOI": "10.1093/cvr/cvaa097",
    "volume": "116",
    "issue": "10",
    "page": "1688-1699",
    "publisher": "Oxford University Press (OUP)",
    "title": "Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19",
    "URL": "https://doi.org/ggtwpj",
    "PMCID": "PMC7184480",
    "PMID": "32293003",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1093/cvr/cvaa097\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 17xTGqKp2"
  },
  {
    "type": "article-journal",
    "id": "vJVD0Wle",
    "author": [
      {
        "family": "Galiuto",
        "given": "Leonarda"
      },
      {
        "family": "Patrono",
        "given": "Carlo"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          12,
          7
        ]
      ]
    },
    "container-title": "European Heart Journal",
    "DOI": "10.1093/eurheartj/ehaa934",
    "volume": "41",
    "issue": "46",
    "page": "4387-4388",
    "publisher": "Oxford University Press (OUP)",
    "title": "Conflicting results on the efficacy of remdesivir in hospitalized Covid-19 patients: comment on the Adaptive Covid-19 Treatment Trial",
    "URL": "https://doi.org/ghp4kw",
    "PMCID": "PMC7799042",
    "PMID": "33306101",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1093/eurheartj/ehaa934\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: vJVD0Wle"
  },
  {
    "type": "article-journal",
    "id": "ZhhV4ztO",
    "author": [
      {
        "family": "Walters",
        "given": "Tomos E."
      },
      {
        "family": "Kalman",
        "given": "Jonathan M."
      },
      {
        "family": "Patel",
        "given": "Sheila K."
      },
      {
        "family": "Mearns",
        "given": "Megan"
      },
      {
        "family": "Velkoska",
        "given": "Elena"
      },
      {
        "family": "Burrell",
        "given": "Louise M."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2016,
          10,
          12
        ]
      ]
    },
    "container-title": "Europace",
    "DOI": "10.1093/europace/euw246",
    "page": "euw246",
    "publisher": "Oxford University Press (OUP)",
    "title": "Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling",
    "URL": "https://doi.org/gbt2jw",
    "PMID": "27738071",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1093/europace/euw246\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: ZhhV4ztO"
  },
  {
    "type": "article-journal",
    "id": "f50jNbA8",
    "author": [
      {
        "family": "Houser",
        "given": "Katherine V."
      },
      {
        "family": "Gretebeck",
        "given": "Lisa"
      },
      {
        "family": "Ying",
        "given": "Tianlei"
      },
      {
        "family": "Wang",
        "given": "Yanping"
      },
      {
        "family": "Vogel",
        "given": "Leatrice"
      },
      {
        "family": "Lamirande",
        "given": "Elaine W."
      },
      {
        "family": "Bock",
        "given": "Kevin W."
      },
      {
        "family": "Moore",
        "given": "Ian N."
      },
      {
        "family": "Dimitrov",
        "given": "Dimiter S."
      },
      {
        "family": "Subbarao",
        "given": "Kanta"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2016,
          5,
          15
        ]
      ]
    },
    "container-title": "Journal of Infectious Diseases",
    "DOI": "10.1093/infdis/jiw080",
    "volume": "213",
    "issue": "10",
    "page": "1557-1561",
    "publisher": "Oxford University Press (OUP)",
    "title": "Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)–Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection",
    "URL": "https://doi.org/f8pm7j",
    "PMCID": "PMC4837915",
    "PMID": "26941283",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1093/infdis/jiw080"
  },
  {
    "type": "article-journal",
    "id": "WFGcbZhe",
    "author": [
      {
        "family": "Zhou",
        "given": "Dan"
      },
      {
        "family": "Dai",
        "given": "Sheng-Ming"
      },
      {
        "family": "Tong",
        "given": "Qiang"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          7
        ]
      ]
    },
    "abstract": "A novel coronavirus disease (COVID-19), caused by infection with SARS-CoV-2, has swept across 31 provinces in China and over 40 countries worldwide. The transition from first symptoms to acute respiratory distress syndrome (ARDS) is highly likely to be due to uncontrolled cytokine release. There is an urgent need to identify safe and effective drugs for treatment. Chloroquine (CQ) exhibits a promising inhibitory effect. However, the clinical use of CQ can cause severe side effects. We propose that hydroxychloroquine (HCQ), which exhibits an antiviral effect highly similar to that of CQ, could serve as a better therapeutic approach. HCQ is likely to attenuate the severe progression of COVID-19, inhibiting the cytokine storm by suppressing T cell activation. It has a safer clinical profile and is suitable for those who are pregnant. It is cheaper and more readily available in China. We herein strongly urge that clinical trials are performed to assess the preventive effects of HCQ in both disease infection and progression.",
    "container-title": "Journal of Antimicrobial Chemotherapy",
    "DOI": "10.1093/jac/dkaa114",
    "volume": "75",
    "issue": "7",
    "page": "1667-1670",
    "publisher": "Oxford University Press (OUP)",
    "title": "COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression",
    "URL": "https://doi.org/ggq84c",
    "PMCID": "PMC7184499",
    "PMID": "32196083",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1093/jac/dkaa114\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: WFGcbZhe"
  },
  {
    "type": "article-journal",
    "id": "WEqfULN1",
    "author": [
      {
        "family": "Rojas-Marte",
        "given": "G"
      },
      {
        "family": "Khalid",
        "given": "M"
      },
      {
        "family": "Mukhtar",
        "given": "O"
      },
      {
        "family": "Hashmi",
        "given": "A T"
      },
      {
        "family": "Waheed",
        "given": "M A"
      },
      {
        "family": "Ehrlich",
        "given": "S"
      },
      {
        "family": "Aslam",
        "given": "A"
      },
      {
        "family": "Siddiqui",
        "given": "S"
      },
      {
        "family": "Agarwal",
        "given": "C"
      },
      {
        "family": "Malyshev",
        "given": "Y"
      },
      {
        "family": "Henriquez-Felipe",
        "given": "C"
      },
      {
        "family": "Sharma",
        "given": "D"
      },
      {
        "family": "Sharma",
        "given": "S"
      },
      {
        "family": "Chukwuka",
        "given": "N"
      },
      {
        "family": "Rodriguez",
        "given": "D C"
      },
      {
        "family": "Alliu",
        "given": "S"
      },
      {
        "family": "Le",
        "given": "J"
      },
      {
        "family": "Shani",
        "given": "J"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          8
        ]
      ]
    },
    "container-title": "QJM: An International Journal of Medicine",
    "DOI": "10.1093/qjmed/hcaa206",
    "volume": "113",
    "issue": "8",
    "page": "546-550",
    "publisher": "Oxford University Press (OUP)",
    "title": "Outcomes in patients with severe COVID-19 disease treated with tocilizumab: a case–controlled study",
    "URL": "https://doi.org/gg496t",
    "PMCID": "PMC7337835",
    "PMID": "32569363",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1093/qjmed/hcaa206\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: WEqfULN1"
  },
  {
    "type": "article-journal",
    "id": "6Agll71m",
    "author": [
      {
        "family": "Campbell",
        "given": "L."
      },
      {
        "family": "Chen",
        "given": "C."
      },
      {
        "family": "Bhagat",
        "given": "S. S."
      },
      {
        "family": "Parker",
        "given": "R. A."
      },
      {
        "family": "Ostor",
        "given": "A. J. K."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2010,
          11,
          14
        ]
      ]
    },
    "container-title": "Rheumatology",
    "DOI": "10.1093/rheumatology/keq343",
    "volume": "50",
    "issue": "3",
    "page": "552-562",
    "publisher": "Oxford University Press (OUP)",
    "title": "Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials",
    "URL": "https://doi.org/crqn7c",
    "PMID": "21078627",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1093/rheumatology/keq343\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 6Agll71m"
  },
  {
    "type": "article-journal",
    "id": "TgV8gb30",
    "author": [
      {
        "family": "Lang",
        "given": "Veronika R."
      },
      {
        "family": "Englbrecht",
        "given": "Matthias"
      },
      {
        "family": "Rech",
        "given": "Jürgen"
      },
      {
        "family": "Nüsslein",
        "given": "Hubert"
      },
      {
        "family": "Manger",
        "given": "Karin"
      },
      {
        "family": "Schuch",
        "given": "Florian"
      },
      {
        "family": "Tony",
        "given": "Hans-Peter"
      },
      {
        "family": "Fleck",
        "given": "Martin"
      },
      {
        "family": "Manger",
        "given": "Bernhard"
      },
      {
        "family": "Schett",
        "given": "Georg"
      },
      {
        "family": "Zwerina",
        "given": "Jochen"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2012,
          5
        ]
      ]
    },
    "container-title": "Rheumatology",
    "DOI": "10.1093/rheumatology/ker223",
    "volume": "51",
    "issue": "5",
    "page": "852-857",
    "publisher": "Oxford University Press (OUP)",
    "title": "Risk of infections in rheumatoid arthritis patients treated with tocilizumab",
    "URL": "https://doi.org/d3b3rh",
    "PMID": "21865281",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1093/rheumatology/ker223\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: TgV8gb30"
  },
  {
    "type": "article-journal",
    "id": "6xLhs9st",
    "author": [
      {
        "family": "Saito",
        "given": "Jumpei"
      },
      {
        "family": "Yakuwa",
        "given": "Naho"
      },
      {
        "family": "Kaneko",
        "given": "Kayoko"
      },
      {
        "family": "Takai",
        "given": "Chinatsu"
      },
      {
        "family": "Goto",
        "given": "Mikako"
      },
      {
        "family": "Nakajima",
        "given": "Ken"
      },
      {
        "family": "Yamatani",
        "given": "Akimasa"
      },
      {
        "family": "Murashima",
        "given": "Atsuko"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          8
        ]
      ]
    },
    "container-title": "Rheumatology",
    "DOI": "10.1093/rheumatology/kez100",
    "volume": "58",
    "issue": "8",
    "page": "1505-1507",
    "publisher": "Oxford University Press (OUP)",
    "title": "Tocilizumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk and infant serum",
    "URL": "https://doi.org/ggzhks",
    "PMID": "30945743",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1093/rheumatology/kez100\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 6xLhs9st"
  },
  {
    "type": "article-journal",
    "id": "41WAtZmB",
    "author": [
      {
        "family": "Sun",
        "given": "Chunyun"
      },
      {
        "family": "Chen",
        "given": "Long"
      },
      {
        "family": "Yang",
        "given": "Ji"
      },
      {
        "family": "Luo",
        "given": "Chunxia"
      },
      {
        "family": "Zhang",
        "given": "Yanjing"
      },
      {
        "family": "Li",
        "given": "Jing"
      },
      {
        "family": "Yang",
        "given": "Jiahui"
      },
      {
        "family": "Zhang",
        "given": "Jie"
      },
      {
        "family": "Xie",
        "given": "Liangzhi"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          20
        ]
      ]
    },
    "abstract": "SARS-CoV-2 and SARS-CoV share a common human receptor ACE2. Protein-protein interaction structure modeling indicates that spike-RBD of the two viruses also has similar overall binding conformation and binding free energy to ACE2. assays using recombinant ACE2 proteins and ACE2 expressing cells confirmed the two coronaviruses’ similar binding affinities to ACE2. The above studies provide experimental supporting evidences and possible explanation for the high transmissibility observed in the SARS-CoV-2 outbreak. Potent ACE2-blocking SARS-CoV neutralizing antibodies showed limited cross-binding and neutralizing activities to SARS-CoV-2. ACE2-non-blocking SARS-CoV RBD antibodies, though with weaker neutralizing activities against SARS-CoV, showed positive cross-neutralizing activities to SARS-CoV-2 with an unknown mechanism. These findings suggest a trade-off between the efficacy and spectrum for therapeutic antibodies to different coronaviruses, and hence highlight the possibilities and challenges in developing broadly protecting antibodies and vaccines against SARS-CoV-2 and its future mutants.",
    "container-title": "Cold Spring Harbor Laboratory",
    "DOI": "10.1101/2020.02.16.951723",
    "publisher": "Cold Spring Harbor Laboratory",
    "title": "SARS-CoV-2 and SARS-CoV Spike-RBD Structure and Receptor Binding Comparison and Potential Implications on Neutralizing Antibody and Vaccine Development",
    "URL": "https://doi.org/ggq63j",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.16.951723\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 41WAtZmB"
  },
  {
    "type": "article-journal",
    "id": "zoLViMNg",
    "author": [
      {
        "family": "Kujawski",
        "given": "Stephanie A."
      },
      {
        "family": "Wong",
        "given": "Karen K"
      },
      {
        "family": "Collins",
        "given": "Jennifer P."
      },
      {
        "family": "Epstein",
        "given": "Lauren"
      },
      {
        "family": "Killerby",
        "given": "Marie E."
      },
      {
        "family": "Midgley",
        "given": "Claire M."
      },
      {
        "family": "Abedi",
        "given": "Glen R."
      },
      {
        "family": "Ahmed",
        "given": "N. Seema"
      },
      {
        "family": "Almendares",
        "given": "Olivia"
      },
      {
        "family": "Alvarez",
        "given": "Francisco N."
      },
      {
        "family": "Anderson",
        "given": "Kayla N."
      },
      {
        "family": "Balter",
        "given": "Sharon"
      },
      {
        "family": "Barry",
        "given": "Vaughn"
      },
      {
        "family": "Bartlett",
        "given": "Karri"
      },
      {
        "family": "Beer",
        "given": "Karlyn"
      },
      {
        "family": "Ben-Aderet",
        "given": "Michael A."
      },
      {
        "family": "Benowitz",
        "given": "Isaac"
      },
      {
        "family": "Biggs",
        "given": "Holly"
      },
      {
        "family": "Binder",
        "given": "Alison M."
      },
      {
        "family": "Black",
        "given": "Stephanie R."
      },
      {
        "family": "Bonin",
        "given": "Brandon"
      },
      {
        "family": "Brown",
        "given": "Catherine M."
      },
      {
        "family": "Bruce",
        "given": "Hollianne"
      },
      {
        "family": "Bryant-Genevier",
        "given": "Jonathan"
      },
      {
        "family": "Budd",
        "given": "Alicia"
      },
      {
        "family": "Buell",
        "given": "Diane"
      },
      {
        "family": "Bystritsky",
        "given": "Rachel"
      },
      {
        "family": "Cates",
        "given": "Jordan"
      },
      {
        "family": "Charles",
        "given": "E. Matt"
      },
      {
        "family": "Chatham-Stephens",
        "given": "Kevin"
      },
      {
        "family": "Chea",
        "given": "Nora"
      },
      {
        "family": "Chiou",
        "given": "Howard"
      },
      {
        "family": "Christiansen",
        "given": "Demian"
      },
      {
        "family": "Chu",
        "given": "Victoria"
      },
      {
        "family": "Cody",
        "given": "Sara"
      },
      {
        "family": "Cohen",
        "given": "Max"
      },
      {
        "family": "Conners",
        "given": "Erin"
      },
      {
        "family": "Curns",
        "given": "Aaron"
      },
      {
        "family": "Dasari",
        "given": "Vishal"
      },
      {
        "family": "Dawson",
        "given": "Patrick"
      },
      {
        "family": "DeSalvo",
        "given": "Traci"
      },
      {
        "family": "Diaz",
        "given": "George"
      },
      {
        "family": "Donahue",
        "given": "Matthew"
      },
      {
        "family": "Donovan",
        "given": "Suzanne"
      },
      {
        "family": "Duca",
        "given": "Lindsey M."
      },
      {
        "family": "Erickson",
        "given": "Keith"
      },
      {
        "family": "Esona",
        "given": "Mathew D."
      },
      {
        "family": "Evans",
        "given": "Suzanne"
      },
      {
        "family": "Falk",
        "given": "Jeremy"
      },
      {
        "family": "Feldstein",
        "given": "Leora R."
      },
      {
        "family": "Fenstersheib",
        "given": "Martin"
      },
      {
        "family": "Fischer",
        "given": "Marc"
      },
      {
        "family": "Fisher",
        "given": "Rebecca"
      },
      {
        "family": "Foo",
        "given": "Chelsea"
      },
      {
        "family": "Fricchione",
        "given": "Marielle J."
      },
      {
        "family": "Friedman",
        "given": "Oren"
      },
      {
        "family": "Fry",
        "given": "Alicia M."
      },
      {
        "family": "Galang",
        "given": "Romeo R."
      },
      {
        "family": "Garcia",
        "given": "Melissa M."
      },
      {
        "family": "Gerber",
        "given": "Susa I."
      },
      {
        "family": "Gerrard",
        "given": "Graham"
      },
      {
        "family": "Ghinai",
        "given": "Isaac"
      },
      {
        "family": "Gounder",
        "given": "Prabhu"
      },
      {
        "family": "Grein",
        "given": "Jonathan"
      },
      {
        "family": "Grigg",
        "given": "Cheri"
      },
      {
        "family": "Gunzenhauser",
        "given": "Jeffrey D."
      },
      {
        "family": "Gutkin",
        "given": "Gary I."
      },
      {
        "family": "Haddix",
        "given": "Meredith"
      },
      {
        "family": "Hall",
        "given": "Aron J."
      },
      {
        "family": "Han",
        "given": "George"
      },
      {
        "family": "Harcourt",
        "given": "Jennifer"
      },
      {
        "family": "Harriman",
        "given": "Kathleen"
      },
      {
        "family": "Haupt",
        "given": "Thomas"
      },
      {
        "family": "Haynes",
        "given": "Amber"
      },
      {
        "family": "Holshue",
        "given": "Michelle"
      },
      {
        "family": "Hoover",
        "given": "Cora"
      },
      {
        "family": "Hunter",
        "given": "Jennifer C."
      },
      {
        "family": "Jacobs",
        "given": "Max W."
      },
      {
        "family": "Jarashow",
        "given": "Claire"
      },
      {
        "family": "Jhung",
        "given": "Michael A."
      },
      {
        "family": "Joshi",
        "given": "Kiran"
      },
      {
        "family": "Kamali",
        "given": "Talar"
      },
      {
        "family": "Kamili",
        "given": "Shifaq"
      },
      {
        "family": "Kim",
        "given": "Lindsay"
      },
      {
        "family": "Kim",
        "given": "Moon"
      },
      {
        "family": "King",
        "given": "Jan"
      },
      {
        "family": "Kirking",
        "given": "Hannah L."
      },
      {
        "family": "Kita-Yarbro",
        "given": "Amanda"
      },
      {
        "family": "Klos",
        "given": "Rachel"
      },
      {
        "family": "Kobayashi",
        "given": "Miwako"
      },
      {
        "family": "Kocharian",
        "given": "Anna"
      },
      {
        "family": "Komatsu",
        "given": "Kenneth K."
      },
      {
        "family": "Koppaka",
        "given": "Ram"
      },
      {
        "family": "Layden",
        "given": "Jennifer E."
      },
      {
        "family": "Li",
        "given": "Yan"
      },
      {
        "family": "Lindquist",
        "given": "Scott"
      },
      {
        "family": "Lindstrom",
        "given": "Stephen"
      },
      {
        "family": "Link-Gelles",
        "given": "Ruth"
      },
      {
        "family": "Lively",
        "given": "Joana"
      },
      {
        "family": "Livingston",
        "given": "Michelle"
      },
      {
        "family": "Lo",
        "given": "Kelly"
      },
      {
        "family": "Lo",
        "given": "Jennifer"
      },
      {
        "family": "Lu",
        "given": "Xiaoyan"
      },
      {
        "family": "Lynch",
        "given": "Brian"
      },
      {
        "family": "Madoff",
        "given": "Larry"
      },
      {
        "family": "Malapati",
        "given": "Lakshmi"
      },
      {
        "family": "Marks",
        "given": "Gregory"
      },
      {
        "family": "Marlow",
        "given": "Mariel"
      },
      {
        "family": "Mathisen",
        "given": "Glenn E."
      },
      {
        "family": "McClung",
        "given": "Nancy"
      },
      {
        "family": "McGovern",
        "given": "Olivia"
      },
      {
        "family": "McPherson",
        "given": "Tristan D."
      },
      {
        "family": "Mehta",
        "given": "Mitali"
      },
      {
        "family": "Meier",
        "given": "Audrey"
      },
      {
        "family": "Mello",
        "given": "Lynn"
      },
      {
        "family": "Moon",
        "given": "Sung-sil"
      },
      {
        "family": "Morgan",
        "given": "Margie"
      },
      {
        "family": "Moro",
        "given": "Ruth N."
      },
      {
        "family": "Murray",
        "given": "Janna'"
      },
      {
        "family": "Murthy",
        "given": "Rekha"
      },
      {
        "family": "Novosad",
        "given": "Shannon"
      },
      {
        "family": "Oliver",
        "given": "Sara E."
      },
      {
        "family": "O'Shea",
        "given": "Jennifer"
      },
      {
        "family": "Pacilli",
        "given": "Massimo"
      },
      {
        "family": "Paden",
        "given": "Clinton R."
      },
      {
        "family": "Pallansch",
        "given": "Mark A."
      },
      {
        "family": "Patel",
        "given": "Manisha"
      },
      {
        "family": "Patel",
        "given": "Sajan"
      },
      {
        "family": "Pedraza",
        "given": "Isabel"
      },
      {
        "family": "Pillai",
        "given": "Satish K."
      },
      {
        "family": "Pindyck",
        "given": "Talia"
      },
      {
        "family": "Pray",
        "given": "Ian"
      },
      {
        "family": "Queen",
        "given": "Krista"
      },
      {
        "family": "Quick",
        "given": "Nichole"
      },
      {
        "family": "Reese",
        "given": "Heather"
      },
      {
        "family": "Rha",
        "given": "Brian"
      },
      {
        "family": "Rhodes",
        "given": "Heather"
      },
      {
        "family": "Robinson",
        "given": "Susan"
      },
      {
        "family": "Robinson",
        "given": "Philip"
      },
      {
        "family": "Rolfes",
        "given": "Melissa"
      },
      {
        "family": "Routh",
        "given": "Janell"
      },
      {
        "family": "Rubin",
        "given": "Rachel"
      },
      {
        "family": "Rudman",
        "given": "Sarah L."
      },
      {
        "family": "Sakthivel",
        "given": "Senthilkumar K."
      },
      {
        "family": "Scott",
        "given": "Sarah"
      },
      {
        "family": "Shepherd",
        "given": "Christopher"
      },
      {
        "family": "Shetty",
        "given": "Varun"
      },
      {
        "family": "Smith",
        "given": "Ethan A."
      },
      {
        "family": "Smith",
        "given": "Shanon"
      },
      {
        "family": "Stierman",
        "given": "Bryan"
      },
      {
        "family": "Stoecker",
        "given": "William"
      },
      {
        "family": "Sunenshine",
        "given": "Rebecca"
      },
      {
        "family": "Sy-Santos",
        "given": "Regina"
      },
      {
        "family": "Tamin",
        "given": "Azaibi"
      },
      {
        "family": "Tao",
        "given": "Ying"
      },
      {
        "family": "Terashita",
        "given": "Dawn"
      },
      {
        "family": "Thornburg",
        "given": "Natalie J."
      },
      {
        "family": "Tong",
        "given": "Suxiang"
      },
      {
        "family": "Traub",
        "given": "Elizabeth"
      },
      {
        "family": "Tural",
        "given": "Ahmet"
      },
      {
        "family": "Uehara",
        "given": "Anna"
      },
      {
        "family": "Uyeki",
        "given": "Timothy M."
      },
      {
        "family": "Vahey",
        "given": "Grace"
      },
      {
        "family": "Verani",
        "given": "Jennifer R."
      },
      {
        "family": "Villarino",
        "given": "Elsa"
      },
      {
        "family": "Wallace",
        "given": "Megan"
      },
      {
        "family": "Wang",
        "given": "Lijuan"
      },
      {
        "family": "Watson",
        "given": "John T."
      },
      {
        "family": "Westercamp",
        "given": "Matthew"
      },
      {
        "family": "Whitaker",
        "given": "Brett"
      },
      {
        "family": "Wilkerson",
        "given": "Sarah"
      },
      {
        "family": "Woodruff",
        "given": "Rebecca C."
      },
      {
        "family": "Wortham",
        "given": "Jonathan M."
      },
      {
        "family": "Wu",
        "given": "Tiffany"
      },
      {
        "family": "Xie",
        "given": "Amy"
      },
      {
        "family": "Yousaf",
        "given": "Anna"
      },
      {
        "family": "Zahn",
        "given": "Matthew"
      },
      {
        "family": "Zhang",
        "given": "Jing"
      },
      {
        "literal": "The COVID-19 Investigation Team"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          12
        ]
      ]
    },
    "container-title": "Cold Spring Harbor Laboratory",
    "DOI": "10.1101/2020.03.09.20032896",
    "publisher": "Cold Spring Harbor Laboratory",
    "title": "First 12 patients with coronavirus disease 2019 (COVID-19) in the United States",
    "URL": "https://doi.org/ggqm6z",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.09.20032896\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: zoLViMNg"
  },
  {
    "type": "article-journal",
    "id": "XcuzhxrJ",
    "author": [
      {
        "family": "Wang",
        "given": "Chunyan"
      },
      {
        "family": "Li",
        "given": "Wentao"
      },
      {
        "family": "Drabek",
        "given": "Dubravka"
      },
      {
        "family": "Okba",
        "given": "Nisreen M.A."
      },
      {
        "family": "van Haperen",
        "given": "Rien"
      },
      {
        "family": "Osterhaus",
        "given": "Albert D.M.E."
      },
      {
        "family": "van Kuppeveld",
        "given": "Frank J.M."
      },
      {
        "family": "Haagmans",
        "given": "Bart L."
      },
      {
        "family": "Grosveld",
        "given": "Frank"
      },
      {
        "family": "Bosch",
        "given": "Berend-Jan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          12
        ]
      ]
    },
    "abstract": "The emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19). Vaccines and targeted therapeutics for treatment of this disease are currently lacking. Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV). This cross-neutralizing antibody targets a communal epitope on these viruses and offers potential for prevention and treatment of COVID-19.",
    "container-title": "Cold Spring Harbor Laboratory",
    "DOI": "10.1101/2020.03.11.987958",
    "publisher": "Cold Spring Harbor Laboratory",
    "title": "A human monoclonal antibody blocking SARS-CoV-2 infection",
    "URL": "https://doi.org/ggnw4t",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.11.987958\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: XcuzhxrJ"
  },
  {
    "type": "article-journal",
    "id": "wzHb7Mj5",
    "author": [
      {
        "family": "Chen",
        "given": "Zhaowei"
      },
      {
        "family": "Hu",
        "given": "Jijia"
      },
      {
        "family": "Zhang",
        "given": "Zongwei"
      },
      {
        "family": "Jiang",
        "given": "Shan"
      },
      {
        "family": "Han",
        "given": "Shoumeng"
      },
      {
        "family": "Yan",
        "given": "Dandan"
      },
      {
        "family": "Zhuang",
        "given": "Ruhong"
      },
      {
        "family": "Hu",
        "given": "Ben"
      },
      {
        "family": "Zhang",
        "given": "Zhan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4,
          10
        ]
      ]
    },
    "container-title": "Cold Spring Harbor Laboratory",
    "DOI": "10.1101/2020.03.22.20040758",
    "publisher": "Cold Spring Harbor Laboratory",
    "title": "Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial",
    "URL": "https://doi.org/ggqm4v",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.22.20040758\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: wzHb7Mj5"
  },
  {
    "type": "article-journal",
    "id": "1CgZR55GZ",
    "author": [
      {
        "family": "Silva Borba",
        "given": "Mayla Gabriela"
      },
      {
        "family": "Almeida Val",
        "given": "Fernando Fonseca"
      },
      {
        "family": "Sampaio",
        "given": "Vanderson Souza"
      },
      {
        "family": "Araújo Alexandre",
        "given": "Marcia Almeida"
      },
      {
        "family": "Melo",
        "given": "Gisely Cardoso"
      },
      {
        "family": "Brito",
        "given": "Marcelo"
      },
      {
        "family": "Gomes Mourão",
        "given": "Maria Paula"
      },
      {
        "family": "Brito-Sousa",
        "given": "José Diego"
      },
      {
        "family": "Baía-da-Silva",
        "given": "Djane"
      },
      {
        "family": "Farias Guerra",
        "given": "Marcus Vinitius"
      },
      {
        "family": "Abrahão Hajjar",
        "given": "Ludhmila"
      },
      {
        "family": "Pinto",
        "given": "Rosemary Costa"
      },
      {
        "family": "Silva Balieiro",
        "given": "Antonio Alcirley"
      },
      {
        "family": "Naveca",
        "given": "Felipe Gomes"
      },
      {
        "family": "Simão Xavier",
        "given": "Mariana"
      },
      {
        "family": "Salomão",
        "given": "Alexandre"
      },
      {
        "family": "Siqueira",
        "given": "André Machado"
      },
      {
        "family": "Schwarzbolt",
        "given": "Alexandre"
      },
      {
        "family": "Rosa Croda",
        "given": "Júlio Henrique"
      },
      {
        "family": "Nogueira",
        "given": "Maurício Lacerda"
      },
      {
        "family": "Sierra Romero",
        "given": "Gustavo Adolfo"
      },
      {
        "family": "Bassat",
        "given": "Quique"
      },
      {
        "family": "Fontes",
        "given": "Cor Jesus"
      },
      {
        "family": "Cláudio Albuquerque",
        "given": "Bernardino"
      },
      {
        "family": "Daniel-Ribeiro",
        "given": "Cláudio Tadeu"
      },
      {
        "family": "Monteiro",
        "given": "Wuelton Marcelo"
      },
      {
        "family": "Guimarães Lacerda",
        "given": "Marcus Vinícius"
      },
      {
        "literal": "CloroCovid-19 Team"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4,
          16
        ]
      ]
    },
    "container-title": "Cold Spring Harbor Laboratory",
    "DOI": "10.1101/2020.04.07.20056424",
    "publisher": "Cold Spring Harbor Laboratory",
    "title": "Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: Preliminary safety results of a randomized, double-blinded, phase IIb clinical trial (CloroCovid-19 Study)",
    "URL": "https://doi.org/ggr3nj",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.04.07.20056424\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 1CgZR55GZ"
  },
  {
    "type": "article-journal",
    "id": "OQ0b31BA",
    "author": [
      {
        "family": "C.E.Lane",
        "given": "Jennifer"
      },
      {
        "family": "Weaver",
        "given": "James"
      },
      {
        "family": "Kostka",
        "given": "Kristin"
      },
      {
        "family": "Duarte-Salles",
        "given": "Talita"
      },
      {
        "family": "Abrahao",
        "given": "Maria Tereza F."
      },
      {
        "family": "Alghoul",
        "given": "Heba"
      },
      {
        "family": "Alser",
        "given": "Osaid"
      },
      {
        "family": "Alshammari",
        "given": "Thamir M"
      },
      {
        "family": "Biedermann",
        "given": "Patricia"
      },
      {
        "family": "Burn",
        "given": "Edward"
      },
      {
        "family": "Casajust",
        "given": "Paula"
      },
      {
        "family": "Conover",
        "given": "Mitch"
      },
      {
        "family": "Culhane",
        "given": "Aedin C."
      },
      {
        "family": "Davydov",
        "given": "Alexander"
      },
      {
        "family": "DuVall",
        "given": "Scott L."
      },
      {
        "family": "Dymshyts",
        "given": "Dmitry"
      },
      {
        "family": "Fernandez-Bertolin",
        "given": "Sergio"
      },
      {
        "family": "Fišter",
        "given": "Kristina"
      },
      {
        "family": "Hardin",
        "given": "Jill"
      },
      {
        "family": "Hester",
        "given": "Laura"
      },
      {
        "family": "Hripcsak",
        "given": "George"
      },
      {
        "family": "Kent",
        "given": "Seamus"
      },
      {
        "family": "Khosla",
        "given": "Sajan"
      },
      {
        "family": "Kolovos",
        "given": "Spyros"
      },
      {
        "family": "Lambert",
        "given": "Christophe G."
      },
      {
        "family": "van der Lei",
        "given": "Johan"
      },
      {
        "family": "Londhe",
        "given": "Ajit A."
      },
      {
        "family": "Lynch",
        "given": "Kristine E."
      },
      {
        "family": "Makadia",
        "given": "Rupa"
      },
      {
        "family": "Margulis",
        "given": "Andrea V."
      },
      {
        "family": "Matheny",
        "given": "Michael E."
      },
      {
        "family": "Mehta",
        "given": "Paras"
      },
      {
        "family": "Morales",
        "given": "Daniel R."
      },
      {
        "family": "Morgan-Stewart",
        "given": "Henry"
      },
      {
        "family": "Mosseveld",
        "given": "Mees"
      },
      {
        "family": "Newby",
        "given": "Danielle"
      },
      {
        "family": "Nyberg",
        "given": "Fredrik"
      },
      {
        "family": "Ostropolets",
        "given": "Anna"
      },
      {
        "family": "Park",
        "given": "Rae Woong"
      },
      {
        "family": "Prats-Uribe",
        "given": "Albert"
      },
      {
        "family": "Rao",
        "given": "Gowtham A."
      },
      {
        "family": "Reich",
        "given": "Christian"
      },
      {
        "family": "Reps",
        "given": "Jenna"
      },
      {
        "family": "Rijnbeek",
        "given": "Peter"
      },
      {
        "family": "Kumaran Sathappan",
        "given": "Selva Muthu"
      },
      {
        "family": "Schuemie",
        "given": "Martijn"
      },
      {
        "family": "Seager",
        "given": "Sarah"
      },
      {
        "family": "Sena",
        "given": "Anthony"
      },
      {
        "family": "Shoaibi",
        "given": "Azza"
      },
      {
        "family": "Spotnitz",
        "given": "Matthew"
      },
      {
        "family": "Suchard",
        "given": "Marc A."
      },
      {
        "family": "Swerdel",
        "given": "Joel"
      },
      {
        "family": "Torre",
        "given": "Carmen O."
      },
      {
        "family": "Vizcaya",
        "given": "David"
      },
      {
        "family": "Wen",
        "given": "Haini"
      },
      {
        "family": "de Wilde",
        "given": "Marcel"
      },
      {
        "family": "You",
        "given": "Seng Chan"
      },
      {
        "family": "Zhang",
        "given": "Lin"
      },
      {
        "family": "Zhuk",
        "given": "Oleg"
      },
      {
        "family": "Ryan",
        "given": "Patrick"
      },
      {
        "family": "Prieto-Alhambra",
        "given": "Daniel"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4,
          10
        ]
      ]
    },
    "container-title": "Cold Spring Harbor Laboratory",
    "DOI": "10.1101/2020.04.08.20054551",
    "publisher": "Cold Spring Harbor Laboratory",
    "title": "Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study",
    "URL": "https://doi.org/ggrn7s",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.04.08.20054551\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: OQ0b31BA"
  },
  {
    "type": "article-journal",
    "id": "RXr9BKKT",
    "author": [
      {
        "family": "Tang",
        "given": "Wei"
      },
      {
        "family": "Cao",
        "given": "Zhujun"
      },
      {
        "family": "Han",
        "given": "Mingfeng"
      },
      {
        "family": "Wang",
        "given": "Zhengyan"
      },
      {
        "family": "Chen",
        "given": "Junwen"
      },
      {
        "family": "Sun",
        "given": "Wenjin"
      },
      {
        "family": "Wu",
        "given": "Yaojie"
      },
      {
        "family": "Xiao",
        "given": "Wei"
      },
      {
        "family": "Liu",
        "given": "Shengyong"
      },
      {
        "family": "Chen",
        "given": "Erzhen"
      },
      {
        "family": "Chen",
        "given": "Wei"
      },
      {
        "family": "Wang",
        "given": "Xiongbiao"
      },
      {
        "family": "Yang",
        "given": "Jiuyong"
      },
      {
        "family": "Lin",
        "given": "Jun"
      },
      {
        "family": "Zhao",
        "given": "Qingxia"
      },
      {
        "family": "Yan",
        "given": "Youqin"
      },
      {
        "family": "Xie",
        "given": "Zhibin"
      },
      {
        "family": "Li",
        "given": "Dan"
      },
      {
        "family": "Yang",
        "given": "Yaofeng"
      },
      {
        "family": "Liu",
        "given": "Leshan"
      },
      {
        "family": "Qu",
        "given": "Jieming"
      },
      {
        "family": "Ning",
        "given": "Guang"
      },
      {
        "family": "Shi",
        "given": "Guochao"
      },
      {
        "family": "Xie",
        "given": "Qing"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          5,
          7
        ]
      ]
    },
    "container-title": "Cold Spring Harbor Laboratory",
    "DOI": "10.1101/2020.04.10.20060558",
    "publisher": "Cold Spring Harbor Laboratory",
    "title": "Hydroxychloroquine in patients mainly with mild to moderate COVID–19: an open–label, randomized, controlled trial",
    "URL": "https://doi.org/ggr68m",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.04.10.20060558\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: RXr9BKKT"
  },
  {
    "type": "article-journal",
    "id": "MENbRfOl",
    "author": [
      {
        "family": "Magagnoli",
        "given": "Joseph"
      },
      {
        "family": "Narendran",
        "given": "Siddharth"
      },
      {
        "family": "Pereira",
        "given": "Felipe"
      },
      {
        "family": "Cummings",
        "given": "Tammy"
      },
      {
        "family": "Hardin",
        "given": "James W."
      },
      {
        "family": "Sutton",
        "given": "S. Scott"
      },
      {
        "family": "Ambati",
        "given": "Jayakrishna"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4,
          21
        ]
      ]
    },
    "container-title": "Cold Spring Harbor Laboratory",
    "DOI": "10.1101/2020.04.16.20065920",
    "publisher": "Cold Spring Harbor Laboratory",
    "title": "Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19",
    "URL": "https://doi.org/ggspt6",
    "PMCID": "PMC7276049",
    "PMID": "32511622",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.04.16.20065920\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: MENbRfOl"
  },
  {
    "type": "article-journal",
    "id": "xnPm1mx8",
    "author": [
      {
        "family": "Elezkurtaj",
        "given": "Sefer"
      },
      {
        "family": "Greuel",
        "given": "Selina"
      },
      {
        "family": "Ihlow",
        "given": "Jana"
      },
      {
        "family": "Michaelis",
        "given": "Edward"
      },
      {
        "family": "Bischoff",
        "given": "Philip"
      },
      {
        "family": "Kunze",
        "given": "Catarina Alisa"
      },
      {
        "family": "Sinn",
        "given": "Bruno Valentin"
      },
      {
        "family": "Gerhold",
        "given": "Manuela"
      },
      {
        "family": "Hauptmann",
        "given": "Kathrin"
      },
      {
        "family": "Ingold-Heppner",
        "given": "Barbara"
      },
      {
        "family": "Miller",
        "given": "Florian"
      },
      {
        "family": "Herbst",
        "given": "Hermann"
      },
      {
        "family": "Corman",
        "given": "Victor Max"
      },
      {
        "family": "Martin",
        "given": "Hubert"
      },
      {
        "family": "Radbruch",
        "given": "Helena"
      },
      {
        "family": "Heppner",
        "given": "Frank L."
      },
      {
        "family": "Horst",
        "given": "David"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          6,
          17
        ]
      ]
    },
    "abstract": "Infection by the new corona virus strain SARS-CoV-2 and its related syndrome COVID-19 has caused several hundreds of thousands of deaths worldwide. Patients of higher age and with preexisting chronic health conditions are at an increased risk of fatal disease outcome. However, detailed information on causes of death and the contribution of comorbidities to death yet is missing. Here, we report autopsy findings on causes of death and comorbidities of 26 decedents that had clinically presented with severe COVID-19. We found that septic shock and multi organ failure was the most common immediate cause of death, often due to suppurative pulmonary infection. Respiratory failure due to diffuse alveolar damage presented as the most immediate cause of death in fewer cases. Several comorbidities, such as hypertension, ischemic heart disease, and obesity were present in the vast majority of patients. Our findings reveal that causes of death were directly related to COVID-19 in the majority of decedents, while they appear not to be an immediate result of preexisting health conditions and comorbidities. We therefore suggest that the majority of patients had died of COVID-19 with only contributory implications of preexisting health conditions to the mechanism of death.",
    "container-title": "Cold Spring Harbor Laboratory",
    "DOI": "10.1101/2020.06.15.20131540",
    "publisher": "Cold Spring Harbor Laboratory",
    "title": "Causes of Death and Comorbidities in Patients with COVID-19",
    "URL": "https://doi.org/gg926j",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.06.15.20131540\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: xnPm1mx8"
  },
  {
    "type": "article-journal",
    "id": "pzQoUwz3",
    "author": [
      {
        "family": "Horby",
        "given": "Peter"
      },
      {
        "family": "Lim",
        "given": "Wei Shen"
      },
      {
        "family": "Emberson",
        "given": "Jonathan"
      },
      {
        "family": "Mafham",
        "given": "Marion"
      },
      {
        "family": "Bell",
        "given": "Jennifer"
      },
      {
        "family": "Linsell",
        "given": "Louise"
      },
      {
        "family": "Staplin",
        "given": "Natalie"
      },
      {
        "family": "Brightling",
        "given": "Christopher"
      },
      {
        "family": "Ustianowski",
        "given": "Andrew"
      },
      {
        "family": "Elmahi",
        "given": "Einas"
      },
      {
        "family": "Prudon",
        "given": "Benjamin"
      },
      {
        "family": "Green",
        "given": "Christopher"
      },
      {
        "family": "Felton",
        "given": "Timothy"
      },
      {
        "family": "Chadwick",
        "given": "David"
      },
      {
        "family": "Rege",
        "given": "Kanchan"
      },
      {
        "family": "Fegan",
        "given": "Christopher"
      },
      {
        "family": "Chappell",
        "given": "Lucy C"
      },
      {
        "family": "Faust",
        "given": "Saul N"
      },
      {
        "family": "Jaki",
        "given": "Thomas"
      },
      {
        "family": "Jeffery",
        "given": "Katie"
      },
      {
        "family": "Montgomery",
        "given": "Alan"
      },
      {
        "family": "Rowan",
        "given": "Kathryn"
      },
      {
        "family": "Juszczak",
        "given": "Edmund"
      },
      {
        "family": "Baillie",
        "given": "J Kenneth"
      },
      {
        "family": "Haynes",
        "given": "Richard"
      },
      {
        "family": "Landray",
        "given": "Martin J"
      },
      {
        "literal": "RECOVERY Collaborative Group"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          6,
          22
        ]
      ]
    },
    "container-title": "Cold Spring Harbor Laboratory",
    "DOI": "10.1101/2020.06.22.20137273",
    "publisher": "Cold Spring Harbor Laboratory",
    "title": "Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report",
    "URL": "https://doi.org/dz5x",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.06.22.20137273\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: pzQoUwz3"
  },
  {
    "type": "article-journal",
    "id": "ZHqWXFcN",
    "author": [
      {
        "family": "Kaye",
        "given": "Avi"
      },
      {
        "family": "Siegel",
        "given": "Robert"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          7,
          14
        ]
      ]
    },
    "abstract": "Without proven, targeted therapies against SARS-CoV-2, it is crucial to counter the known pathophysiological causes of severe COVID-19, potentially utilizing existing drugs. Severe COVID-19 is largely the result of a dysregulated immune response characterized by lymphocytopenia, neutrophilia and critical hypercytokinemia – also called a “cytokine storm.” The IL-6 inhibitor tocilizumab (TCZ) could potentially suppress effects of the pro-inflammatory cytokine which drives the cytokine storm and thereby lower mortality from the disease. This systematic analysis aimed to investigate and synthesize existing evidence for the efficacy of TCZ in reducing COVID-19 mortality. PubMed and SearchWorks searches were performed to locate clinical studies with primary data on TCZ treatment for severe COVID-19. 9 case-control studies comparing mortality between TCZ and standard of care (SOC) were identified for a qualitative synthesis. In all of the studies, the odds ratio of mortality from COVID-19 pointed towards lower fatality with TCZ versus the SOC and a combined random effects odds ratio calculation yielded an odds ratio of 0.482 (p&lt;0.001, 95% CI 0.326-0.713). Additionally, 12 uncontrolled trials were identified for a qualitative analysis producing a raw combined mortality rate of 13.6%. Results from the systematic analysis provide positive evidence for the potential efficacy of TCZ, validating the merit and need for ongoing clinical trials of the drug to treat severe COVID-19.",
    "container-title": "Cold Spring Harbor Laboratory",
    "DOI": "10.1101/2020.07.10.20150938",
    "publisher": "Cold Spring Harbor Laboratory",
    "title": "The Efficacy of IL-6 Inhibitor Tocilizumab in Reducing Severe COVID-19 Mortality: A Systematic Review",
    "URL": "https://doi.org/gg62hv",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.07.10.20150938\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: ZHqWXFcN"
  },
  {
    "type": "article-journal",
    "id": "f44jpdvR",
    "author": [
      {
        "family": "Jones",
        "given": "Bryan E."
      },
      {
        "family": "Brown-Augsburger",
        "given": "Patricia L."
      },
      {
        "family": "Corbett",
        "given": "Kizzmekia S."
      },
      {
        "family": "Westendorf",
        "given": "Kathryn"
      },
      {
        "family": "Davies",
        "given": "Julian"
      },
      {
        "family": "Cujec",
        "given": "Thomas P."
      },
      {
        "family": "Wiethoff",
        "given": "Christopher M."
      },
      {
        "family": "Blackbourne",
        "given": "Jamie L."
      },
      {
        "family": "Heinz",
        "given": "Beverly A."
      },
      {
        "family": "Foster",
        "given": "Denisa"
      },
      {
        "family": "Higgs",
        "given": "Richard E."
      },
      {
        "family": "Balasubramaniam",
        "given": "Deepa"
      },
      {
        "family": "Wang",
        "given": "Lingshu"
      },
      {
        "family": "Bidshahri",
        "given": "Roza"
      },
      {
        "family": "Kraft",
        "given": "Lucas"
      },
      {
        "family": "Hwang",
        "given": "Yuri"
      },
      {
        "family": "Žentelis",
        "given": "Stefanie"
      },
      {
        "family": "Jepson",
        "given": "Kevin R."
      },
      {
        "family": "Goya",
        "given": "Rodrigo"
      },
      {
        "family": "Smith",
        "given": "Maia A."
      },
      {
        "family": "Collins",
        "given": "David W."
      },
      {
        "family": "Hinshaw",
        "given": "Samuel J."
      },
      {
        "family": "Tycho",
        "given": "Sean A."
      },
      {
        "family": "Pellacani",
        "given": "Davide"
      },
      {
        "family": "Xiang",
        "given": "Ping"
      },
      {
        "family": "Muthuraman",
        "given": "Krithika"
      },
      {
        "family": "Sobhanifar",
        "given": "Solmaz"
      },
      {
        "family": "Piper",
        "given": "Marissa H."
      },
      {
        "family": "Triana",
        "given": "Franz J."
      },
      {
        "family": "Hendle",
        "given": "Jorg"
      },
      {
        "family": "Pustilnik",
        "given": "Anna"
      },
      {
        "family": "Adams",
        "given": "Andrew C."
      },
      {
        "family": "Berens",
        "given": "Shawn J."
      },
      {
        "family": "Baric",
        "given": "Ralph S."
      },
      {
        "family": "Martinez",
        "given": "David R."
      },
      {
        "family": "Cross",
        "given": "Robert W."
      },
      {
        "family": "Geisbert",
        "given": "Thomas W."
      },
      {
        "family": "Borisevich",
        "given": "Viktoriya"
      },
      {
        "family": "Abiona",
        "given": "Olubukola"
      },
      {
        "family": "Belli",
        "given": "Hayley M."
      },
      {
        "family": "de Vries",
        "given": "Maren"
      },
      {
        "family": "Mohamed",
        "given": "Adil"
      },
      {
        "family": "Dittmann",
        "given": "Meike"
      },
      {
        "family": "Samanovic",
        "given": "Marie"
      },
      {
        "family": "Mulligan",
        "given": "Mark J."
      },
      {
        "family": "Goldsmith",
        "given": "Jory A."
      },
      {
        "family": "Hsieh",
        "given": "Ching-Lin"
      },
      {
        "family": "Johnson",
        "given": "Nicole V."
      },
      {
        "family": "Wrapp",
        "given": "Daniel"
      },
      {
        "family": "McLellan",
        "given": "Jason S."
      },
      {
        "family": "Barnhart",
        "given": "Bryan C."
      },
      {
        "family": "Graham",
        "given": "Barney S."
      },
      {
        "family": "Mascola",
        "given": "John R."
      },
      {
        "family": "Hansen",
        "given": "Carl L."
      },
      {
        "family": "Falconer",
        "given": "Ester"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          10,
          9
        ]
      ]
    },
    "abstract": "SARS-CoV-2 poses a public health threat for which therapeutic agents are urgently needed. Herein, we report that high-throughput microfluidic screening of antigen-specific B-cells led to the identification of LY-CoV555, a potent anti-spike neutralizing antibody from a convalescent COVID-19 patient. Biochemical, structural, and functional characterization revealed high-affinity binding to the receptor-binding domain, ACE2 binding inhibition, and potent neutralizing activity. In a rhesus macaque challenge model, prophylaxis doses as low as 2.5 mg/kg reduced viral replication in the upper and lower respiratory tract. These data demonstrate that high-throughput screening can lead to the identification of a potent antiviral antibody that protects against SARS-CoV-2 infection.",
    "container-title": "Cold Spring Harbor Laboratory",
    "DOI": "10.1101/2020.09.30.318972",
    "publisher": "Cold Spring Harbor Laboratory",
    "title": "LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection",
    "URL": "https://doi.org/gh4sjm",
    "PMCID": "PMC7536866",
    "PMID": "33024963",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1101/2020.09.30.318972"
  },
  {
    "type": "article-journal",
    "id": "K18v3qZ",
    "author": [
      {
        "family": "Wang",
        "given": "Pengfei"
      },
      {
        "family": "Nair",
        "given": "Manoj S."
      },
      {
        "family": "Liu",
        "given": "Lihong"
      },
      {
        "family": "Iketani",
        "given": "Sho"
      },
      {
        "family": "Luo",
        "given": "Yang"
      },
      {
        "family": "Guo",
        "given": "Yicheng"
      },
      {
        "family": "Wang",
        "given": "Maple"
      },
      {
        "family": "Yu",
        "given": "Jian"
      },
      {
        "family": "Zhang",
        "given": "Baoshan"
      },
      {
        "family": "Kwong",
        "given": "Peter D."
      },
      {
        "family": "Graham",
        "given": "Barney S."
      },
      {
        "family": "Mascola",
        "given": "John R."
      },
      {
        "family": "Chang",
        "given": "Jennifer Y."
      },
      {
        "family": "Yin",
        "given": "Michael T."
      },
      {
        "family": "Sobieszczyk",
        "given": "Magdalena"
      },
      {
        "family": "Kyratsous",
        "given": "Christos A."
      },
      {
        "family": "Shapiro",
        "given": "Lawrence"
      },
      {
        "family": "Sheng",
        "given": "Zizhang"
      },
      {
        "family": "Huang",
        "given": "Yaoxing"
      },
      {
        "family": "Ho",
        "given": "David D."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          2,
          12
        ]
      ]
    },
    "abstract": "The COVID-19 pandemic has ravaged the globe, and its causative agent, SARS-CoV-2, continues to rage. Prospects of ending this pandemic rest on the development of effective interventions. Single and combination monoclonal antibody (mAb) therapeutics have received emergency use authorization , with more in the pipeline . Furthermore, multiple vaccine constructs have shown promise , including two with ~95% protective efficacy against COVID-19 . However, these interventions were directed toward the initial SARS-CoV-2 that emerged in 2019. The recent emergence of new SARS-CoV-2 variants B.1.1.7 in the UK and B.1.351 in South Africa is of concern because of their purported ease of transmission and extensive mutations in the spike protein. We now report that B.1.1.7 is refractory to neutralization by most mAbs to the N-terminal domain (NTD) of spike and relatively resistant to a few mAbs to the receptor-binding domain (RBD). It is not more resistant to convalescent plasma or vaccinee sera. Findings on B.1.351 are more worrisome in that this variant is not only refractory to neutralization by most NTD mAbs but also by multiple individual mAbs to the receptor-binding motif on RBD, largely due to an E484K mutation. Moreover, B.1.351 is markedly more resistant to neutralization by convalescent plasma (9.4 fold) and vaccinee sera (10.3-12.4 fold). B.1.351 and emergent variants with similar spike mutations present new challenges for mAb therapy and threaten the protective efficacy of current vaccines.",
    "container-title": "Cold Spring Harbor Laboratory",
    "DOI": "10.1101/2021.01.25.428137",
    "publisher": "Cold Spring Harbor Laboratory",
    "title": "Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7",
    "URL": "https://doi.org/gh4sjp",
    "PMCID": "PMC7852271",
    "PMID": "33532778",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1101/2021.01.25.428137"
  },
  {
    "type": "article-journal",
    "id": "ZDM0wbnx",
    "author": [
      {
        "family": "Graham",
        "given": "Carl"
      },
      {
        "family": "Seow",
        "given": "Jeffrey"
      },
      {
        "family": "Huettner",
        "given": "Isabella"
      },
      {
        "family": "Khan",
        "given": "Hataf"
      },
      {
        "family": "Kouphou",
        "given": "Neophytos"
      },
      {
        "family": "Acors",
        "given": "Sam"
      },
      {
        "family": "Winstone",
        "given": "Helena"
      },
      {
        "family": "Pickering",
        "given": "Suzanne"
      },
      {
        "family": "Pedro Galao",
        "given": "Rui"
      },
      {
        "family": "Jose Lista",
        "given": "Maria"
      },
      {
        "family": "Jimenez-Guardeno",
        "given": "Jose M"
      },
      {
        "family": "Laing",
        "given": "Adam G."
      },
      {
        "family": "Wu",
        "given": "Yin"
      },
      {
        "family": "Joseph",
        "given": "Magdalene"
      },
      {
        "family": "Muir",
        "given": "Luke"
      },
      {
        "family": "Ng",
        "given": "Weng M"
      },
      {
        "family": "Duyvesteyn",
        "given": "Helen M. E."
      },
      {
        "family": "Zhao",
        "given": "Yuguang"
      },
      {
        "family": "Bowden",
        "given": "Thomas A."
      },
      {
        "family": "Shankar-Hari",
        "given": "Manu"
      },
      {
        "family": "Rosa",
        "given": "Annachiara"
      },
      {
        "family": "Cherepanov",
        "given": "Peter"
      },
      {
        "family": "McCoy",
        "given": "Laura E"
      },
      {
        "family": "Hayday",
        "given": "Adrian C"
      },
      {
        "family": "Neil",
        "given": "Stuart J.D."
      },
      {
        "family": "Malim",
        "given": "Michael H"
      },
      {
        "family": "Doores",
        "given": "Katie J"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          2,
          3
        ]
      ]
    },
    "abstract": "The interaction of the SARS–CoV–2 Spike receptor binding domain (RBD) with the ACE2 receptor on host cells is essential for viral entry. RBD is the dominant target for neutralizing antibodies and several neutralizing epitopes on RBD have been molecularly characterized. Analysis of circulating SARS–CoV–2 variants has revealed mutations arising in the RBD, the N–terminal domain (NTD) and S2 subunits of Spike. To fully understand how these mutations affect the antigenicity of Spike, we have isolated and characterized neutralizing antibodies targeting epitopes beyond the already identified RBD epitopes. Using recombinant Spike as a sorting bait, we isolated &gt;100 Spike–reactive monoclonal antibodies from SARS–CoV–2 infected individuals. ≈45% showed neutralizing activity of which ≈20% were NTD–specific. None of the S2–specific antibodies showed neutralizing activity. Competition ELISA revealed that NTD–specific mAbs formed two distinct groups: the first group was highly potent against infectious virus, whereas the second was less potent and displayed glycan–dependant neutralization activity. Importantly, mutations present in B.1.1.7 Spike frequently conferred resistance to neutralization by the NTD–specific neutralizing antibodies. This work demonstrates that neutralizing antibodies targeting subdominant epitopes need to be considered when investigating antigenic drift in emerging variants.",
    "container-title": "Cold Spring Harbor Laboratory",
    "DOI": "10.1101/2021.02.03.429355",
    "publisher": "Cold Spring Harbor Laboratory",
    "title": "Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS–CoV–2 Spike",
    "URL": "https://doi.org/gh4sjq",
    "PMCID": "PMC7872354",
    "PMID": "33564766",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1101/2021.02.03.429355"
  },
  {
    "type": "article-journal",
    "id": "9wnr4sOS",
    "author": [
      {
        "family": "Horby",
        "given": "Peter W"
      },
      {
        "family": "Pessoa-Amorim",
        "given": "Guilherme"
      },
      {
        "family": "Peto",
        "given": "Leon"
      },
      {
        "family": "Brightling",
        "given": "Christopher E"
      },
      {
        "family": "Sarkar",
        "given": "Rahuldeb"
      },
      {
        "family": "Thomas",
        "given": "Koshy"
      },
      {
        "family": "Jeebun",
        "given": "Vandana"
      },
      {
        "family": "Ashish",
        "given": "Abdul"
      },
      {
        "family": "Tully",
        "given": "Redmond"
      },
      {
        "family": "Chadwick",
        "given": "David"
      },
      {
        "family": "Sharafat",
        "given": "Muhammad"
      },
      {
        "family": "Stewart",
        "given": "Richard"
      },
      {
        "family": "Rudran",
        "given": "Banu"
      },
      {
        "family": "Baillie",
        "given": "J Kenneth"
      },
      {
        "family": "Buch",
        "given": "Maya H"
      },
      {
        "family": "Chappell",
        "given": "Lucy C"
      },
      {
        "family": "Day",
        "given": "Jeremy N"
      },
      {
        "family": "Furst",
        "given": "Saul N"
      },
      {
        "family": "Jaki",
        "given": "Thomas"
      },
      {
        "family": "Jeffery",
        "given": "Katie"
      },
      {
        "family": "Juszczak",
        "given": "Edmund"
      },
      {
        "family": "Lim",
        "given": "Wei Shen"
      },
      {
        "family": "Montgomery",
        "given": "Alan"
      },
      {
        "family": "Mumford",
        "given": "Andrew"
      },
      {
        "family": "Rowan",
        "given": "Kathryn"
      },
      {
        "family": "Thwaites",
        "given": "Guy"
      },
      {
        "family": "Mafham",
        "given": "Marion"
      },
      {
        "family": "Haynes",
        "given": "Richard"
      },
      {
        "family": "Landray",
        "given": "Martin J"
      },
      {
        "literal": "RECOVERY Collaborative Group"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          2,
          11
        ]
      ]
    },
    "container-title": "Cold Spring Harbor Laboratory",
    "DOI": "10.1101/2021.02.11.21249258",
    "publisher": "Cold Spring Harbor Laboratory",
    "title": "Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial",
    "URL": "https://doi.org/fvqj",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1101/2021.02.11.21249258"
  },
  {
    "type": "article-journal",
    "id": "124Fu0rXD",
    "author": [
      {
        "family": "Horby",
        "given": "Peter W"
      },
      {
        "family": "Estcourt",
        "given": "Lise"
      },
      {
        "family": "Peto",
        "given": "Leon"
      },
      {
        "family": "Emberson",
        "given": "Jonathan R"
      },
      {
        "family": "Staplin",
        "given": "Natalie"
      },
      {
        "family": "Spata",
        "given": "Enti"
      },
      {
        "family": "Pessoa-Amorim",
        "given": "Guilherme"
      },
      {
        "family": "Campbell",
        "given": "Mark"
      },
      {
        "family": "Roddick",
        "given": "Alistair"
      },
      {
        "family": "Brunskill",
        "given": "Nigel E"
      },
      {
        "family": "George",
        "given": "Tina"
      },
      {
        "family": "Zehnder",
        "given": "Daniel"
      },
      {
        "family": "Tiberi",
        "given": "Simon"
      },
      {
        "family": "Aung",
        "given": "Ni Ni"
      },
      {
        "family": "Uriel",
        "given": "Alison"
      },
      {
        "family": "Widdrington",
        "given": "John"
      },
      {
        "family": "Koshy",
        "given": "George"
      },
      {
        "family": "Brown",
        "given": "Thomas"
      },
      {
        "family": "Scott",
        "given": "Steven"
      },
      {
        "family": "Baillie",
        "given": "J Kenneth"
      },
      {
        "family": "Buch",
        "given": "Maya H"
      },
      {
        "family": "Chappell",
        "given": "Lucy C"
      },
      {
        "family": "Day",
        "given": "Jeremy N"
      },
      {
        "family": "Faust",
        "given": "Saul N"
      },
      {
        "family": "Jaki",
        "given": "Thomas"
      },
      {
        "family": "Jeffery",
        "given": "Katie"
      },
      {
        "family": "Juszczak",
        "given": "Edmund"
      },
      {
        "family": "Lim",
        "given": "Wei Shen"
      },
      {
        "family": "Montgomery",
        "given": "Alan"
      },
      {
        "family": "Mumford",
        "given": "Andrew"
      },
      {
        "family": "Rowan",
        "given": "Kathryn"
      },
      {
        "family": "Thwaites",
        "given": "Guy"
      },
      {
        "family": "Mafham",
        "given": "Marion"
      },
      {
        "family": "Roberts",
        "given": "David"
      },
      {
        "family": "Haynes",
        "given": "Richard"
      },
      {
        "family": "Landray",
        "given": "Martin J"
      },
      {
        "literal": "The RECOVERY Collaborative Group"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          3,
          10
        ]
      ]
    },
    "container-title": "Cold Spring Harbor Laboratory",
    "DOI": "10.1101/2021.03.09.21252736",
    "publisher": "Cold Spring Harbor Laboratory",
    "title": "Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial",
    "URL": "https://doi.org/gmcq2g",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1101/2021.03.09.21252736"
  },
  {
    "type": "article-journal",
    "id": "NDRyNd61",
    "author": [
      {
        "family": "Tanaka",
        "given": "T."
      },
      {
        "family": "Narazaki",
        "given": "M."
      },
      {
        "family": "Kishimoto",
        "given": "T."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2014,
          9,
          4
        ]
      ]
    },
    "container-title": "Cold Spring Harbor Perspectives in Biology",
    "DOI": "10.1101/cshperspect.a016295",
    "volume": "6",
    "issue": "10",
    "page": "a016295-a016295",
    "publisher": "Cold Spring Harbor Laboratory",
    "title": "IL-6 in Inflammation, Immunity, and Disease",
    "URL": "https://doi.org/gftpjs",
    "PMCID": "PMC4176007",
    "PMID": "25190079",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1101/cshperspect.a016295\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: NDRyNd61"
  },
  {
    "type": "article-journal",
    "id": "IJzmtJOr",
    "author": [
      {
        "family": "Chen",
        "given": "Le-Feng"
      },
      {
        "family": "Mo",
        "given": "Ying-Qian"
      },
      {
        "family": "Jing",
        "given": "Jun"
      },
      {
        "family": "Ma",
        "given": "Jian-Da"
      },
      {
        "family": "Zheng",
        "given": "Dong-Hui"
      },
      {
        "family": "Dai",
        "given": "Lie"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          7
        ]
      ]
    },
    "container-title": "International Journal of Rheumatic Diseases",
    "DOI": "10.1111/1756-185x.13010",
    "volume": "20",
    "issue": "7",
    "page": "859-869",
    "publisher": "Wiley",
    "title": "Short-course tocilizumab increases risk of hepatitis B virus reactivation in patients with rheumatoid arthritis: a prospective clinical observation",
    "URL": "https://doi.org/f9pbc5",
    "PMID": "28160426",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1111/1756-185x.13010\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: IJzmtJOr"
  },
  {
    "type": "article-journal",
    "id": "DOd7lUdu",
    "author": [
      {
        "family": "Zheng",
        "given": "Wei"
      },
      {
        "family": "Sun",
        "given": "Wei"
      },
      {
        "family": "Simeonov",
        "given": "Anton"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          1
        ]
      ]
    },
    "container-title": "British Journal of Pharmacology",
    "DOI": "10.1111/bph.13895",
    "volume": "175",
    "issue": "2",
    "page": "181-191",
    "publisher": "Wiley",
    "title": "Drug repurposing screens and synergistic drug-combinations for infectious diseases",
    "URL": "https://doi.org/gj3v6j",
    "PMCID": "PMC5758396",
    "PMID": "28685814",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1111/bph.13895"
  },
  {
    "type": "article-journal",
    "id": "3gp7t98X",
    "author": [
      {
        "family": "Hsueh",
        "given": "P.-R."
      },
      {
        "family": "Huang",
        "given": "L.-M."
      },
      {
        "family": "Chen",
        "given": "P.-J."
      },
      {
        "family": "Kao",
        "given": "C.-L."
      },
      {
        "family": "Yang",
        "given": "P.-C."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2004,
          12
        ]
      ]
    },
    "container-title": "Clinical Microbiology and Infection",
    "DOI": "10.1111/j.1469-0691.2004.01009.x",
    "volume": "10",
    "issue": "12",
    "page": "1062-1066",
    "publisher": "Elsevier BV",
    "title": "Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus",
    "URL": "https://doi.org/cwwg87",
    "PMID": "15606632",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1111/j.1469-0691.2004.01009.x\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 3gp7t98X"
  },
  {
    "type": "article-journal",
    "id": "16IRfGFKb",
    "author": [
      {
        "family": "Kalia",
        "given": "Sunil"
      },
      {
        "family": "Dutz",
        "given": "Jan P"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2007,
          7
        ]
      ]
    },
    "container-title": "Dermatologic Therapy",
    "DOI": "10.1111/j.1529-8019.2007.00131.x",
    "volume": "20",
    "issue": "4",
    "page": "160-174",
    "publisher": "Wiley",
    "title": "New concepts in antimalarial use and mode of action in dermatology",
    "URL": "https://doi.org/fv69cb",
    "PMCID": "PMC7163426",
    "PMID": "17970883",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1111/j.1529-8019.2007.00131.x\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 16IRfGFKb"
  },
  {
    "type": "article-journal",
    "id": "Riev3em1",
    "author": [
      {
        "family": "ELENKOV",
        "given": "ILIA J."
      },
      {
        "family": "CHROUSOS",
        "given": "GEORGE P."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2002,
          6
        ]
      ]
    },
    "container-title": "Annals of the New York Academy of Sciences",
    "DOI": "10.1111/j.1749-6632.2002.tb04229.x",
    "volume": "966",
    "issue": "1",
    "page": "290-303",
    "publisher": "Wiley",
    "title": "Stress Hormones, Proinflammatory and Antiinflammatory Cytokines, and Autoimmunity",
    "URL": "https://doi.org/fmwpx2",
    "PMID": "12114286",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1111/j.1749-6632.2002.tb04229.x\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: Riev3em1"
  },
  {
    "type": "article-journal",
    "id": "1Dj5HnmXS",
    "author": [
      {
        "family": "Ekiert",
        "given": "D. C."
      },
      {
        "family": "Bhabha",
        "given": "G."
      },
      {
        "family": "Elsliger",
        "given": "M.-A."
      },
      {
        "family": "Friesen",
        "given": "R. H. E."
      },
      {
        "family": "Jongeneelen",
        "given": "M."
      },
      {
        "family": "Throsby",
        "given": "M."
      },
      {
        "family": "Goudsmit",
        "given": "J."
      },
      {
        "family": "Wilson",
        "given": "I. A."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2009,
          4,
          10
        ]
      ]
    },
    "container-title": "Science",
    "DOI": "10.1126/science.1171491",
    "volume": "324",
    "issue": "5924",
    "page": "246-251",
    "publisher": "American Association for the Advancement of Science (AAAS)",
    "title": "Antibody Recognition of a Highly Conserved Influenza Virus Epitope",
    "URL": "https://doi.org/ffsb4r",
    "PMCID": "PMC2758658",
    "PMID": "19251591",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1126/science.1171491"
  },
  {
    "type": "article-journal",
    "id": "ZtfLQJhh",
    "author": [
      {
        "family": "Drews",
        "given": "J."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2000,
          3,
          17
        ]
      ]
    },
    "container-title": "Science",
    "DOI": "10.1126/science.287.5460.1960",
    "volume": "287",
    "issue": "5460",
    "page": "1960-1964",
    "publisher": "American Association for the Advancement of Science (AAAS)",
    "title": "Drug Discovery: A Historical Perspective",
    "URL": "https://doi.org/d6bvp7",
    "PMID": "10720314",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1126/science.287.5460.1960\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: ZtfLQJhh"
  },
  {
    "type": "article-journal",
    "id": "CqQVkaqj",
    "author": [
      {
        "family": "Wrapp",
        "given": "Daniel"
      },
      {
        "family": "Wang",
        "given": "Nianshuang"
      },
      {
        "family": "Corbett",
        "given": "Kizzmekia S."
      },
      {
        "family": "Goldsmith",
        "given": "Jory A."
      },
      {
        "family": "Hsieh",
        "given": "Ching-Lin"
      },
      {
        "family": "Abiona",
        "given": "Olubukola"
      },
      {
        "family": "Graham",
        "given": "Barney S."
      },
      {
        "family": "McLellan",
        "given": "Jason S."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          13
        ]
      ]
    },
    "abstract": "The outbreak of a novel coronavirus (2019-nCoV) represents a pandemic threat that has been declared a public health emergency of international concern. The CoV spike (S) glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. To facilitate medical countermeasure development, we determined a 3.5-angstrom-resolution cryo–electron microscopy structure of the 2019-nCoV S trimer in the prefusion conformation. The predominant state of the trimer has one of the three receptor-binding domains (RBDs) rotated up in a receptor-accessible conformation. We also provide biophysical and structural evidence that the 2019-nCoV S protein binds angiotensin-converting enzyme 2 (ACE2) with higher affinity than does severe acute respiratory syndrome (SARS)-CoV S. Additionally, we tested several published SARS-CoV RBD-specific monoclonal antibodies and found that they do not have appreciable binding to 2019-nCoV S, suggesting that antibody cross-reactivity may be limited between the two RBDs. The structure of 2019-nCoV S should enable the rapid development and evaluation of medical countermeasures to address the ongoing public health crisis.",
    "container-title": "Science",
    "DOI": "10.1126/science.abb2507",
    "volume": "367",
    "issue": "6483",
    "page": "1260-1263",
    "publisher": "American Association for the Advancement of Science (AAAS)",
    "title": "Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation",
    "URL": "https://doi.org/ggmtk2",
    "PMID": "32075877",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1126/science.abb2507\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: CqQVkaqj"
  },
  {
    "type": "article-journal",
    "id": "10NcfBSiT",
    "author": [
      {
        "family": "Zhang",
        "given": "Linlin"
      },
      {
        "family": "Lin",
        "given": "Daizong"
      },
      {
        "family": "Sun",
        "given": "Xinyuanyuan"
      },
      {
        "family": "Curth",
        "given": "Ute"
      },
      {
        "family": "Drosten",
        "given": "Christian"
      },
      {
        "family": "Sauerhering",
        "given": "Lucie"
      },
      {
        "family": "Becker",
        "given": "Stephan"
      },
      {
        "family": "Rox",
        "given": "Katharina"
      },
      {
        "family": "Hilgenfeld",
        "given": "Rolf"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4,
          24
        ]
      ]
    },
    "abstract": "The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) is a global health emergency. An attractive drug target among coronaviruses is the main protease (M , also called 3CL ) because of its essential role in processing the polyproteins that are translated from the viral RNA. We report the x-ray structures of the unliganded SARS-CoV-2 M and its complex with an α-ketoamide inhibitor. This was derived from a previously designed inhibitor but with the P3-P2 amide bond incorporated into a pyridone ring to enhance the half-life of the compound in plasma. On the basis of the unliganded structure, we developed the lead compound into a potent inhibitor of the SARS-CoV-2 M . The pharmacokinetic characterization of the optimized inhibitor reveals a pronounced lung tropism and suitability for administration by the inhalative route.",
    "container-title": "Science",
    "DOI": "10.1126/science.abb3405",
    "volume": "368",
    "issue": "6489",
    "page": "409-412",
    "publisher": "American Association for the Advancement of Science (AAAS)",
    "title": "Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors",
    "URL": "https://doi.org/ggp9sb",
    "PMCID": "PMC7164518",
    "PMID": "32198291",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1126/science.abb3405\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 10NcfBSiT"
  },
  {
    "type": "article-journal",
    "id": "D4HwvRMd",
    "author": [
      {
        "family": "Cohen",
        "given": "Jon"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          13
        ]
      ]
    },
    "container-title": "Science",
    "DOI": "10.1126/science.abb7243",
    "publisher": "American Association for the Advancement of Science (AAAS)",
    "title": "Did an experimental drug help a U.S. coronavirus patient?",
    "URL": "https://doi.org/ggqm62",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1126/science.abb7243\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: D4HwvRMd"
  },
  {
    "type": "article-journal",
    "id": "fom0jw7s",
    "author": [
      {
        "family": "Hansen",
        "given": "Johanna"
      },
      {
        "family": "Baum",
        "given": "Alina"
      },
      {
        "family": "Pascal",
        "given": "Kristen E."
      },
      {
        "family": "Russo",
        "given": "Vincenzo"
      },
      {
        "family": "Giordano",
        "given": "Stephanie"
      },
      {
        "family": "Wloga",
        "given": "Elzbieta"
      },
      {
        "family": "Fulton",
        "given": "Benjamin O."
      },
      {
        "family": "Yan",
        "given": "Ying"
      },
      {
        "family": "Koon",
        "given": "Katrina"
      },
      {
        "family": "Patel",
        "given": "Krunal"
      },
      {
        "family": "Chung",
        "given": "Kyung Min"
      },
      {
        "family": "Hermann",
        "given": "Aynur"
      },
      {
        "family": "Ullman",
        "given": "Erica"
      },
      {
        "family": "Cruz",
        "given": "Jonathan"
      },
      {
        "family": "Rafique",
        "given": "Ashique"
      },
      {
        "family": "Huang",
        "given": "Tammy"
      },
      {
        "family": "Fairhurst",
        "given": "Jeanette"
      },
      {
        "family": "Libertiny",
        "given": "Christen"
      },
      {
        "family": "Malbec",
        "given": "Marine"
      },
      {
        "family": "Lee",
        "given": "Wen-yi"
      },
      {
        "family": "Welsh",
        "given": "Richard"
      },
      {
        "family": "Farr",
        "given": "Glen"
      },
      {
        "family": "Pennington",
        "given": "Seth"
      },
      {
        "family": "Deshpande",
        "given": "Dipali"
      },
      {
        "family": "Cheng",
        "given": "Jemmie"
      },
      {
        "family": "Watty",
        "given": "Anke"
      },
      {
        "family": "Bouffard",
        "given": "Pascal"
      },
      {
        "family": "Babb",
        "given": "Robert"
      },
      {
        "family": "Levenkova",
        "given": "Natasha"
      },
      {
        "family": "Chen",
        "given": "Calvin"
      },
      {
        "family": "Zhang",
        "given": "Bojie"
      },
      {
        "family": "Romero Hernandez",
        "given": "Annabel"
      },
      {
        "family": "Saotome",
        "given": "Kei"
      },
      {
        "family": "Zhou",
        "given": "Yi"
      },
      {
        "family": "Franklin",
        "given": "Matthew"
      },
      {
        "family": "Sivapalasingam",
        "given": "Sumathi"
      },
      {
        "family": "Lye",
        "given": "David Chien"
      },
      {
        "family": "Weston",
        "given": "Stuart"
      },
      {
        "family": "Logue",
        "given": "James"
      },
      {
        "family": "Haupt",
        "given": "Robert"
      },
      {
        "family": "Frieman",
        "given": "Matthew"
      },
      {
        "family": "Chen",
        "given": "Gang"
      },
      {
        "family": "Olson",
        "given": "William"
      },
      {
        "family": "Murphy",
        "given": "Andrew J."
      },
      {
        "family": "Stahl",
        "given": "Neil"
      },
      {
        "family": "Yancopoulos",
        "given": "George D."
      },
      {
        "family": "Kyratsous",
        "given": "Christos A."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          8,
          21
        ]
      ]
    },
    "abstract": "Neutralizing antibodies have become an important tool in treating infectious diseases. Recently, two separate approaches yielded successful antibody treatments for Ebola—one from genetically humanized mice and the other from a human survivor. Here, we describe parallel efforts using both humanized mice and convalescent patients to generate antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein, which yielded a large collection of fully human antibodies that were characterized for binding, neutralization, and three-dimensional structure. On the basis of these criteria, we selected pairs of highly potent individual antibodies that simultaneously bind the receptor binding domain of the spike protein, thereby providing ideal partners for a therapeutic antibody cocktail that aims to decrease the potential for virus escape mutants that might arise in response to selective pressure from a single-antibody treatment.",
    "container-title": "Science",
    "DOI": "10.1126/science.abd0827",
    "volume": "369",
    "issue": "6506",
    "page": "1010-1014",
    "publisher": "American Association for the Advancement of Science (AAAS)",
    "title": "Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail",
    "URL": "https://doi.org/fcqh",
    "PMCID": "PMC7299284",
    "PMID": "32540901",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1126/science.abd0827"
  },
  {
    "type": "article-journal",
    "id": "B1wzHRpt",
    "author": [
      {
        "family": "Rappazzo",
        "given": "C. Garrett"
      },
      {
        "family": "Tse",
        "given": "Longping V."
      },
      {
        "family": "Kaku",
        "given": "Chengzi I."
      },
      {
        "family": "Wrapp",
        "given": "Daniel"
      },
      {
        "family": "Sakharkar",
        "given": "Mrunal"
      },
      {
        "family": "Huang",
        "given": "Deli"
      },
      {
        "family": "Deveau",
        "given": "Laura M."
      },
      {
        "family": "Yockachonis",
        "given": "Thomas J."
      },
      {
        "family": "Herbert",
        "given": "Andrew S."
      },
      {
        "family": "Battles",
        "given": "Michael B."
      },
      {
        "family": "O’Brien",
        "given": "Cecilia M."
      },
      {
        "family": "Brown",
        "given": "Michael E."
      },
      {
        "family": "Geoghegan",
        "given": "James C."
      },
      {
        "family": "Belk",
        "given": "Jonathan"
      },
      {
        "family": "Peng",
        "given": "Linghang"
      },
      {
        "family": "Yang",
        "given": "Linlin"
      },
      {
        "family": "Hou",
        "given": "Yixuan"
      },
      {
        "family": "Scobey",
        "given": "Trevor D."
      },
      {
        "family": "Burton",
        "given": "Dennis R."
      },
      {
        "family": "Nemazee",
        "given": "David"
      },
      {
        "family": "Dye",
        "given": "John M."
      },
      {
        "family": "Voss",
        "given": "James E."
      },
      {
        "family": "Gunn",
        "given": "Bronwyn M."
      },
      {
        "family": "McLellan",
        "given": "Jason S."
      },
      {
        "family": "Baric",
        "given": "Ralph S."
      },
      {
        "family": "Gralinski",
        "given": "Lisa E."
      },
      {
        "family": "Walker",
        "given": "Laura M."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          2,
          19
        ]
      ]
    },
    "abstract": "The recurrent zoonotic spillover of coronaviruses (CoVs) into the human population underscores the need for broadly active countermeasures. We employed a directed evolution approach to engineer three severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies for enhanced neutralization breadth and potency. One of the affinity-matured variants, ADG-2, displays strong binding activity to a large panel of sarbecovirus receptor binding domains and neutralizes representative epidemic sarbecoviruses with high potency. Structural and biochemical studies demonstrate that ADG-2 employs a distinct angle of approach to recognize a highly conserved epitope that overlaps the receptor binding site. In immunocompetent mouse models of SARS and COVID-19, prophylactic administration of ADG-2 provided complete protection against respiratory burden, viral replication in the lungs, and lung pathology. Altogether, ADG-2 represents a promising broad-spectrum therapeutic candidate against clade 1 sarbecoviruses.",
    "container-title": "Science",
    "DOI": "10.1126/science.abf4830",
    "volume": "371",
    "issue": "6531",
    "page": "823-829",
    "publisher": "American Association for the Advancement of Science (AAAS)",
    "title": "Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody",
    "URL": "https://doi.org/fsbc",
    "PMCID": "PMC7963221",
    "PMID": "33495307",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1126/science.abf4830"
  },
  {
    "type": "article-journal",
    "id": "j2enN2JO",
    "author": [
      {
        "family": "Tummino",
        "given": "Tia A."
      },
      {
        "family": "Rezelj",
        "given": "Veronica V."
      },
      {
        "family": "Fischer",
        "given": "Benoit"
      },
      {
        "family": "Fischer",
        "given": "Audrey"
      },
      {
        "family": "O’Meara",
        "given": "Matthew J."
      },
      {
        "family": "Monel",
        "given": "Blandine"
      },
      {
        "family": "Vallet",
        "given": "Thomas"
      },
      {
        "family": "White",
        "given": "Kris M."
      },
      {
        "family": "Zhang",
        "given": "Ziyang"
      },
      {
        "family": "Alon",
        "given": "Assaf"
      },
      {
        "family": "Schadt",
        "given": "Heiko"
      },
      {
        "family": "O’Donnell",
        "given": "Henry R."
      },
      {
        "family": "Lyu",
        "given": "Jiankun"
      },
      {
        "family": "Rosales",
        "given": "Romel"
      },
      {
        "family": "McGovern",
        "given": "Briana L."
      },
      {
        "family": "Rathnasinghe",
        "given": "Raveen"
      },
      {
        "family": "Jangra",
        "given": "Sonia"
      },
      {
        "family": "Schotsaert",
        "given": "Michael"
      },
      {
        "family": "Galarneau",
        "given": "Jean-René"
      },
      {
        "family": "Krogan",
        "given": "Nevan J."
      },
      {
        "family": "Urban",
        "given": "Laszlo"
      },
      {
        "family": "Shokat",
        "given": "Kevan M."
      },
      {
        "family": "Kruse",
        "given": "Andrew C."
      },
      {
        "family": "García-Sastre",
        "given": "Adolfo"
      },
      {
        "family": "Schwartz",
        "given": "Olivier"
      },
      {
        "family": "Moretti",
        "given": "Francesca"
      },
      {
        "family": "Vignuzzi",
        "given": "Marco"
      },
      {
        "family": "Pognan",
        "given": "Francois"
      },
      {
        "family": "Shoichet",
        "given": "Brian K."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          7,
          30
        ]
      ]
    },
    "abstract": "Repurposing drugs as treatments for COVID-19, the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has drawn much attention. Beginning with sigma receptor ligands and expanding to other drugs from screening in the field, we became concerned that phospholipidosis was a shared mechanism underlying the antiviral activity of many repurposed drugs. For all of the 23 cationic amphiphilic drugs we tested, including hydroxychloroquine, azithromycin, amiodarone, and four others already in clinical trials, phospholipidosis was monotonically correlated with antiviral efficacy. Conversely, drugs active against the same targets that did not induce phospholipidosis were not antiviral. Phospholipidosis depends on the physicochemical properties of drugs and does not reflect specific target-based activities—rather, it may be considered a toxic confound in early drug discovery. Early detection of phospholipidosis could eliminate these artifacts, enabling a focus on molecules with therapeutic potential.",
    "container-title": "Science",
    "DOI": "10.1126/science.abi4708",
    "volume": "373",
    "issue": "6554",
    "page": "541-547",
    "publisher": "American Association for the Advancement of Science (AAAS)",
    "title": "Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2",
    "URL": "https://doi.org/gmgx79",
    "PMID": "34326236",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1126/science.abi4708"
  },
  {
    "type": "article-journal",
    "id": "1H0NPTMw9",
    "author": [
      {
        "family": "Sheahan",
        "given": "Timothy P."
      },
      {
        "family": "Sims",
        "given": "Amy C."
      },
      {
        "family": "Graham",
        "given": "Rachel L."
      },
      {
        "family": "Menachery",
        "given": "Vineet D."
      },
      {
        "family": "Gralinski",
        "given": "Lisa E."
      },
      {
        "family": "Case",
        "given": "James B."
      },
      {
        "family": "Leist",
        "given": "Sarah R."
      },
      {
        "family": "Pyrc",
        "given": "Krzysztof"
      },
      {
        "family": "Feng",
        "given": "Joy Y."
      },
      {
        "family": "Trantcheva",
        "given": "Iva"
      },
      {
        "family": "Bannister",
        "given": "Roy"
      },
      {
        "family": "Park",
        "given": "Yeojin"
      },
      {
        "family": "Babusis",
        "given": "Darius"
      },
      {
        "family": "Clarke",
        "given": "Michael O."
      },
      {
        "family": "Mackman",
        "given": "Richard L."
      },
      {
        "family": "Spahn",
        "given": "Jamie E."
      },
      {
        "family": "Palmiotti",
        "given": "Christopher A."
      },
      {
        "family": "Siegel",
        "given": "Dustin"
      },
      {
        "family": "Ray",
        "given": "Adrian S."
      },
      {
        "family": "Cihlar",
        "given": "Tomas"
      },
      {
        "family": "Jordan",
        "given": "Robert"
      },
      {
        "family": "Denison",
        "given": "Mark R."
      },
      {
        "family": "Baric",
        "given": "Ralph S."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          6,
          28
        ]
      ]
    },
    "container-title": "Science Translational Medicine",
    "DOI": "10.1126/scitranslmed.aal3653",
    "volume": "9",
    "issue": "396",
    "page": "eaal3653",
    "publisher": "American Association for the Advancement of Science (AAAS)",
    "title": "Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses",
    "URL": "https://doi.org/gc3grb",
    "PMCID": "PMC5567817",
    "PMID": "28659436",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1126/scitranslmed.aal3653\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 1H0NPTMw9"
  },
  {
    "type": "article-journal",
    "id": "TZleuwHX",
    "author": [
      {
        "family": "Sheahan",
        "given": "Timothy P."
      },
      {
        "family": "Sims",
        "given": "Amy C."
      },
      {
        "family": "Zhou",
        "given": "Shuntai"
      },
      {
        "family": "Graham",
        "given": "Rachel L."
      },
      {
        "family": "Pruijssers",
        "given": "Andrea J."
      },
      {
        "family": "Agostini",
        "given": "Maria L."
      },
      {
        "family": "Leist",
        "given": "Sarah R."
      },
      {
        "family": "Schäfer",
        "given": "Alexandra"
      },
      {
        "family": "Dinnon",
        "given": "Kenneth H."
      },
      {
        "family": "Stevens",
        "given": "Laura J."
      },
      {
        "family": "Chappell",
        "given": "James D."
      },
      {
        "family": "Lu",
        "given": "Xiaotao"
      },
      {
        "family": "Hughes",
        "given": "Tia M."
      },
      {
        "family": "George",
        "given": "Amelia S."
      },
      {
        "family": "Hill",
        "given": "Collin S."
      },
      {
        "family": "Montgomery",
        "given": "Stephanie A."
      },
      {
        "family": "Brown",
        "given": "Ariane J."
      },
      {
        "family": "Bluemling",
        "given": "Gregory R."
      },
      {
        "family": "Natchus",
        "given": "Michael G."
      },
      {
        "family": "Saindane",
        "given": "Manohar"
      },
      {
        "family": "Kolykhalov",
        "given": "Alexander A."
      },
      {
        "family": "Painter",
        "given": "George"
      },
      {
        "family": "Harcourt",
        "given": "Jennifer"
      },
      {
        "family": "Tamin",
        "given": "Azaibi"
      },
      {
        "family": "Thornburg",
        "given": "Natalie J."
      },
      {
        "family": "Swanstrom",
        "given": "Ronald"
      },
      {
        "family": "Denison",
        "given": "Mark R."
      },
      {
        "family": "Baric",
        "given": "Ralph S."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4,
          29
        ]
      ]
    },
    "abstract": "Coronaviruses (CoVs) traffic frequently between species resulting in novel disease outbreaks, most recently exemplified by the newly emerged SARS-CoV-2, the causative agent of COVID-19. Here, we show that the ribonucleoside analog β- -N -hydroxycytidine (NHC; EIDD-1931) has broad-spectrum antiviral activity against SARS-CoV-2, MERS-CoV, SARS-CoV, and related zoonotic group 2b or 2c bat-CoVs, as well as increased potency against a CoV bearing resistance mutations to the nucleoside analog inhibitor remdesivir. In mice infected with SARS-CoV or MERS-CoV, both prophylactic and therapeutic administration of EIDD-2801, an orally bioavailable NHC prodrug (β- -N -hydroxycytidine-5′-isopropyl ester), improved pulmonary function and reduced virus titer and body weight loss. Decreased MERS-CoV yields in vitro and in vivo were associated with increased transition mutation frequency in viral, but not host cell RNA, supporting a mechanism of lethal mutagenesis in CoV. The potency of NHC/EIDD-2801 against multiple CoVs and oral bioavailability highlights its potential utility as an effective antiviral against SARS-CoV-2 and other future zoonotic CoVs.",
    "container-title": "Science Translational Medicine",
    "DOI": "10.1126/scitranslmed.abb5883",
    "volume": "12",
    "issue": "541",
    "page": "eabb5883",
    "publisher": "American Association for the Advancement of Science (AAAS)",
    "title": "An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice",
    "URL": "https://doi.org/ggrqd2",
    "PMCID": "PMC7164393",
    "PMID": "32253226",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1126/scitranslmed.abb5883\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: TZleuwHX"
  },
  {
    "type": "article-journal",
    "id": "IYEoCGHy",
    "author": [
      {
        "family": "Gowen",
        "given": "Brian B."
      },
      {
        "family": "Wong",
        "given": "Min-Hui"
      },
      {
        "family": "Jung",
        "given": "Kie-Hoon"
      },
      {
        "family": "Sanders",
        "given": "Andrew B."
      },
      {
        "family": "Mendenhall",
        "given": "Michelle"
      },
      {
        "family": "Bailey",
        "given": "Kevin W."
      },
      {
        "family": "Furuta",
        "given": "Yousuke"
      },
      {
        "family": "Sidwell",
        "given": "Robert W."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2007,
          9
        ]
      ]
    },
    "abstract": "There is a need for the development of effective antivirals for the treatment of severe viral diseases caused by members of the virus families and . The pyrazine derivative T-705 (6-fluoro-3-hydroxy-2-pyrazinecarboxamide) has demonstrated remarkable antiviral activity against influenza virus and, to a lesser degree, against some other RNA viruses (Y. Furuta, K. Takahashi, Y. Fukuda, M. Kuno, T. Kamiyama, K. Kozaki, N. Nomura, H. Egawa, S. Minami, Y. Watanabe, H. Narita, and K. Shiraki, Antimicrob. Agents Chemother., 977-981, 2002). Here, we report that T-705 is highly active against a panel of bunyaviruses (La Crosse, Punta Toro, Rift Valley fever, and sandfly fever viruses) and arenaviruses (Junin, Pichinde, and Tacaribe viruses) by cytopathic effect and virus yield reduction cell-based assays. The 50% effective concentrations for T-705 ranged from 5 to 30 μg/ml and 0.7 to 1.2 μg/ml against the bunyaviruses and arenaviruses examined, respectively. We also demonstrate that orally administered T-705 is efficacious in treating Punta Toro virus in the mouse and hamster infection models, as well as Pichinde virus infection in hamsters. When administered twice daily for 5 to 6 days, beginning 4 h pre- or 24 h post-Punta Toro virus challenge, a 30-mg/kg of body weight/day dose provided complete protection from death and limited viral burden and liver disease. A dose of 50 mg/kg/day was found to be optimal for treating Pichinde infection and limiting viral replication and disease severity. In general, T-705 was found to be more active than ribavirin in cell-based assays and in vivo, as reflected by substantially greater therapeutic indexes. Our results suggest that T-705 may be a viable alternative for the treatment of life-threatening bunyaviral and arenaviral infections.",
    "container-title": "Antimicrobial Agents and Chemotherapy",
    "DOI": "10.1128/aac.00356-07",
    "volume": "51",
    "issue": "9",
    "page": "3168-3176",
    "publisher": "American Society for Microbiology",
    "title": "In Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus Infections",
    "URL": "https://doi.org/d98c87",
    "PMCID": "PMC2043187",
    "PMID": "17606691",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1128/aac.00356-07\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: IYEoCGHy"
  },
  {
    "type": "article-journal",
    "id": "rG5RCRdJ",
    "author": [
      {
        "family": "Sidwell",
        "given": "Robert W."
      },
      {
        "family": "Barnard",
        "given": "Dale L."
      },
      {
        "family": "Day",
        "given": "Craig W."
      },
      {
        "family": "Smee",
        "given": "Donald F."
      },
      {
        "family": "Bailey",
        "given": "Kevin W."
      },
      {
        "family": "Wong",
        "given": "Min-Hui"
      },
      {
        "family": "Morrey",
        "given": "John D."
      },
      {
        "family": "Furuta",
        "given": "Yousuke"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2007,
          3
        ]
      ]
    },
    "abstract": "T-705 (6-fluoro-3-hydroxy-2-pyrazinecarboxamide) was inhibitory to four strains of avian H5N1 influenza virus in MDCK cells, with the 90% effective concentrations ranging from 1.3 to 7.7 μM, as determined by a virus yield reduction assay. The efficacy was less than that exerted by oseltamivir carboxylate or zanamivir but was greater than that exerted by ribavirin. Experiments with mice lethally infected with influenza A/Duck/MN/1525/81 (H5N1) virus showed that T-705 administered per os once, twice, or four times daily for 5 days beginning 1 h after virus exposure was highly inhibitory to the infection. Dosages from 30 to 300 mg/kg of body weight/day were well tolerated; each prevented death, lessened the decline of arterial oxygen saturation (SaO ), and inhibited lung consolidation and lung virus titers. Dosages from 30 to 300 mg/kg/day administered once or twice daily also significantly prevented the death of the mice. Oseltamivir (20 mg/kg/day), administered per os twice daily for 5 days, was tested in parallel in two experiments; it was only weakly effective against the infection. The four-times-daily T-705 treatments at 300 mg/kg/day could be delayed until 96 h after virus exposure and still significantly inhibit the infection. Single T-705 treatments administered up to 60 h after virus exposure also prevented death and the decline of SaO . Characterization of the pathogenesis of the duck influenza H5N1 virus used in these studies was undertaken; although the virus was highly pathogenic to mice, it was less neurotropic than has been described for clinical isolates of the H5N1 virus. These data indicate that T-705 may be useful for the treatment of avian influenza virus infections.",
    "container-title": "Antimicrobial Agents and Chemotherapy",
    "DOI": "10.1128/aac.01051-06",
    "volume": "51",
    "issue": "3",
    "page": "845-851",
    "publisher": "American Society for Microbiology",
    "title": "Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in Mice",
    "URL": "https://doi.org/dm9xr2",
    "PMCID": "PMC1803113",
    "PMID": "17194832",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1128/aac.01051-06\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: rG5RCRdJ"
  },
  {
    "type": "article-journal",
    "id": "xMRJgRES",
    "author": [
      {
        "family": "Davoudi-Monfared",
        "given": "Effat"
      },
      {
        "family": "Rahmani",
        "given": "Hamid"
      },
      {
        "family": "Khalili",
        "given": "Hossein"
      },
      {
        "family": "Hajiabdolbaghi",
        "given": "Mahboubeh"
      },
      {
        "family": "Salehi",
        "given": "Mohamadreza"
      },
      {
        "family": "Abbasian",
        "given": "Ladan"
      },
      {
        "family": "Kazemzadeh",
        "given": "Hossein"
      },
      {
        "family": "Yekaninejad",
        "given": "Mir Saeed"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          8,
          20
        ]
      ]
    },
    "abstract": "To the best of our knowledge, there is no published study on the use of interferon β-1a (IFN β-1a) in the treatment of severe COVID-19. In this randomized clinical trial, the efficacy and safety of IFN β-1a were evaluated in patients with severe COVID-19. Forty-two patients in the interferon group received IFN β-1a in addition to the national protocol medications (hydroxychloroquine plus lopinavir-ritonavir or atazanavir-ritonavir). Each 44-μg/ml (12 million IU/ml) dose of interferon β-1a was subcutaneously injected three times weekly for two consecutive weeks.",
    "container-title": "Antimicrobial Agents and Chemotherapy",
    "DOI": "10.1128/aac.01061-20",
    "volume": "64",
    "issue": "9",
    "publisher": "American Society for Microbiology",
    "title": "A Randomized Clinical Trial of the Efficacy and Safety of Interferon β-1a in Treatment of Severe COVID-19",
    "URL": "https://doi.org/gg5xvm",
    "PMCID": "PMC7449227",
    "PMID": "32661006",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1128/aac.01061-20"
  },
  {
    "type": "article-journal",
    "id": "9j7NVPJS",
    "author": [
      {
        "family": "Julander",
        "given": "Justin G."
      },
      {
        "family": "Shafer",
        "given": "Kristiina"
      },
      {
        "family": "Smee",
        "given": "Donald F."
      },
      {
        "family": "Morrey",
        "given": "John D."
      },
      {
        "family": "Furuta",
        "given": "Yousuke"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2009,
          1
        ]
      ]
    },
    "abstract": "Treatment with the nucleoside analog T-1106 was previously shown to be effective in a hamster model of yellow fever virus (YFV) disease, even though it had only slight activity in cell culture. In the study described in this report, the activity of T-705, a chemically related compound currently undergoing clinical trials for the treatment of influenza (FDANews 4:1, 2007), was tested against YFV in cell culture and in the hamster model. The antiviral efficacy of T-705 in cell culture occurred at a concentration of 330 μM, which was more than threefold lower than the concentration at which T-1106 had antiviral efficacy, as determined by a virus yield reduction assay and confirmed by a luciferase-based ATP detection assay. Time-of-addition studies revealed that addition of T-705, T-1106, or ribavirin at 0, 4, 8, or 12 h after virus challenge was effective in inhibiting virus in Vero cells, suggesting that these three agents have similar mechanisms of action in cell culture. Because of its more potent activity in cell culture, it was anticipated that T-705 treatment of hamsters infected with YFV would result in protection from disease. Significant improvements in survival and disease parameters were seen in infected animals when T-705 was administered orally at a dose of 200 or 400 mg/kg of body weight per day when it was given twice a day for 8 days. Significant improvements were also observed with a dose of 400 mg/kg/day when treatment initiation was delayed as late as 3 days after virus inoculation. Although the dose of T-705 required for efficacy in hamsters is higher than that of T-1106 required for efficacy, T-705 treatment is effective in significantly improving disease parameters in YFV-infected hamsters, which may indicate its potential utility in the treatment of YFV disease in humans.",
    "container-title": "Antimicrobial Agents and Chemotherapy",
    "DOI": "10.1128/aac.01074-08",
    "volume": "53",
    "issue": "1",
    "page": "202-209",
    "publisher": "American Society for Microbiology",
    "title": "Activity of T-705 in a Hamster Model of Yellow Fever Virus Infection in Comparison with That of a Chemically Related Compound, T-1106",
    "URL": "https://doi.org/brknds",
    "PMCID": "PMC2612161",
    "PMID": "18955536",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1128/aac.01074-08\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 9j7NVPJS"
  },
  {
    "type": "article-journal",
    "id": "15kQ4QYbx",
    "author": [
      {
        "family": "Mendenhall",
        "given": "Michelle"
      },
      {
        "family": "Russell",
        "given": "Andrew"
      },
      {
        "family": "Juelich",
        "given": "Terry"
      },
      {
        "family": "Messina",
        "given": "Emily L."
      },
      {
        "family": "Smee",
        "given": "Donald F."
      },
      {
        "family": "Freiberg",
        "given": "Alexander N."
      },
      {
        "family": "Holbrook",
        "given": "Michael R."
      },
      {
        "family": "Furuta",
        "given": "Yousuke"
      },
      {
        "family": "de la Torre",
        "given": "Juan-Carlos"
      },
      {
        "family": "Nunberg",
        "given": "Jack H."
      },
      {
        "family": "Gowen",
        "given": "Brian B."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2011,
          2
        ]
      ]
    },
    "abstract": "A number of New World arenaviruses (Junín [JUNV], Machupo [MACV], and Guanarito [GTOV] viruses) can cause human disease ranging from mild febrile illness to a severe and often fatal hemorrhagic fever syndrome. These highly pathogenic viruses and the Old World Lassa fever virus pose a significant threat to public health and national security. The only licensed antiviral agent with activity against these viruses, ribavirin, has had mixed success in treating severe arenaviral disease and is associated with significant toxicities. A novel pyrazine derivative currently in clinical trials for the treatment of influenza virus infections, T-705 (favipiravir), has demonstrated broad-spectrum activity against a number of RNA viruses, including arenaviruses. T-705 has also been shown to be effective against Pichinde arenavirus infection in a hamster model. Here, we demonstrate the robust antiviral activity of T-705 against authentic highly pathogenic arenaviruses in cell culture. We show that T-705 disrupts an early or intermediate stage in viral replication, distinct from absorption or release, and that its antiviral activity in cell culture is reversed by the addition of purine bases and nucleosides, but not with pyrimidines. Specific inhibition of viral replication/transcription by T-705 was demonstrated using a lymphocytic choriomeningitis arenavirus replicon system. Our findings indicate that T-705 acts to inhibit arenavirus replication/transcription and may directly target the viral RNA-dependent RNA polymerase.",
    "container-title": "Antimicrobial Agents and Chemotherapy",
    "DOI": "10.1128/aac.01219-10",
    "volume": "55",
    "issue": "2",
    "page": "782-787",
    "publisher": "American Society for Microbiology",
    "title": "T-705 (Favipiravir) Inhibition of Arenavirus Replication in Cell Culture",
    "URL": "https://doi.org/cppwsc",
    "PMCID": "PMC3028760",
    "PMID": "21115797",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1128/aac.01219-10\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 15kQ4QYbx"
  },
  {
    "type": "article-journal",
    "id": "EgoJKtW4",
    "author": [
      {
        "family": "Furuta",
        "given": "Y."
      },
      {
        "family": "Takahashi",
        "given": "K."
      },
      {
        "family": "Fukuda",
        "given": "Y."
      },
      {
        "family": "Kuno",
        "given": "M."
      },
      {
        "family": "Kamiyama",
        "given": "T."
      },
      {
        "family": "Kozaki",
        "given": "K."
      },
      {
        "family": "Nomura",
        "given": "N."
      },
      {
        "family": "Egawa",
        "given": "H."
      },
      {
        "family": "Minami",
        "given": "S."
      },
      {
        "family": "Watanabe",
        "given": "Y."
      },
      {
        "family": "Narita",
        "given": "H."
      },
      {
        "family": "Shiraki",
        "given": "K."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2002,
          4
        ]
      ]
    },
    "abstract": "T-705 (6-fluoro-3-hydroxy-2-pyrazinecarboxamide) has been found to have potent and selective inhibitory activity against influenza virus. In an in vitro plaque reduction assay, T-705 showed potent inhibitory activity against influenza A, B, and C viruses, with 50% inhibitory concentrations (IC s) of 0.013 to 0.48 μg/ml, while it showed no cytotoxicity at concentrations up to 1,000 μg/ml in Madin-Darby canine kidney cells. The selectivity index for influenza virus was more than 2,000. It was also active against a neuraminidase inhibitor-resistant virus and some amantadine-resistant viruses. T-705 showed weak activity against non-influenza virus RNA viruses, with the IC s being higher for non-influenza virus RNA viruses than for influenza virus, and it had no activity against DNA viruses. Orally administered T-705 at 100 mg/kg of body weight/day (four times a day) for 5 days significantly reduced the mean pulmonary virus yields and the rate of mortality in mice infected with influenza virus A/PR/8/34 (3 × 10 PFU). These results suggest that T-705 may be a compound that is useful and highly selective against influenza virus infections and that has a mode of action different from those of commercially available drugs, such as amantadine, rimantadine, and neuraminidase inhibitors.",
    "container-title": "Antimicrobial Agents and Chemotherapy",
    "DOI": "10.1128/aac.46.4.977-981.2002",
    "volume": "46",
    "issue": "4",
    "page": "977-981",
    "publisher": "American Society for Microbiology",
    "title": "In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705",
    "URL": "https://doi.org/cndw7n",
    "PMCID": "PMC127093",
    "PMID": "11897578",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1128/aac.46.4.977-981.2002\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: EgoJKtW4"
  },
  {
    "type": "article-journal",
    "id": "DpdKJbki",
    "author": [
      {
        "family": "Furuta",
        "given": "Yousuke"
      },
      {
        "family": "Takahashi",
        "given": "Kazumi"
      },
      {
        "family": "Kuno-Maekawa",
        "given": "Masako"
      },
      {
        "family": "Sangawa",
        "given": "Hidehiro"
      },
      {
        "family": "Uehara",
        "given": "Sayuri"
      },
      {
        "family": "Kozaki",
        "given": "Kyo"
      },
      {
        "family": "Nomura",
        "given": "Nobuhiko"
      },
      {
        "family": "Egawa",
        "given": "Hiroyuki"
      },
      {
        "family": "Shiraki",
        "given": "Kimiyasu"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2005,
          3
        ]
      ]
    },
    "abstract": "T-705, a substituted pyrazine compound, has been found to exhibit potent anti-influenza virus activity in vitro and in vivo. In a time-of-addition study, it was indicated that T-705 targeted an early to middle stage of the viral replication cycle but had no effect on the adsorption or release stage. The anti-influenza virus activity of T-705 was attenuated by addition of purines and purine nucleosides, including adenosine, guanosine, inosine, and hypoxanthine, whereas pyrimidines did not affect its activity. T-705-4-ribofuranosyl-5′-triphosphate (T-705RTP) and T-705-4-ribofuranosyl-5′-monophosphate (T-705RMP) were detected in MDCK cells treated with T-705. T-705RTP inhibited influenza virus RNA polymerase activity in a dose-dependent and a GTP-competitive manner. Unlike ribavirin, T-705 did not have an influence on cellular DNA or RNA synthesis. Inhibition of cellular IMP dehydrogenase by T-705RMP was about 150-fold weaker than that by ribavirin monophosphate, indicating the specificity of the anti-influenza virus activity and lower level of cytotoxicity of T-705. These results suggest that T-705RTP, which is generated in infected cells, may function as a specific inhibitor of influenza virus RNA polymerase and contributes to the selective anti-influenza virus activity of T-705.",
    "container-title": "Antimicrobial Agents and Chemotherapy",
    "DOI": "10.1128/aac.49.3.981-986.2005",
    "volume": "49",
    "issue": "3",
    "page": "981-986",
    "publisher": "American Society for Microbiology",
    "title": "Mechanism of Action of T-705 against Influenza Virus",
    "URL": "https://doi.org/dgbwdh",
    "PMCID": "PMC549233",
    "PMID": "15728892",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1128/aac.49.3.981-986.2005\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: DpdKJbki"
  },
  {
    "type": "article-journal",
    "id": "Ull2rQ5L",
    "author": [
      {
        "family": "Zhao",
        "given": "J."
      },
      {
        "family": "Wohlford-Lenane",
        "given": "C."
      },
      {
        "family": "Zhao",
        "given": "J."
      },
      {
        "family": "Fleming",
        "given": "E."
      },
      {
        "family": "Lane",
        "given": "T. E."
      },
      {
        "family": "McCray",
        "given": "P. B."
      },
      {
        "family": "Perlman",
        "given": "S."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2012,
          8,
          22
        ]
      ]
    },
    "container-title": "Journal of Virology",
    "DOI": "10.1128/jvi.01410-12",
    "volume": "86",
    "issue": "21",
    "page": "11416-11424",
    "publisher": "American Society for Microbiology",
    "title": "Intranasal Treatment with Poly(I{middle dot}C) Protects Aged Mice from Lethal Respiratory Virus Infections",
    "URL": "https://doi.org/f4bzfp",
    "PMCID": "PMC3486278",
    "PMID": "22915814",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1128/jvi.01410-12\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: Ull2rQ5L"
  },
  {
    "type": "article-journal",
    "id": "lIko9Imd",
    "author": [
      {
        "family": "Agostini",
        "given": "Maria L."
      },
      {
        "family": "Andres",
        "given": "Erica L."
      },
      {
        "family": "Sims",
        "given": "Amy C."
      },
      {
        "family": "Graham",
        "given": "Rachel L."
      },
      {
        "family": "Sheahan",
        "given": "Timothy P."
      },
      {
        "family": "Lu",
        "given": "Xiaotao"
      },
      {
        "family": "Smith",
        "given": "Everett Clinton"
      },
      {
        "family": "Case",
        "given": "James Brett"
      },
      {
        "family": "Feng",
        "given": "Joy Y."
      },
      {
        "family": "Jordan",
        "given": "Robert"
      },
      {
        "family": "Ray",
        "given": "Adrian S."
      },
      {
        "family": "Cihlar",
        "given": "Tomas"
      },
      {
        "family": "Siegel",
        "given": "Dustin"
      },
      {
        "family": "Mackman",
        "given": "Richard L."
      },
      {
        "family": "Clarke",
        "given": "Michael O."
      },
      {
        "family": "Baric",
        "given": "Ralph S."
      },
      {
        "family": "Denison",
        "given": "Mark R."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          3,
          6
        ]
      ]
    },
    "container-title": "mBio",
    "DOI": "10.1128/mbio.00221-18",
    "volume": "9",
    "issue": "2",
    "page": "e00221-18",
    "publisher": "American Society for Microbiology",
    "title": "Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease",
    "URL": "https://doi.org/gc45v6",
    "PMCID": "PMC5844999",
    "PMID": "29511076",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1128/mbio.00221-18\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: lIko9Imd"
  },
  {
    "type": "article-journal",
    "id": "bZMKqj6e",
    "author": [
      {
        "family": "Tisoncik",
        "given": "J. R."
      },
      {
        "family": "Korth",
        "given": "M. J."
      },
      {
        "family": "Simmons",
        "given": "C. P."
      },
      {
        "family": "Farrar",
        "given": "J."
      },
      {
        "family": "Martin",
        "given": "T. R."
      },
      {
        "family": "Katze",
        "given": "M. G."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2012,
          3,
          5
        ]
      ]
    },
    "container-title": "Microbiology and Molecular Biology Reviews",
    "DOI": "10.1128/mmbr.05015-11",
    "volume": "76",
    "issue": "1",
    "page": "16-32",
    "publisher": "American Society for Microbiology",
    "title": "Into the Eye of the Cytokine Storm",
    "URL": "https://doi.org/f4n9h2",
    "PMCID": "PMC3294426",
    "PMID": "22390970",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1128/mmbr.05015-11\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: bZMKqj6e"
  },
  {
    "type": "article-journal",
    "id": "zRRSvckT",
    "author": [
      {
        "family": "Pawar",
        "given": "Ajinkya"
      },
      {
        "family": "Desai",
        "given": "Rishi J"
      },
      {
        "family": "Solomon",
        "given": "Daniel H"
      },
      {
        "family": "Santiago Ortiz",
        "given": "Adrian J"
      },
      {
        "family": "Gale",
        "given": "Sara"
      },
      {
        "family": "Bao",
        "given": "Min"
      },
      {
        "family": "Sarsour",
        "given": "Khaled"
      },
      {
        "family": "Schneeweiss",
        "given": "Sebastian"
      },
      {
        "family": "Kim",
        "given": "Seoyoung C"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          4
        ]
      ]
    },
    "container-title": "Annals of the Rheumatic Diseases",
    "DOI": "10.1136/annrheumdis-2018-214367",
    "volume": "78",
    "issue": "4",
    "page": "456-464",
    "publisher": "BMJ",
    "title": "Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study",
    "URL": "https://doi.org/gg62hx",
    "PMID": "30679153",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1136/annrheumdis-2018-214367\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: zRRSvckT"
  },
  {
    "type": "article-journal",
    "id": "4f82Cr8A",
    "author": [
      {
        "family": "Peter",
        "given": "John Victor"
      },
      {
        "family": "John",
        "given": "Preeta"
      },
      {
        "family": "Graham",
        "given": "Petra L"
      },
      {
        "family": "Moran",
        "given": "John L"
      },
      {
        "family": "George",
        "given": "Ige Abraham"
      },
      {
        "family": "Bersten",
        "given": "Andrew"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2008,
          5,
          3
        ]
      ]
    },
    "container-title": "BMJ",
    "DOI": "10.1136/bmj.39537.939039.be",
    "volume": "336",
    "issue": "7651",
    "page": "1006-1009",
    "publisher": "BMJ",
    "title": "Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis",
    "URL": "https://doi.org/b7qtn2",
    "PMCID": "PMC2364864",
    "PMID": "18434379",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1136/bmj.39537.939039.be"
  },
  {
    "type": "article-journal",
    "id": "e3ZiDOSQ",
    "author": [
      {
        "family": "Mahase",
        "given": "Elisabeth"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          6,
          23
        ]
      ]
    },
    "container-title": "BMJ",
    "DOI": "10.1136/bmj.m2512",
    "page": "m2512",
    "publisher": "BMJ",
    "title": "Covid-19: Demand for dexamethasone surges as RECOVERY trial publishes preprint",
    "URL": "https://doi.org/gj4qgp",
    "PMID": "32576548",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1136/bmj.m2512"
  },
  {
    "type": "article-journal",
    "id": "ncMFeSeO",
    "author": [
      {
        "family": "Tang",
        "given": "Julian W"
      },
      {
        "family": "Marr",
        "given": "Linsey C"
      },
      {
        "family": "Li",
        "given": "Yuguo"
      },
      {
        "family": "Dancer",
        "given": "Stephanie J"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          4,
          14
        ]
      ]
    },
    "container-title": "BMJ",
    "DOI": "10.1136/bmj.n913",
    "page": "n913",
    "publisher": "BMJ",
    "title": "Covid-19 has redefined airborne transmission",
    "URL": "https://doi.org/gj3jh4",
    "PMID": "33853842",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1136/bmj.n913"
  },
  {
    "type": "article-journal",
    "id": "6qEFbCHC",
    "author": [
      {
        "family": "Yu",
        "given": "W C"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2004,
          8,
          1
        ]
      ]
    },
    "container-title": "Thorax",
    "DOI": "10.1136/thx.2003.017665",
    "volume": "59",
    "issue": "8",
    "page": "643-645",
    "publisher": "BMJ",
    "title": "Antiviral agents and corticosteroids in the treatment of severe acute respiratory syndrome (SARS)",
    "URL": "https://doi.org/bks99t",
    "PMCID": "PMC1747111",
    "PMID": "15282381",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1136/thx.2003.017665"
  },
  {
    "type": "article-journal",
    "id": "yumBaJ6U",
    "author": [
      {
        "family": "Corti",
        "given": "Davide"
      },
      {
        "family": "Lanzavecchia",
        "given": "Antonio"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2013,
          3,
          21
        ]
      ]
    },
    "container-title": "Annual Review of Immunology",
    "DOI": "10.1146/annurev-immunol-032712-095916",
    "volume": "31",
    "issue": "1",
    "page": "705-742",
    "publisher": "Annual Reviews",
    "title": "Broadly Neutralizing Antiviral Antibodies",
    "URL": "https://doi.org/gf25g8",
    "PMID": "23330954",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1146/annurev-immunol-032712-095916\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: yumBaJ6U"
  },
  {
    "type": "article-journal",
    "id": "dY9kXLAS",
    "author": [
      {
        "family": "O’Laughlin",
        "given": "John P."
      },
      {
        "family": "Mehta",
        "given": "Parag H."
      },
      {
        "family": "Wong",
        "given": "Brian C."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2016
        ]
      ]
    },
    "abstract": "We present a case of a syncopal episode resulting from significant QT interval prolongation in a patient on hydroxychloroquine for the treatment of systemic lupus erythematosus and end stage renal disease. The patient had been treated with hydroxychloroquine for two years prior to presentation. After thorough workup for secondary causes of QT interval prolongation hydroxychloroquine was discontinued and the patient’s QT interval shortened. The patient was treated with mexiletine to prevent sudden ventricular arrhythmias, which was unique compared to other documented cases in which lidocaine was used. The patient was noted to have mild prolongation of the QT interval on electrocardiogram prior to initiation of hydroxychloroquine therapy which was exacerbated by its use and may have been caused due to toxicity from underlying renal failure.",
    "container-title": "Case Reports in Cardiology",
    "DOI": "10.1155/2016/4626279",
    "volume": "2016",
    "page": "1-4",
    "publisher": "Hindawi Limited",
    "title": "Life Threatening Severe QTc Prolongation in Patient with Systemic Lupus Erythematosus due to Hydroxychloroquine",
    "URL": "https://doi.org/ggqzrc",
    "PMCID": "PMC4960328",
    "PMID": "27478650",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1155/2016/4626279\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: dY9kXLAS"
  },
  {
    "type": "article-journal",
    "id": "JZyVNRCN",
    "author": [
      {
        "family": "García",
        "given": "Arantxa"
      },
      {
        "family": "Martí",
        "given": "Octavi"
      },
      {
        "family": "Vallès",
        "given": "Astrid"
      },
      {
        "family": "Dal-Zotto",
        "given": "Silvina"
      },
      {
        "family": "Armario",
        "given": "Antonio"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2000
        ]
      ]
    },
    "container-title": "Neuroendocrinology",
    "DOI": "10.1159/000054578",
    "volume": "72",
    "issue": "2",
    "page": "114-125",
    "publisher": "S. Karger AG",
    "title": "Recovery of the Hypothalamic-Pituitary-Adrenal Response to Stress",
    "URL": "https://doi.org/b2cq8n",
    "PMID": "10971146",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1159/000054578\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: JZyVNRCN"
  },
  {
    "type": "article-journal",
    "id": "ZMzupz3m",
    "author": [
      {
        "family": "Huentelman",
        "given": "Matthew J."
      },
      {
        "family": "Zubcevic",
        "given": "Jasenka"
      },
      {
        "family": "Hernández Prada",
        "given": "Jose A."
      },
      {
        "family": "Xiao",
        "given": "Xiaodong"
      },
      {
        "family": "Dimitrov",
        "given": "Dimiter S."
      },
      {
        "family": "Raizada",
        "given": "Mohan K."
      },
      {
        "family": "Ostrov",
        "given": "David A."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2004,
          12
        ]
      ]
    },
    "container-title": "Hypertension",
    "DOI": "10.1161/01.hyp.0000146120.29648.36",
    "volume": "44",
    "issue": "6",
    "page": "903-906",
    "publisher": "Ovid Technologies (Wolters Kluwer Health)",
    "title": "Structure-Based Discovery of a Novel Angiotensin-Converting Enzyme 2 Inhibitor",
    "URL": "https://doi.org/d5szrp",
    "PMID": "15492138",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1161/01.hyp.0000146120.29648.36"
  },
  {
    "type": "article-journal",
    "id": "19quOF2kK",
    "author": [
      {
        "family": "Cohen",
        "given": "Jordana B."
      },
      {
        "family": "Hanff",
        "given": "Thomas C."
      },
      {
        "family": "South",
        "given": "Andrew M."
      },
      {
        "family": "Sparks",
        "given": "Matthew A."
      },
      {
        "family": "Hiremath",
        "given": "Swapnil"
      },
      {
        "family": "Bress",
        "given": "Adam P."
      },
      {
        "family": "Byrd",
        "given": "J. Brian"
      },
      {
        "family": "Chirinos",
        "given": "Julio A."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          6,
          5
        ]
      ]
    },
    "container-title": "Circulation Research",
    "DOI": "10.1161/circresaha.120.317205",
    "volume": "126",
    "issue": "12",
    "publisher": "Ovid Technologies (Wolters Kluwer Health)",
    "title": "Response by Cohen et al to Letter Regarding Article, “Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19”",
    "URL": "https://doi.org/gg3xsg",
    "PMCID": "PMC7265880",
    "PMID": "32496917",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1161/circresaha.120.317205\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 19quOF2kK"
  },
  {
    "type": "article-journal",
    "id": "CRriJXDk",
    "author": [
      {
        "family": "Jones",
        "given": "Graeme"
      },
      {
        "family": "Panova",
        "given": "Elena"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          10,
          7
        ]
      ]
    },
    "abstract": "Rheumatoid arthritis is a leading musculoskeletal cause of disability in Western society. Therapeutic options have expanded rapidly with the advent of biological agents as treatment options. One of these, tocilizumab, targets the interleukin-6 receptor and has been approved since the late 2000s in many jurisdictions. This approval was based on 6–12 month trials. It is now appropriate to look at longer-term studies and what new insights they have provided into this agent. Data are based largely on observational studies with their well-known limitations as well as some further randomized trials and provide a number of important observations regarding both efficacy and safety. In conclusion, the longer-term data suggest tocilizumab efficacy increases over time for both signs and symptoms and radiographic change. It is also corticosteroid sparing. The safety data are consistent with the shorter-term trials and are largely reassuring but some questions still remain over cardiovascular safety and cancer risk.",
    "container-title": "Therapeutic Advances in Musculoskeletal Disease",
    "DOI": "10.1177/1759720x18798462",
    "volume": "10",
    "issue": "10",
    "page": "195-199",
    "publisher": "SAGE Publications",
    "title": "New insights and long-term safety of tocilizumab in rheumatoid arthritis",
    "URL": "https://doi.org/gffsdt",
    "PMCID": "PMC6178374",
    "PMID": "30327685",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1177/1759720x18798462\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: CRriJXDk"
  },
  {
    "type": "article-journal",
    "id": "nbiwprc",
    "author": [
      {
        "family": "Orlicka",
        "given": "Katarzyna"
      },
      {
        "family": "Barnes",
        "given": "Eleanor"
      },
      {
        "family": "Culver",
        "given": "Emma L."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2013,
          4,
          22
        ]
      ]
    },
    "container-title": "Therapeutic Advances in Chronic Disease",
    "DOI": "10.1177/2040622313485275",
    "volume": "4",
    "issue": "4",
    "page": "167-185",
    "publisher": "SAGE Publications",
    "title": "Prevention of infection caused by immunosuppressive drugs in gastroenterology",
    "URL": "https://doi.org/ggrqd3",
    "PMCID": "PMC3697844",
    "PMID": "23819020",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1177/2040622313485275\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: nbiwprc"
  },
  {
    "type": "article-journal",
    "id": "134vCyU3E",
    "author": [
      {
        "family": "Wang",
        "given": "Tzu-Fei"
      },
      {
        "family": "Lim",
        "given": "Wendy"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2016,
          12,
          2
        ]
      ]
    },
    "abstract": "A 35-year-old man presents with an acute unprovoked deep vein thrombosis of the left lower extremity. He is treated with anticoagulation and elects to discontinue treatment after 6 months. He subsequently develops polyarthralgias, fatigue, and a malar rash, and a diagnosis of systemic lupus erythematosus is made based on laboratory and clinical findings. Additional laboratory testing reveals persistent triple positive antiphospholipid antibodies, including lupus anticoagulant, high titer anticardiolipin antibodies, and anti–β2-glycoprotein I antibodies. The patient is reinitiated on anticoagulation, and the patient’s rheumatologist inquires if the addition of hydroxychloroquine could help to prevent recurrent thrombosis.",
    "container-title": "Hematology",
    "DOI": "10.1182/asheducation-2016.1.714",
    "volume": "2016",
    "issue": "1",
    "page": "714-716",
    "publisher": "American Society of Hematology",
    "title": "What is the role of hydroxychloroquine in reducing thrombotic risk in patients with antiphospholipid antibodies?",
    "URL": "https://doi.org/ggrn3k",
    "PMCID": "PMC6142483",
    "PMID": "27913551",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1182/asheducation-2016.1.714\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 134vCyU3E"
  },
  {
    "type": "article-journal",
    "id": "H70g2GF9",
    "author": [
      {
        "family": "Lee",
        "given": "Daniel W."
      },
      {
        "family": "Gardner",
        "given": "Rebecca"
      },
      {
        "family": "Porter",
        "given": "David L."
      },
      {
        "family": "Louis",
        "given": "Chrystal U."
      },
      {
        "family": "Ahmed",
        "given": "Nabil"
      },
      {
        "family": "Jensen",
        "given": "Michael"
      },
      {
        "family": "Grupp",
        "given": "Stephan A."
      },
      {
        "family": "Mackall",
        "given": "Crystal L."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2014,
          7,
          10
        ]
      ]
    },
    "abstract": "As immune-based therapies for cancer become potent, more effective, and more widely available, optimal management of their unique toxicities becomes increasingly important. Cytokine release syndrome (CRS) is a potentially life-threatening toxicity that has been observed following administration of natural and bispecific antibodies and, more recently, following adoptive T-cell therapies for cancer. CRS is associated with elevated circulating levels of several cytokines including interleukin (IL)-6 and interferon γ, and uncontrolled studies demonstrate that immunosuppression using tocilizumab, an anti-IL-6 receptor antibody, with or without corticosteroids, can reverse the syndrome. However, because early and aggressive immunosuppression could limit the efficacy of the immunotherapy, current approaches seek to limit administration of immunosuppressive therapy to patients at risk for life-threatening consequences of the syndrome. This report presents a novel system to grade the severity of CRS in individual patients and a treatment algorithm for management of CRS based on severity. The goal of our approach is to maximize the chance for therapeutic benefit from the immunotherapy while minimizing the risk for life threatening complications of CRS.",
    "container-title": "Blood",
    "DOI": "10.1182/blood-2014-05-552729",
    "volume": "124",
    "issue": "2",
    "page": "188-195",
    "publisher": "American Society of Hematology",
    "title": "Current concepts in the diagnosis and management of cytokine release syndrome",
    "URL": "https://doi.org/ggsrwk",
    "PMCID": "PMC4093680",
    "PMID": "24876563",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1182/blood-2014-05-552729\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: H70g2GF9"
  },
  {
    "type": "article-journal",
    "id": "nEaG534R",
    "author": [
      {
        "family": "Müller-Calleja",
        "given": "Nadine"
      },
      {
        "family": "Manukyan",
        "given": "Davit"
      },
      {
        "family": "Ruf",
        "given": "Wolfram"
      },
      {
        "family": "Lackner",
        "given": "Karl"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2016,
          12,
          2
        ]
      ]
    },
    "container-title": "Blood",
    "DOI": "10.1182/blood.v128.22.5023.5023",
    "volume": "128",
    "issue": "22",
    "page": "5023-5023",
    "publisher": "American Society of Hematology",
    "title": "Mechanism of Action of Hydroxychloroquine in the Antiphospholipid Syndrome",
    "URL": "https://doi.org/ggrm82",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1182/blood.v128.22.5023.5023\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: nEaG534R"
  },
  {
    "type": "article-journal",
    "id": "11fgsEIDI",
    "author": [
      {
        "family": "Sibila",
        "given": "O."
      },
      {
        "family": "Agusti",
        "given": "C."
      },
      {
        "family": "Torres",
        "given": "A."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2008,
          3,
          19
        ]
      ]
    },
    "container-title": "European Respiratory Journal",
    "DOI": "10.1183/09031936.00154107",
    "volume": "32",
    "issue": "2",
    "page": "259-264",
    "publisher": "European Respiratory Society (ERS)",
    "title": "Corticosteroids in severe pneumonia",
    "URL": "https://doi.org/bmdrvg",
    "PMID": "18669784",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1183/09031936.00154107"
  },
  {
    "type": "article-journal",
    "id": "LDQlolY3",
    "author": [
      {
        "family": "Tobinick",
        "given": "Edward"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2008,
          9,
          22
        ]
      ]
    },
    "container-title": "Current Medical Research and Opinion",
    "DOI": "10.1185/030079903125002757",
    "volume": "20",
    "issue": "1",
    "page": "39-40",
    "publisher": "Informa Healthcare",
    "title": "TNF-α inhibition for potential therapeutic modulation of SARS coronavirus infection",
    "URL": "https://doi.org/bq4cx2",
    "PMID": "14741070",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1185/030079903125002757\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: LDQlolY3"
  },
  {
    "type": "article-journal",
    "id": "ggYRK4FU",
    "author": [
      {
        "family": "Ashfaq",
        "given": "Usman A"
      },
      {
        "family": "Javed",
        "given": "Tariq"
      },
      {
        "family": "Rehman",
        "given": "Sidra"
      },
      {
        "family": "Nawaz",
        "given": "Zafar"
      },
      {
        "family": "Riazuddin",
        "given": "Sheikh"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2011,
          4,
          12
        ]
      ]
    },
    "container-title": "Virology Journal",
    "DOI": "10.1186/1743-422x-8-163",
    "volume": "8",
    "issue": "1",
    "page": "163",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Lysosomotropic agents as HCV entry inhibitors",
    "URL": "https://doi.org/dr5g4m",
    "PMCID": "PMC3090357",
    "PMID": "21481279",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1186/1743-422x-8-163\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: ggYRK4FU"
  },
  {
    "type": "article-journal",
    "id": "KGBLpge1",
    "author": [
      {
        "family": "Fernández-Serrano",
        "given": "Silvia"
      },
      {
        "family": "Dorca",
        "given": "Jordi"
      },
      {
        "family": "Garcia-Vidal",
        "given": "Carolina"
      },
      {
        "family": "Fernández-Sabé",
        "given": "Núria"
      },
      {
        "family": "Carratalà",
        "given": "Jordi"
      },
      {
        "family": "Fernández-Agüera",
        "given": "Ana"
      },
      {
        "family": "Corominas",
        "given": "Mercè"
      },
      {
        "family": "Padrones",
        "given": "Susana"
      },
      {
        "family": "Gudiol",
        "given": "Francesc"
      },
      {
        "family": "Manresa",
        "given": "Frederic"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2011
        ]
      ]
    },
    "container-title": "Critical Care",
    "DOI": "10.1186/cc10103",
    "volume": "15",
    "issue": "2",
    "page": "R96",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial",
    "URL": "https://doi.org/c8ksgr",
    "PMCID": "PMC3219361",
    "PMID": "21406101",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1186/cc10103"
  },
  {
    "type": "article-journal",
    "id": "1AKi0FYUB",
    "author": [
      {
        "family": "Lu",
        "given": "Ruei-Min"
      },
      {
        "family": "Hwang",
        "given": "Yu-Chyi"
      },
      {
        "family": "Liu",
        "given": "I-Ju"
      },
      {
        "family": "Lee",
        "given": "Chi-Chiu"
      },
      {
        "family": "Tsai",
        "given": "Han-Zen"
      },
      {
        "family": "Li",
        "given": "Hsin-Jung"
      },
      {
        "family": "Wu",
        "given": "Han-Chung"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          1,
          2
        ]
      ]
    },
    "abstract": "It has been more than three decades since the first monoclonal antibody was approved by the United States Food and Drug Administration (US FDA) in 1986, and during this time, antibody engineering has dramatically evolved. Current antibody drugs have increasingly fewer adverse effects due to their high specificity. As a result, therapeutic antibodies have become the predominant class of new drugs developed in recent years. Over the past five years, antibodies have become the best-selling drugs in the pharmaceutical market, and in 2018, eight of the top ten bestselling drugs worldwide were biologics. The global therapeutic monoclonal antibody market was valued at approximately US$115.2 billion in 2018 and is expected to generate revenue of $150 billion by the end of 2019 and $300 billion by 2025. Thus, the market for therapeutic antibody drugs has experienced explosive growth as new drugs have been approved for treating various human diseases, including many cancers, autoimmune, metabolic and infectious diseases. As of December 2019, 79 therapeutic mAbs have been approved by the US FDA, but there is still significant growth potential. This review summarizes the latest market trends and outlines the preeminent antibody engineering technologies used in the development of therapeutic antibody drugs, such as humanization of monoclonal antibodies, phage display, the human antibody mouse, single B cell antibody technology, and affinity maturation. Finally, future applications and perspectives are also discussed.",
    "container-title": "Journal of Biomedical Science",
    "DOI": "10.1186/s12929-019-0592-z",
    "volume": "27",
    "issue": "1",
    "page": "1",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Development of therapeutic antibodies for the treatment of diseases",
    "URL": "https://doi.org/ggqbpx",
    "PMCID": "PMC6939334",
    "PMID": "31894001",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1186/s12929-019-0592-z\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 1AKi0FYUB"
  },
  {
    "type": "article-journal",
    "id": "SiOKIbl3",
    "author": [
      {
        "family": "Fu",
        "given": "Binqing"
      },
      {
        "family": "Xu",
        "given": "Xiaoling"
      },
      {
        "family": "Wei",
        "given": "Haiming"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4,
          14
        ]
      ]
    },
    "container-title": "Journal of Translational Medicine",
    "DOI": "10.1186/s12967-020-02339-3",
    "volume": "18",
    "issue": "1",
    "page": "164",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Why tocilizumab could be an effective treatment for severe COVID-19?",
    "URL": "https://doi.org/ggv5c8",
    "PMCID": "PMC7154566",
    "PMID": "32290839",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1186/s12967-020-02339-3\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: SiOKIbl3"
  },
  {
    "type": "article-journal",
    "id": "epRQ9yZu",
    "author": [
      {
        "family": "Tzotzos",
        "given": "Susan J."
      },
      {
        "family": "Fischer",
        "given": "Bernhard"
      },
      {
        "family": "Fischer",
        "given": "Hendrik"
      },
      {
        "family": "Zeitlinger",
        "given": "Markus"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          8,
          21
        ]
      ]
    },
    "container-title": "Critical Care",
    "DOI": "10.1186/s13054-020-03240-7",
    "volume": "24",
    "issue": "1",
    "page": "516",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey",
    "URL": "https://doi.org/gh294r",
    "PMCID": "PMC7441837",
    "PMID": "32825837",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1186/s13054-020-03240-7"
  },
  {
    "type": "article-journal",
    "id": "15JYG0AIU",
    "author": [
      {
        "family": "Yang",
        "given": "Haitao"
      },
      {
        "family": "Xie",
        "given": "Weiqing"
      },
      {
        "family": "Xue",
        "given": "Xiaoyu"
      },
      {
        "family": "Yang",
        "given": "Kailin"
      },
      {
        "family": "Ma",
        "given": "Jing"
      },
      {
        "family": "Liang",
        "given": "Wenxue"
      },
      {
        "family": "Zhao",
        "given": "Qi"
      },
      {
        "family": "Zhou",
        "given": "Zhe"
      },
      {
        "family": "Pei",
        "given": "Duanqing"
      },
      {
        "family": "Ziebuhr",
        "given": "John"
      },
      {
        "family": "Hilgenfeld",
        "given": "Rolf"
      },
      {
        "family": "Yuen",
        "given": "Kwok Yung"
      },
      {
        "family": "Wong",
        "given": "Luet"
      },
      {
        "family": "Gao",
        "given": "Guangxia"
      },
      {
        "family": "Chen",
        "given": "Saijuan"
      },
      {
        "family": "Chen",
        "given": "Zhu"
      },
      {
        "family": "Ma",
        "given": "Dawei"
      },
      {
        "family": "Bartlam",
        "given": "Mark"
      },
      {
        "family": "Rao",
        "given": "Zihe"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2005,
          9,
          6
        ]
      ]
    },
    "container-title": "PLoS Biology",
    "DOI": "10.1371/journal.pbio.0030324",
    "volume": "3",
    "issue": "10",
    "page": "e324",
    "publisher": "Public Library of Science (PLoS)",
    "title": "Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases",
    "URL": "https://doi.org/bcm9k7",
    "PMCID": "PMC1197287",
    "PMID": "16128623",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1371/journal.pbio.0030324\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 15JYG0AIU"
  },
  {
    "type": "article-journal",
    "id": "jJCnee9O",
    "author": [
      {
        "family": "Stockman",
        "given": "Lauren J"
      },
      {
        "family": "Bellamy",
        "given": "Richard"
      },
      {
        "family": "Garner",
        "given": "Paul"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2006,
          9,
          12
        ]
      ]
    },
    "container-title": "PLoS Medicine",
    "DOI": "10.1371/journal.pmed.0030343",
    "volume": "3",
    "issue": "9",
    "page": "e343",
    "publisher": "Public Library of Science (PLoS)",
    "title": "SARS: Systematic Review of Treatment Effects",
    "URL": "https://doi.org/d7xwh2",
    "PMCID": "PMC1564166",
    "PMID": "16968120",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1371/journal.pmed.0030343"
  },
  {
    "type": "article-journal",
    "id": "yl2THbEA",
    "author": [
      {
        "family": "Nie",
        "given": "Wei"
      },
      {
        "family": "Zhang",
        "given": "Yi"
      },
      {
        "family": "Cheng",
        "given": "Jinwei"
      },
      {
        "family": "Xiu",
        "given": "Qingyu"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2012,
          10,
          24
        ]
      ]
    },
    "container-title": "PLoS ONE",
    "DOI": "10.1371/journal.pone.0047926",
    "volume": "7",
    "issue": "10",
    "page": "e47926",
    "publisher": "Public Library of Science (PLoS)",
    "title": "Corticosteroids in the Treatment of Community-Acquired Pneumonia in Adults: A Meta-Analysis",
    "URL": "https://doi.org/gj3jh5",
    "PMCID": "PMC3480455",
    "PMID": "23112872",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1371/journal.pone.0047926"
  },
  {
    "type": "article-journal",
    "id": "ukZRKllk",
    "author": [
      {
        "family": "Jin",
        "given": "Zhinan"
      },
      {
        "family": "Smith",
        "given": "Lucas K."
      },
      {
        "family": "Rajwanshi",
        "given": "Vivek K."
      },
      {
        "family": "Kim",
        "given": "Baek"
      },
      {
        "family": "Deval",
        "given": "Jerome"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2013,
          7,
          10
        ]
      ]
    },
    "container-title": "PLoS ONE",
    "DOI": "10.1371/journal.pone.0068347",
    "volume": "8",
    "issue": "7",
    "page": "e68347",
    "publisher": "Public Library of Science (PLoS)",
    "title": "The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus Polymerase",
    "URL": "https://doi.org/f5br92",
    "PMCID": "PMC3707847",
    "PMID": "23874596",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1371/journal.pone.0068347\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: ukZRKllk"
  },
  {
    "type": "article-journal",
    "id": "16mSlRgM3",
    "author": [
      {
        "family": "Zhang",
        "given": "Bicheng"
      },
      {
        "family": "Zhou",
        "given": "Xiaoyang"
      },
      {
        "family": "Qiu",
        "given": "Yanru"
      },
      {
        "family": "Song",
        "given": "Yuxiao"
      },
      {
        "family": "Feng",
        "given": "Fan"
      },
      {
        "family": "Feng",
        "given": "Jia"
      },
      {
        "family": "Song",
        "given": "Qibin"
      },
      {
        "family": "Jia",
        "given": "Qingzhu"
      },
      {
        "family": "Wang",
        "given": "Jun"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          7,
          9
        ]
      ]
    },
    "container-title": "PLOS ONE",
    "DOI": "10.1371/journal.pone.0235458",
    "volume": "15",
    "issue": "7",
    "page": "e0235458",
    "publisher": "Public Library of Science (PLoS)",
    "title": "Clinical characteristics of 82 cases of death from COVID-19",
    "URL": "https://doi.org/gg4sgx",
    "PMCID": "PMC7347130",
    "PMID": "32645044",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1371/journal.pone.0235458\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 16mSlRgM3"
  },
  {
    "type": "article-journal",
    "id": "DWCwruB0",
    "author": [
      {
        "family": "Calfee",
        "given": "Carolyn S."
      },
      {
        "family": "Matthay",
        "given": "Michael A."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2007,
          3
        ]
      ]
    },
    "container-title": "Chest",
    "DOI": "10.1378/chest.06-1743",
    "volume": "131",
    "issue": "3",
    "page": "913-920",
    "publisher": "Elsevier BV",
    "title": "Nonventilatory Treatments for Acute Lung Injury and ARDS",
    "URL": "https://doi.org/bqzn5v",
    "PMCID": "PMC2789489",
    "PMID": "17356114",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1378/chest.06-1743"
  },
  {
    "type": "article-journal",
    "id": "vx02q3mZ",
    "author": [
      {
        "family": "Meduri",
        "given": "G. Umberto"
      },
      {
        "family": "Marik",
        "given": "Paul E."
      },
      {
        "family": "Pastores",
        "given": "Stephen M."
      },
      {
        "family": "Annane",
        "given": "Djillali"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2007,
          9
        ]
      ]
    },
    "container-title": "Chest",
    "DOI": "10.1378/chest.07-0714",
    "volume": "132",
    "issue": "3",
    "page": "1093-1094",
    "publisher": "Elsevier BV",
    "title": "Corticosteroids in ARDS",
    "URL": "https://doi.org/cjdz2d",
    "PMID": "17873207",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1378/chest.07-0714"
  },
  {
    "type": "article-journal",
    "id": "M4yLbwsC",
    "author": [
      {
        "family": "Breiden",
        "given": "Bernadette"
      },
      {
        "family": "Sandhoff",
        "given": "Konrad"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          12,
          18
        ]
      ]
    },
    "abstract": "Drug-induced phospholipidosis is a lysosomal storage disorder characterized by excessive accumulation of phospholipids. Its cellular mechanism is still not well understood, but it is known that cationic amphiphilic drugs can induce it. These drugs have a hydrophilic amine head group that can be protonated in the endolysosomal compartment. As cationic amphiphiles, they are trapped in lysosomes, where they interfere with negatively charged intralysosomal vesicles, the major platforms of cellular sphingolipid degradation. Metabolic principles observed in sphingolipid and phospholipid catabolism and inherited sphingolipidoses are of great importance for lysosomal function and physiological lipid turnover at large. Therefore, we also propose intralysosomal vesicles as major platforms for degradation of lipids and phospholipids reaching them by intracellular pathways like autophagy and endocytosis. Phospholipids are catabolized as components of vesicle surfaces by protonated, positively charged phospholipases, electrostatically attracted to the negatively charged vesicles. Model experiments suggest that progressively accumulating cationic amphiphilic drugs inserting into the vesicle membrane with their hydrophobic molecular moieties disturb and attenuate the main mechanism of lipid degradation as discussed here. By compensating the negative surface charge, cationic enzymes are released from the surface of vesicles and proteolytically degraded, triggering a progressive lipid storage and the formation of inactive lamellar bodies.",
    "container-title": "Biological Chemistry",
    "DOI": "10.1515/hsz-2019-0270",
    "volume": "401",
    "issue": "1",
    "page": "31-46",
    "publisher": "Walter de Gruyter GmbH",
    "title": "Emerging mechanisms of drug-induced phospholipidosis",
    "URL": "https://doi.org/gjkv8x",
    "PMID": "31408430",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.1515/hsz-2019-0270"
  },
  {
    "type": "article-journal",
    "id": "MTcTiS7i",
    "author": [
      {
        "family": "Prabakaran",
        "given": "Ponraj"
      },
      {
        "family": "Zhu",
        "given": "Zhongyu"
      },
      {
        "family": "Xiao",
        "given": "Xiaodong"
      },
      {
        "family": "Biragyn",
        "given": "Arya"
      },
      {
        "family": "Dimitrov",
        "given": "Antony S"
      },
      {
        "family": "Broder",
        "given": "Christopher C"
      },
      {
        "family": "Dimitrov",
        "given": "Dimiter S"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2009,
          4,
          8
        ]
      ]
    },
    "container-title": "Expert Opinion on Biological Therapy",
    "DOI": "10.1517/14712590902763755",
    "volume": "9",
    "issue": "3",
    "page": "355-368",
    "publisher": "Informa Healthcare",
    "title": "Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses",
    "URL": "https://doi.org/b88kw8",
    "PMCID": "PMC2705284",
    "PMID": "19216624",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.1517/14712590902763755\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: MTcTiS7i"
  },
  {
    "type": "article-journal",
    "id": "1BVslkmfk",
    "author": [
      {
        "family": "Bian",
        "given": "Boyang"
      },
      {
        "family": "Kelton",
        "given": "Christina M.L."
      },
      {
        "family": "Guo",
        "given": "Jeff J."
      },
      {
        "family": "Wigle",
        "given": "Patricia R."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2010,
          11
        ]
      ]
    },
    "container-title": "Journal of Managed Care Pharmacy",
    "DOI": "10.18553/jmcp.2010.16.9.671",
    "volume": "16",
    "issue": "9",
    "page": "671-679",
    "publisher": "Academy of Managed Care Pharmacy",
    "title": "ACE Inhibitor and ARB Utilization and Expenditures in the Medicaid Fee-For-Service Program from 1991 to 2008",
    "URL": "https://doi.org/gh294c",
    "PMID": "21067253",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.18553/jmcp.2010.16.9.671"
  },
  {
    "type": "article-journal",
    "id": "g9k7N6ig",
    "author": [
      {
        "family": "Diamond",
        "given": "Michael"
      },
      {
        "family": "Chen",
        "given": "Rita"
      },
      {
        "family": "Xie",
        "given": "Xuping"
      },
      {
        "family": "Case",
        "given": "James"
      },
      {
        "family": "Zhang",
        "given": "Xianwen"
      },
      {
        "family": "VanBlargan",
        "given": "Laura"
      },
      {
        "family": "Liu",
        "given": "Yang"
      },
      {
        "family": "Liu",
        "given": "Jianying"
      },
      {
        "family": "Errico",
        "given": "John"
      },
      {
        "family": "Winkler",
        "given": "Emma"
      },
      {
        "family": "Suryadevara",
        "given": "Naveenchandra"
      },
      {
        "family": "Tahan",
        "given": "Stephen"
      },
      {
        "family": "Turner",
        "given": "Jackson"
      },
      {
        "family": "Kim",
        "given": "Wooseob"
      },
      {
        "family": "Schmitz",
        "given": "Aaron"
      },
      {
        "family": "Thapa",
        "given": "Mahima"
      },
      {
        "family": "Wang",
        "given": "David"
      },
      {
        "family": "Boon",
        "given": "Andrianus"
      },
      {
        "family": "Pinto",
        "given": "Dora"
      },
      {
        "family": "Presti",
        "given": "Rachel"
      },
      {
        "family": "O’Halloran",
        "given": "Jane"
      },
      {
        "family": "Kim",
        "given": "Alfred"
      },
      {
        "family": "Deepak",
        "given": "Parakkal"
      },
      {
        "family": "Fremont",
        "given": "Daved"
      },
      {
        "family": "Corti",
        "given": "Davide"
      },
      {
        "family": "Virgin",
        "given": "Herbert"
      },
      {
        "family": "Crowe",
        "given": "James"
      },
      {
        "family": "Droit",
        "given": "Lindsay"
      },
      {
        "family": "Ellebedy",
        "given": "Ali"
      },
      {
        "family": "Shi",
        "given": "Pei-Yong"
      },
      {
        "family": "Gilchuk",
        "given": "Pavlo"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          2,
          9
        ]
      ]
    },
    "abstract": "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the global COVID-19 pandemic infecting more than 106 million people and causing 2.3 million deaths. The rapid deployment of antibody-based countermeasures has provided hope for curtailing disease and ending the pandemic . However, the emergence of rapidly-spreading SARS-CoV-2 variants in the United Kingdom (B.1.1.7), South Africa (B.1.351), and elsewhere with mutations in the spike protein has raised concern for escape from neutralizing antibody responses and loss of vaccine efficacy based on preliminary data with pseudoviruses . Here, using monoclonal antibodies (mAbs), animal immune sera, human convalescent sera, and human sera from recipients of the Pfizer-BioNTech (BNT162b2) mRNA vaccine, we report the impact on antibody neutralization of a panel of authentic SARS-CoV-2 variants including a B.1.1.7 isolate, a chimeric Washington strain with a South African spike gene (Wash SA-B.1.351), and isogenic recombinant variants with designed mutations or deletions at positions 69-70, 417, 484, 501, and/or 614 of the spike protein. Several highly neutralizing mAbs engaging the receptor binding domain (RBD) or N-terminal domain (NTD) lost inhibitory activity against Wash SA-B.1.351 or recombinant variants with an E484K spike mutation. Most convalescent sera and virtually all mRNA vaccine-induced immune sera tested showed markedly diminished neutralizing activity against the Wash SA-B.1.351 strain or recombinant viruses containing mutations at position 484 and 501. We also noted that cell line selection used for growth of virus stocks or neutralization assays can impact the potency of antibodies against different SARS-CoV-2 variants, which has implications for assay standardization and congruence of results across laboratories. As several antibodies binding specific regions of the RBD and NTD show loss-of-neutralization potency against emerging variants, updated mAb cocktails, targeting of highly conserved regions, enhancement of mAb potency, or adjustments to the spike sequences of vaccines may be needed to prevent loss of protection .",
    "container-title": "Research Square Platform LLC",
    "DOI": "10.21203/rs.3.rs-228079/v1",
    "publisher": "Research Square Platform LLC",
    "title": "SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodies",
    "URL": "https://doi.org/gh4sjz",
    "PMCID": "PMC7885928",
    "PMID": "33594356",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.21203/rs.3.rs-228079/v1"
  },
  {
    "type": "article-journal",
    "id": "3yV2bL9S",
    "author": [
      {
        "family": "Watad",
        "given": "Abdulla"
      },
      {
        "family": "Bragazzi",
        "given": "Nicola Luigi"
      },
      {
        "family": "Bridgewood",
        "given": "Charlie"
      },
      {
        "family": "Mansour",
        "given": "Muhammad"
      },
      {
        "family": "Mahroum",
        "given": "Naim"
      },
      {
        "family": "Riccò",
        "given": "Matteo"
      },
      {
        "family": "Nasr",
        "given": "Ahmed"
      },
      {
        "family": "Hussein",
        "given": "Amr"
      },
      {
        "family": "Gendelman",
        "given": "Omer"
      },
      {
        "family": "Shoenfeld",
        "given": "Yehuda"
      },
      {
        "family": "Lindar",
        "given": "Merav"
      },
      {
        "family": "Amital",
        "given": "Howard"
      },
      {
        "family": "Wu",
        "given": "Jianhong"
      },
      {
        "family": "McGonagle",
        "given": "Dennis"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020
        ]
      ]
    },
    "container-title": "SSRN Electronic Journal",
    "DOI": "10.2139/ssrn.3642653",
    "publisher": "Elsevier BV",
    "title": "Systematic Review and Meta-Analysis of Case-Control Studies from 7,000 COVID-19 Pneumonia Patients Suggests a Beneficial Impact of Tocilizumab with Benefit Most Evident in Non-Corticosteroid Exposed Subjects.",
    "URL": "https://doi.org/gg62hz",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.2139/ssrn.3642653\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 3yV2bL9S"
  },
  {
    "type": "article-journal",
    "id": "26dpptLw",
    "author": [
      {
        "family": "Kido",
        "given": "Hiroshi"
      },
      {
        "family": "Okumura",
        "given": "Yuushi"
      },
      {
        "family": "Yamada",
        "given": "Hiroshi"
      },
      {
        "family": "Quang Le",
        "given": "Trong"
      },
      {
        "family": "Yano",
        "given": "Mihiro"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2007,
          2,
          1
        ]
      ]
    },
    "container-title": "Current Pharmaceutical Design",
    "DOI": "10.2174/138161207780162971",
    "volume": "13",
    "issue": "4",
    "page": "405-414",
    "publisher": "Bentham Science Publishers Ltd.",
    "title": "Proteases Essential for Human Influenza Virus Entry into Cells and Their Inhibitors as Potential Therapeutic Agents",
    "URL": "https://doi.org/bts3xp",
    "PMID": "17311557",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.2174/138161207780162971\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 26dpptLw"
  },
  {
    "type": "article-journal",
    "id": "OgYDNJt3",
    "author": [
      {
        "family": "Baumann",
        "given": "A."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2006,
          1,
          1
        ]
      ]
    },
    "container-title": "Current Drug Metabolism",
    "DOI": "10.2174/138920006774832604",
    "volume": "7",
    "issue": "1",
    "page": "15-21",
    "publisher": "Bentham Science Publishers Ltd.",
    "title": "Early Development of Therapeutic Biologics - Pharmacokinetics",
    "URL": "https://doi.org/bhcz79",
    "PMID": "16454690",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.2174/138920006774832604\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: OgYDNJt3"
  },
  {
    "type": "article-journal",
    "id": "14p3btkRH",
    "author": [
      {
        "family": "FURUTA",
        "given": "Yousuke"
      },
      {
        "family": "KOMENO",
        "given": "Takashi"
      },
      {
        "family": "NAKAMURA",
        "given": "Takaaki"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017
        ]
      ]
    },
    "container-title": "Proceedings of the Japan Academy, Series B",
    "DOI": "10.2183/pjab.93.027",
    "volume": "93",
    "issue": "7",
    "page": "449-463",
    "publisher": "Japan Academy",
    "title": "Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase",
    "URL": "https://doi.org/gbxcxw",
    "PMCID": "PMC5713175",
    "PMID": "28769016",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.2183/pjab.93.027\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 14p3btkRH"
  },
  {
    "type": "article-journal",
    "id": "k5xEN3Ke",
    "author": [
      {
        "family": "Sparks",
        "given": "Matthew A."
      },
      {
        "family": "South",
        "given": "Andrew"
      },
      {
        "family": "Welling",
        "given": "Paul"
      },
      {
        "family": "Luther",
        "given": "J. Matt"
      },
      {
        "family": "Cohen",
        "given": "Jordana"
      },
      {
        "family": "Byrd",
        "given": "James Brian"
      },
      {
        "family": "Burrell",
        "given": "Louise M."
      },
      {
        "family": "Batlle",
        "given": "Daniel"
      },
      {
        "family": "Tomlinson",
        "given": "Laurie"
      },
      {
        "family": "Bhalla",
        "given": "Vivek"
      },
      {
        "family": "Rheault",
        "given": "Michelle N."
      },
      {
        "family": "Soler",
        "given": "María José"
      },
      {
        "family": "Swaminathan",
        "given": "Sundar"
      },
      {
        "family": "Hiremath",
        "given": "Swapnil"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          5,
          7
        ]
      ]
    },
    "container-title": "Clinical Journal of the American Society of Nephrology",
    "DOI": "10.2215/cjn.03530320",
    "volume": "15",
    "issue": "5",
    "page": "714-716",
    "publisher": "American Society of Nephrology (ASN)",
    "title": "Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19",
    "URL": "https://doi.org/ggq8gn",
    "PMCID": "PMC7269218",
    "PMID": "32220930",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.2215/cjn.03530320\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: k5xEN3Ke"
  },
  {
    "id": "EgvIETTq",
    "type": "article-journal",
    "title": "Dexamethasone for COVID-19? Not so fast.",
    "container-title": "JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS",
    "volume": "34",
    "issue": "4",
    "source": "DOI.org (CSL JSON)",
    "URL": "https://doi.org/ghfkjx",
    "DOI": "10.23812/20-editorial_1-5",
    "ISSN": "0393-974X",
    "shortTitle": "Dexamethasone for COVID-19?",
    "journalAbbreviation": "J Biol Regul Homeost Agents",
    "language": "eng",
    "author": [
      {
        "family": "Theoharides",
        "given": "T.C."
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2020",
          8,
          31
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          2,
          8
        ]
      ]
    },
    "PMID": "32551464",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.23812/20-editorial_1-5\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: EgvIETTq"
  },
  {
    "type": "article-journal",
    "id": "1H8o8TFtM",
    "author": [
      {
        "family": "Tanaka",
        "given": "Toshio"
      },
      {
        "family": "Narazaki",
        "given": "Masashi"
      },
      {
        "family": "Masuda",
        "given": "Kazuya"
      },
      {
        "family": "Kishimoto",
        "given": "Tadamitsu"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2013
        ]
      ]
    },
    "container-title": "Inflammation and Regeneration",
    "DOI": "10.2492/inflammregen.33.054",
    "volume": "33",
    "issue": "1",
    "page": "054-065",
    "publisher": "Japanese Society of Inflammation and Regeneration",
    "title": "Interleukin-6; pathogenesis and treatment of autoimmune inflammatory diseases",
    "URL": "https://doi.org/ggqmgt",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.2492/inflammregen.33.054\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 1H8o8TFtM"
  },
  {
    "type": "article-journal",
    "id": "VXDsRwHC",
    "author": [
      {
        "family": "Luo",
        "given": "Yang"
      },
      {
        "family": "Zheng",
        "given": "Song Guo"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2016,
          12,
          19
        ]
      ]
    },
    "container-title": "Frontiers in Immunology",
    "DOI": "10.3389/fimmu.2016.00604",
    "volume": "7",
    "publisher": "Frontiers Media SA",
    "title": "Hall of Fame among Pro-inflammatory Cytokines: Interleukin-6 Gene and Its Transcriptional Regulation Mechanisms",
    "URL": "https://doi.org/ggqmgv",
    "PMCID": "PMC5165036",
    "PMID": "28066415",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.3389/fimmu.2016.00604\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: VXDsRwHC"
  },
  {
    "type": "article-journal",
    "id": "dUnB3gD6",
    "author": [
      {
        "family": "Iacob",
        "given": "Simona A."
      },
      {
        "family": "Iacob",
        "given": "Diana G."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          11,
          27
        ]
      ]
    },
    "container-title": "Frontiers in Microbiology",
    "DOI": "10.3389/fmicb.2017.02323",
    "volume": "8",
    "page": "2323",
    "publisher": "Frontiers Media SA",
    "title": "Ibalizumab Targeting CD4 Receptors, An Emerging Molecule in HIV Therapy",
    "URL": "https://doi.org/gcn3kh",
    "PMCID": "PMC5711820",
    "PMID": "29230203",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.3389/fmicb.2017.02323\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: dUnB3gD6"
  },
  {
    "type": "article-journal",
    "id": "bOegE5mX",
    "author": [
      {
        "family": "Hua",
        "given": "Jie"
      },
      {
        "family": "Wang",
        "given": "Guohua"
      },
      {
        "family": "Huang",
        "given": "Maolin"
      },
      {
        "family": "Hua",
        "given": "Shuyang"
      },
      {
        "family": "Yang",
        "given": "Shuanghe"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          6,
          3
        ]
      ]
    },
    "abstract": "Virus outbreaks are threats to humanity, and coronaviruses are the latest of many epidemics in the last few decades in the world. SARS-CoV (Severe Acute Respiratory Syndrome Associated Coronavirus) is a member of the coronavirus family, so its study is useful for relevant virus data research. In this work, we conduct a proposed approach that is non-medical/clinical, generate graphs from five features of the SARS outbreak data in five countries and regions, and offer insights from a visual analysis perspective. The results show that prevention measures such as quarantine are the most common control policies used, and areas with strict measures did have fewer peak period days; for instance, Hong Kong handled the outbreak better than other areas. Data conflict issues found with this approach are discussed as well. Visual analysis is also proved to be a useful technique to present the SARS outbreak data at this stage; furthermore, we are proceeding to apply a similar methodology with more features to future COVID-19 research from a visual analysis perfective.",
    "container-title": "International Journal of Environmental Research and Public Health",
    "DOI": "10.3390/ijerph17113973",
    "volume": "17",
    "issue": "11",
    "page": "3973",
    "publisher": "MDPI AG",
    "title": "A Visual Approach for the SARS (Severe Acute Respiratory Syndrome) Outbreak Data Analysis",
    "URL": "https://doi.org/gjqg6z",
    "PMCID": "PMC7312089",
    "PMID": "32503333",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.3390/ijerph17113973"
  },
  {
    "type": "article-journal",
    "id": "Bp847Lfa",
    "author": [
      {
        "family": "Tan",
        "given": "Wenjie"
      },
      {
        "family": "Zhao",
        "given": "Xiang"
      },
      {
        "family": "Ma",
        "given": "Xuejun"
      },
      {
        "family": "Wang",
        "given": "Wenling"
      },
      {
        "family": "Niu",
        "given": "Peihua"
      },
      {
        "family": "Xu",
        "given": "Wenbo"
      },
      {
        "family": "F. Gao",
        "given": "George"
      },
      {
        "family": "Wu",
        "given": "Guizhen"
      },
      {
        "literal": "MHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, China CDC, Beijing, China"
      },
      {
        "literal": "Center for Biosafety Mega-Science, Chinese Academy of Sciences, Beijing, China"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020
        ]
      ]
    },
    "container-title": "China CDC Weekly",
    "DOI": "10.46234/ccdcw2020.017",
    "volume": "2",
    "issue": "4",
    "page": "61-62",
    "publisher": "Chinese Center for Disease Control and Prevention",
    "title": "A Novel Coronavirus Genome Identified in a Cluster of Pneumonia Cases — Wuhan, China 2019−2020",
    "URL": "https://doi.org/gg8z47",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.46234/ccdcw2020.017\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: Bp847Lfa"
  },
  {
    "type": "article-journal",
    "id": "36WPxcLu",
    "author": [
      {
        "family": "Coster",
        "given": "W. J."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2013,
          2,
          22
        ]
      ]
    },
    "container-title": "American Journal of Occupational Therapy",
    "DOI": "10.5014/ajot.2013.006015",
    "volume": "67",
    "issue": "2",
    "page": "162-170",
    "publisher": "AOTA Press",
    "title": "Making the Best Match: Selecting Outcome Measures for Clinical Trials and Outcome Studies",
    "URL": "https://doi.org/f4rf5s",
    "PMCID": "PMC3628620",
    "PMID": "23433270",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.5014/ajot.2013.006015"
  },
  {
    "type": "article-journal",
    "id": "aiItPxSY",
    "author": [
      {
        "family": "Gao",
        "given": "Jianjun"
      },
      {
        "family": "Tian",
        "given": "Zhenxue"
      },
      {
        "family": "Yang",
        "given": "Xu"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          29
        ]
      ]
    },
    "container-title": "BioScience Trends",
    "DOI": "10.5582/bst.2020.01047",
    "volume": "14",
    "issue": "1",
    "page": "72-73",
    "publisher": "International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)",
    "title": "Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies",
    "URL": "https://doi.org/ggm3mv",
    "PMID": "32074550",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.5582/bst.2020.01047\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: aiItPxSY"
  },
  {
    "type": "article-journal",
    "id": "z8XnLYWM",
    "author": [
      {
        "family": "Zheng",
        "given": "Jun"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020
        ]
      ]
    },
    "container-title": "International Journal of Biological Sciences",
    "DOI": "10.7150/ijbs.45053",
    "volume": "16",
    "issue": "10",
    "page": "1678-1685",
    "publisher": "Ivyspring International Publisher",
    "title": "SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat",
    "URL": "https://doi.org/ggqspr",
    "PMCID": "PMC7098030",
    "PMID": "32226285",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.7150/ijbs.45053\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: z8XnLYWM"
  },
  {
    "type": "article-journal",
    "id": "1BdQKtXnY",
    "author": [
      {
        "family": "Yang",
        "given": "Naidi"
      },
      {
        "family": "Shen",
        "given": "Han-Ming"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020
        ]
      ]
    },
    "container-title": "International Journal of Biological Sciences",
    "DOI": "10.7150/ijbs.45498",
    "volume": "16",
    "issue": "10",
    "page": "1724-1731",
    "publisher": "Ivyspring International Publisher",
    "title": "Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19",
    "URL": "https://doi.org/ggqspm",
    "PMCID": "PMC7098027",
    "PMID": "32226290",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.7150/ijbs.45498\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 1BdQKtXnY"
  },
  {
    "type": "article-journal",
    "id": "14xZS2Gic",
    "author": [
      {
        "family": "Rose-John",
        "given": "Stefan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2012
        ]
      ]
    },
    "container-title": "International Journal of Biological Sciences",
    "DOI": "10.7150/ijbs.4989",
    "volume": "8",
    "issue": "9",
    "page": "1237-1247",
    "publisher": "Ivyspring International Publisher",
    "title": "IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6",
    "URL": "https://doi.org/f4c4hf",
    "PMCID": "PMC3491447",
    "PMID": "23136552",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: doi:10.7150/ijbs.4989\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 14xZS2Gic"
  },
  {
    "type": "article-journal",
    "id": "WmK4YTdx",
    "author": [
      {
        "family": "Kaye",
        "given": "Avi Gurion"
      },
      {
        "family": "Siegel",
        "given": "Robert"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          11,
          2
        ]
      ]
    },
    "container-title": "PeerJ",
    "DOI": "10.7717/peerj.10322",
    "volume": "8",
    "page": "e10322",
    "publisher": "PeerJ",
    "title": "The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review",
    "URL": "https://doi.org/ghx8r4",
    "PMCID": "PMC7643559",
    "PMID": "33194450",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.7717/peerj.10322"
  },
  {
    "type": "article-journal",
    "id": "RR3eH1DH",
    "author": [
      {
        "family": "Prager",
        "given": "Ross"
      },
      {
        "family": "Pratte",
        "given": "Michael T"
      },
      {
        "family": "Unni",
        "given": "Rudy R"
      },
      {
        "family": "Bala",
        "given": "Sudarshan"
      },
      {
        "family": "Ng Fat Hing",
        "given": "Nicholas"
      },
      {
        "family": "Wu",
        "given": "Kay"
      },
      {
        "family": "McGrath",
        "given": "Trevor A"
      },
      {
        "family": "Thomas",
        "given": "Adam"
      },
      {
        "family": "Thoma",
        "given": "Brent"
      },
      {
        "family": "Kyeremanteng",
        "given": "Kwadwo"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          2,
          27
        ]
      ]
    },
    "container-title": "Cureus",
    "DOI": "10.7759/cureus.13594",
    "publisher": "Cureus, Inc.",
    "title": "Content Analysis and Characterization of Medical Tweets During the Early Covid-19 Pandemic",
    "URL": "https://doi.org/gjpccg",
    "PMCID": "PMC8007019",
    "PMID": "33815994",
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: doi:10.7759/cureus.13594"
  },
  {
    "id": "o6BQnEt7",
    "type": "book",
    "title": "Molecular biology of the cell",
    "publisher": "Garland Science",
    "publisher-place": "New York",
    "number-of-pages": "1548",
    "edition": "4th ed",
    "source": "Library of Congress ISBN",
    "event-place": "New York",
    "ISBN": "9780815332183",
    "call-number": "QH581.2 .M64 2002",
    "editor": [
      {
        "family": "Alberts",
        "given": "Bruce"
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2002"
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: isbn:9780815332183\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: o6BQnEt7"
  },
  {
    "id": "14gthSuhm",
    "type": "book",
    "title": "Introduction to modern virology",
    "publisher": "Blackwell Pub",
    "publisher-place": "Malden, MA",
    "number-of-pages": "516",
    "edition": "6th ed",
    "source": "Library of Congress ISBN",
    "event-place": "Malden, MA",
    "ISBN": "9781405136457",
    "call-number": "QR360 .D56 2007",
    "note": "OCLC: ocm65207057\nThis CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: isbn:9781405136457\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 14gthSuhm",
    "author": [
      {
        "family": "Dimmock",
        "given": "N. J."
      },
      {
        "family": "Easton",
        "given": "A. J."
      },
      {
        "family": "Leppard",
        "given": "K. N."
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2007"
        ]
      ]
    }
  },
  {
    "title": "Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications.",
    "volume": "108",
    "issue": "5",
    "page": "374-81",
    "container-title": "Proceedings of the Association of American Physicians",
    "container-title-short": "Proc Assoc Am Physicians",
    "ISSN": "1081-650X",
    "issued": {
      "date-parts": [
        [
          1996,
          9
        ]
      ]
    },
    "author": [
      {
        "given": "I J",
        "family": "Elenkov"
      },
      {
        "given": "D A",
        "family": "Papanicolaou"
      },
      {
        "given": "R L",
        "family": "Wilder"
      },
      {
        "given": "G P",
        "family": "Chrousos"
      }
    ],
    "PMID": "8902882",
    "abstract": "Interleukin-12 (IL-12) is a key inducer of differentiation of uncommitted T helper (TH) cells toward the TH1 phenotype, which regulates cellular immunity, whereas IL-10 inhibits TH1 functions and potentiates TH2-regulated responses (i.e., humoral immunity). To examine the potential effects of stress on TH1/TH2 balance, we studied the ability of three prototype stress hormones-dexamethasone (a synthetic glucocorticoid) and the catecholamines norepinephrine and epinephrine-to alter the production of IL-12 (p70) and IL-10 induced by bacterial lipopolysaccharide (LPS) in human whole blood. Dexamethasone inhibited LPS-induced bioactive IL-12 production in a dose-dependent fashion and at physiologically relevant concentrations; it had no effect on IL-10 secretion. The glucocorticoid-induced reduction of IL-12 production was antagonized by RU 486, a glucocorticoid-receptor antagonist, suggesting that it was mediated by the glucocorticoid receptor. Norepinephrine and epinephrine also suppressed IL-12 production in a dose-dependent fashion and at physiological concentrations; both catecholamines, however, dose-dependently increased the production of IL-10. The effects of either catecholamine on IL-12 or IL-10 secretion were blocked completely by propranolol, a beta-adrenoreceptor antagonist, indicating that they were mediated by the beta-adrenergic receptor. These findings suggest that the central nervous system may regulate IL-12 and IL-10 secretion and, hence, TH1/TH2 balance via the peripheral end-effectors of the stress system. Thus, stress may cause a selective suppression of TH1 functions and a shift toward a TH2 cytokine pattern rather than generalized TH suppression. The TH1-to-TH2 shift may be responsible for the stress-induced susceptibility of the organism to certain infections. Through the same or a reciprocal mechanism, states associated with chronic hyperactivity or hypoactivity of the stress system might influence the susceptibility of an individual to certain autoimmune, allergic, infectious, or neoplastic diseases.",
    "URL": "https://www.ncbi.nlm.nih.gov/pubmed/8902882",
    "type": "article-journal",
    "id": "SiXrQUgV",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: pubmed:8902882\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: SiXrQUgV"
  },
  {
    "id": "1FrCknYoc",
    "type": "webpage",
    "title": "GitHub - imdevskp/sars-2003-outbreak-data-webscraping-code: repository contains complete WHO data of 2003 outbreak with code used to web scrap, data mung and cleaning",
    "container-title": "GitHub",
    "abstract": "repository contains complete WHO data of 2003 outbreak with code used to web scrap, data mung and cleaning - GitHub - imdevskp/sars-2003-outbreak-data-webscraping-code: repository contains complete...",
    "URL": "https://github.com/imdevskp/sars-2003-outbreak-data-webscraping-code",
    "shortTitle": "GitHub - imdevskp/sars-2003-outbreak-data-webscraping-code",
    "language": "en",
    "accessed": {
      "date-parts": [
        [
          "2021",
          8,
          13
        ]
      ]
    },
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: url:https://github.com/imdevskp/sars-2003-outbreak-data-webscraping-code"
  },
  {
    "id": "jKRGxazA",
    "type": "webpage",
    "title": "Lilly Begins Clinical Testing of Therapies for COVID-19 | Eli Lilly and Company",
    "URL": "https://investor.lilly.com/news-releases/news-release-details/lilly-begins-clinical-testing-therapies-covid-19",
    "language": "en",
    "accessed": {
      "date-parts": [
        [
          "2021",
          2,
          8
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: url:https://investor.lilly.com/news-releases/news-release-details/lilly-begins-clinical-testing-therapies-covid-19\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: jKRGxazA"
  },
  {
    "id": "hfAF6aDr",
    "type": "post-weblog",
    "title": "Retracted coronavirus (COVID-19) papers",
    "container-title": "Retraction Watch",
    "abstract": "via CDC We’ve been tracking retractions of papers about COVID-19 as part of our database. Here’s a running list, which will be updated as needed. (For some context on these figures, see…",
    "URL": "https://retractionwatch.com/retracted-coronavirus-covid-19-papers/",
    "language": "en-US",
    "issued": {
      "date-parts": [
        [
          "2020",
          4,
          29
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          2,
          8
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: url:https://retractionwatch.com/retracted-coronavirus-covid-19-papers\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: hfAF6aDr"
  },
  {
    "id": "2M8wLShq",
    "type": "webpage",
    "title": "Drug vignettes: Dexamethasone",
    "container-title": "The Centre for Evidence-Based Medicine",
    "abstract": "Robin E Ferner*†, Nicholas DeVito, Jeffrey K Aronson On behalf of the Oxford COVID-19 Evidence Service Team Centre for Evidence-Based",
    "URL": "https://www.cebm.net/covid-19/dexamethasone/",
    "shortTitle": "Drug vignettes",
    "language": "en",
    "accessed": {
      "date-parts": [
        [
          "2021",
          2,
          8
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: url:https://www.cebm.net/covid-19/dexamethasone\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 2M8wLShq"
  },
  {
    "id": "G5cKNGMC",
    "type": "webpage",
    "title": "FDA Clears SPI’s Ebselen For Phase II COVID-19 Trials",
    "container-title": "Contract Pharma",
    "abstract": "SPI-1005 is a novel anti-inflammatory drug which was recently shown to inhibit nCoV2 activity and viral replication.",
    "URL": "https://www.contractpharma.com/contents/view_breaking-news/2020-08-31/fda-clears-spis-ebselen-for-phase-ii-covid-19-trials/",
    "accessed": {
      "date-parts": [
        [
          "2021",
          8,
          13
        ]
      ]
    },
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: url:https://www.contractpharma.com/contents/view_breaking-news/2020-08-31/fda-clears-spis-ebselen-for-phase-ii-covid-19-trials"
  },
  {
    "id": "6FP0Vmy8",
    "type": "webpage",
    "title": "COVID-19: chloroquine and hydroxychloroquine only to be used in clinical trials or emergency use programmes",
    "container-title": "European Medicines Agency",
    "genre": "Text",
    "abstract": "COVID-19: chloroquine and hydroxychloroquine only to be used in clinical trials or emergency use programmes",
    "URL": "https://www.ema.europa.eu/en/news/covid-19-chloroquine-hydroxychloroquine-only-be-used-clinical-trials-emergency-use-programmes",
    "shortTitle": "COVID-19",
    "language": "en",
    "author": [
      {
        "family": "HRABOVSZKI",
        "given": "Georgina"
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2020",
          4,
          1
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          8,
          13
        ]
      ]
    },
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: url:https://www.ema.europa.eu/en/news/covid-19-chloroquine-hydroxychloroquine-only-be-used-clinical-trials-emergency-use-programmes"
  },
  {
    "id": "HGaNhhM7",
    "type": "webpage",
    "title": "Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19",
    "container-title": "FDA",
    "abstract": "The FDA issued an EUA for two monoclonal antibodies to be administered together for treating mild to moderate COVID-19 in adults and pediatric patients.",
    "URL": "https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibodies-treatment-covid-19",
    "shortTitle": "Coronavirus (COVID-19) Update",
    "language": "en",
    "author": [
      {
        "family": "Commissioner",
        "given": "Office",
        "dropping-particle": "of the"
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2020",
          11,
          23
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          8,
          13
        ]
      ]
    },
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: url:https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibodies-treatment-covid-19"
  },
  {
    "id": "1DTFVDWTn",
    "type": "webpage",
    "title": "FDA Approves First Treatment for COVID-19",
    "container-title": "FDA",
    "abstract": "FDA approved Veklury (remdesivir) for adults and pediatric patients 12 years of age and older for the treatment of COVID-19 requiring hospitalization",
    "URL": "https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-covid-19",
    "language": "en",
    "author": [
      {
        "family": "Commissioner",
        "given": "Office",
        "dropping-particle": "of the"
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2020",
          10,
          22
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          2,
          8
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: url:https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-covid-19\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: 1DTFVDWTn"
  },
  {
    "id": "zQT9JLP1",
    "type": "webpage",
    "title": "Gilead Sciences Statement on the Solidarity Trial",
    "URL": "https://www.gilead.com/news-and-press/company-statements/gilead-sciences-statement-on-the-solidarity-trial",
    "language": "en",
    "accessed": {
      "date-parts": [
        [
          "2021",
          2,
          8
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: url:https://www.gilead.com/news-and-press/company-statements/gilead-sciences-statement-on-the-solidarity-trial\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: zQT9JLP1"
  },
  {
    "id": "7fZ9eyMk",
    "URL": "https://www.ncbi.nlm.nih.gov/books/NBK349513/table/T43/",
    "type": "book",
    "title": "Tocilizumab (Actemra): Adult Patients with Moderately to Severely Active Rheumatoid Arthritis",
    "collection-title": "CADTH Common Drug Reviews",
    "publisher": "Canadian Agency for Drugs and Technologies in Health",
    "publisher-place": "Ottawa (ON)",
    "source": "PubMed",
    "event-place": "Ottawa (ON)",
    "abstract": "Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by joint swelling, joint tenderness, and destruction of synovial joints, leading to severe disability and premature mortality. The prevalence of RA in Canada is about 1%. The pharmacological therapy of RA aims to achieve remission and, if remission is not possible, to minimize disease activity while controlling symptoms, halting damage, preventing disability, and improving quality of life. Non-biologic synthetic disease-modifying antirheumatic drugs (DMARDs) have been shown to alter the clinical course of RA and slow or halt radiographic progression when used early and aggressively in the treatment of RA. Methotrexate is the preferred DMARD with respect to efficacy and safety and is recommended as first-line DMARD treatment in patients with RA unless contraindicated or not tolerated. Based on Canadian Rheumatology Association guidelines, if patients do not attain the desired target within three to six months of non-biologic DMARD therapy, treatment with a biologic therapy should be initiated. Tocilizumab (TCZ) is a recombinant humanized anti-human interleukin (IL)-6 receptor monoclonal antibody. It blocks the pleiotropic cytokine IL-6, which is found at high levels in the joints affected by RA. In Canada, TCZ is available as 162 mg/0.9 mL solution in single-use pre-filled syringes for subcutaneous (SC) injection, and in single-use vials containing 80 mg/4 mL, 200 mg/10 mL, or 400 mg/20 mL for intravenous (IV) infusion. The IV formulation of TCZ was previously reviewed by the Canadian Drug Expert Committee for the treatment of RA and received a recommendation to be listed for adults with moderate to severely active RA who have failed to respond to an adequate trial of both DMARDs and a tumour necrosis factor (TNF) alpha inhibitor. The objective of this review was to evaluate the beneficial and harmful effects of the SC formulation of TCZ at recommended doses alone or in combination with methotrexate (MTX) or other DMARDs in adult patients with moderately to severely active RA with an inadequate response to one or more DMARDs and/or TNF alpha inhibitor therapies.",
    "call-number": "NBK349521",
    "shortTitle": "Tocilizumab (Actemra)",
    "language": "eng",
    "issued": {
      "date-parts": [
        [
          "2015",
          8
        ]
      ]
    },
    "note": "Loaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\nstandard_id: url:https://www.ncbi.nlm.nih.gov/books/NBK349513/table/T43"
  },
  {
    "id": "CcEjS89m",
    "type": "webpage",
    "title": "Small Molecules vs Biologics | Drug Development Differences",
    "container-title": "PK / PD and Clinical Pharmacology Consultants",
    "abstract": "Understand the similarities & differences between small molecules and biologics including physiochemical properties, PK/PD, drug-drug interactions & more",
    "URL": "https://www.nuventra.com/resources/blog/small-molecules-versus-biologics/",
    "author": [
      {
        "family": "Parkway",
        "given": "Nuventra Pharma Sciences2525 Meridian"
      },
      {
        "family": "Durham",
        "given": "Suite 200"
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2020",
          5,
          13
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          2,
          8
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: url:https://www.nuventra.com/resources/blog/small-molecules-versus-biologics\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: CcEjS89m"
  },
  {
    "id": "ToVSTZlB",
    "type": "webpage",
    "title": "No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19 — RECOVERY Trial",
    "abstract": "Statement from the Chief Investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on hydroxychloroquine, 5 June 2020",
    "URL": "https://www.recoverytrial.net/news/statement-from-the-chief-investigators-of-the-randomised-evaluation-of-covid-19-therapy-recovery-trial-on-hydroxychloroquine-5-june-2020-no-clinical-benefit-from-use-of-hydroxychloroquine-in-hospitalised-patients-with-covid-19",
    "accessed": {
      "date-parts": [
        [
          "2021",
          8,
          13
        ]
      ]
    },
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: url:https://www.recoverytrial.net/news/statement-from-the-chief-investigators-of-the-randomised-evaluation-of-covid-19-therapy-recovery-trial-on-hydroxychloroquine-5-june-2020-no-clinical-benefit-from-use-of-hydroxychloroquine-in-hospitalised-patients-with-covid-19"
  },
  {
    "id": "pQkqi9ni",
    "type": "webpage",
    "title": "The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug",
    "container-title": "Science | AAAS",
    "abstract": "The Food and Drug Administration held no advisory meeting on antiviral, and the European Union signed contract without knowing of failed trial",
    "URL": "https://www.sciencemag.org/news/2020/10/very-very-bad-look-remdesivir-first-fda-approved-covid-19-drug",
    "language": "en",
    "author": [
      {
        "family": "Cohen",
        "given": "Jon"
      },
      {
        "family": "Kupferschmidt",
        "given": "Kai"
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2020",
          10,
          28
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2021",
          2,
          8
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.4.1 using citation-by-identifier.\nstandard_id: url:https://www.sciencemag.org/news/2020/10/very-very-bad-look-remdesivir-first-fda-approved-covid-19-drug\nLoaded from an external bibliography file by Manubot.\nsource_bibliography: manual-references-2021-02-08.json\noriginal_id: pQkqi9ni"
  },
  {
    "id": "im26z7DR",
    "type": "webpage",
    "title": "Severe Acute Respiratory Syndrome (SARS)",
    "abstract": "There is no cure or vaccine for SARS and treatment should be supportive and based on the patient’s symptoms.",
    "URL": "https://www.who.int/westernpacific/health-topics/severe-acute-respiratory-syndrome",
    "language": "en",
    "accessed": {
      "date-parts": [
        [
          "2021",
          8,
          13
        ]
      ]
    },
    "note": "This CSL Item was generated by Manubot v0.5.1 from its persistent identifier (standard_id).\nstandard_id: url:https://www.who.int/csr/sars/country/en"
  }
]
